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“Much of the difficulties facing the world is because 
 the ignorant are completely safe, and 
the intelligent are full of doubt” 
Bertrand A. W. Russel
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 SUMMARY 
Post-myocardial infarction tissue composition is highly dynamic and can be 
characterized by cardiac magnetic resonance, which has been used to assess 
surrogate outcomes and efficacy endpoints in many experimental and clinical 
studies. However, there is a paucity of studies tracking the temporal dynamics of 
these processes and analyzing their pathophysiology in a comprehensive manner. 
The experimental and clinical work contained in this dissertation shows that the 
degree and extent of post-myocardial infarction tissue composition changes (mainly 
edema; but also necrosis, hemorrhage and microvascular obstruction) as assessed 
by cardiac magnetic resonance are variable according to the time from infarction, 
duration of ischemia, cardioprotective strategies, and the interplay between them. 
These dynamic changes should be taken into consideration when performing image 
acquisition. Comparative studies should be performed at similar timings to avoid the 
bias of these dynamic changes.  
Thus, and in contrast to the accepted view, it is shown for the first time that 
myocardial edema in the week after ischemia/reperfusion is a bimodal phenomenon, 
both in pigs and humans. The initial wave of edema, appearing abruptly upon 
reperfusion and which is significantly attenuated at 24 hours, is due to the 
reperfusion process itself. The deferred wave of edema, appearing progressively 
days after ischemia/reperfusion and reaching a plateau between days 4 to 7, is 
mainly caused by the tissue healing processes.  
These findings highlight the need for standardizing experimental and clinical 
protocols for post-myocardial infarction tissue characterization aiming to quantify 
edema, myocardial area at risk, infarct size, myocardial salvage, intramyocardial 
hemorrhage and microvascular obstruction. The timeframe between day 4 and 7 
post-infarction seems a good compromise solution according to translational data 
here presented. However, further studies and expert consensus are needed to 
stablish more precise recommendations.
 RESUMEN 
La evolución de la composición del tejido miocárdico post-infarto es un proceso muy  
dinámico que se puede caracterizar mediante resonancia magnética cardíaca. Ello 
se ha utilizado para evaluar parámetros de eficacia terapéutica y pronósticos en 
multitud de estudios experimentales y clínicos. Sin embargo, existe una escasez de 
trabajos longitudinales que hayan estudiado de forma detallada la evolución de esta 
dinámica tisular y su fisiopatología. El trabajo experimental y clínico presentado en 
esta tesis demuestra que la severidad y la magnitud de los cambios en la 
composición tisular del miocardio post-infarto (fundamentalmente edema; pero 
también necrosis, hemorragia y obstrucción microvascular) evaluados mediante 
resonancia magnética cardíaca están muy influenciados por el momento temporal 
en que se evalúa al individuo, el tiempo de isquemia, la utilización de estrategias 
cardioprotectoras, y la interacción entre estos factores.  
Así, y contrariamente a la visión establecida, se demuestra por primera vez que el 
edema miocárdico en la semana posterior al proceso de isquemia/reperfusión es 
un fenómeno bimodal, tanto en el modelo porcino como en el ser humano. La onda 
de edema inicial, que aparece abruptamente tras la reperfusión y que se disipa 
alrededor de las 24 horas, está directamente relacionada con el propio proceso de 
reperfusión. La onda de edema posterior, que aparece progresivamente días 
después del proceso de isquemia/reperfusión y alcanza una meseta entre el día 4 
al 7, está originada fundamentalmente por los procesos de cicatrización del tejido. 
Estos hallazgos ponen de relieve la necesidad de estandarizar los protocolos 
experimentales y clínicos de caracterización tisular post-infarto mediante técnicas 
de imagen que tenga por objeto cuantificar el edema miocárdico, el área en riesgo, 
el tamaño del infarto, el área salvada, la hemorragia intramiocárdica, y la 
obstrucción microvascular. En base a los resultados translacionales que aquí se 
presentan, el período de tiempo comprendido entre el día 4 y el 7 después del infarto 
pudiera ser un buen momento para este fin. Sin embargo, se necesitan estudios 
adicionales y un consenso de expertos para establecer recomendaciones más 
precisas. 
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1 INTRODUCTION 
 
1.1 Myocardial infarction: scope of the problem 
1.1.1 Trends in mortality 
Myocardial infarction (MI), presented as ST-segment elevation due to complete 
coronary occlusion of an epicardial coronary artery, is the most severe manifestation 
of ischemic heart disease. Timely reperfusion (blood flow restoration) via 
percutaneous coronary intervention (PCI) and the increased use of adjuvant 
evidence-based pharmacological therapies have been demonstrated as the most 
effective means to reduce the mortality associated with MI.1 Despite a widespread 
implementation of such early invasive strategies, secular trends of mortality 
reduction associated with MI have reached a plateau over the last decade,2 most 
likely due to the changing population of patients undergoing PCI who suffer now 
from additional comorbidities.3 Consequently, MI persists as a major contributor of 
mortality worldwide causing more than a third of deaths in developed nations 
annually,4 suggesting that additional strategies are needed to further reduce 
mortality in this population. 
 
1.1.2 Trends in morbidity 
Paradoxically, the improvement on care delivery systems for patients presenting 
with acute MI has significantly increased the incidence of chronic heart failure (HF):5 
patients with poor post-MI left ventricular function would not have survived to the 
acute phase in the past, but with the advent of reperfusion now survive the index 
episode and continue to live with a significantly damaged heart. Chronic treatment 
of HF represents a huge social and economic burden on individuals and healthcare 
systems.6 Intense research effort has led to interventions (drugs and devices) that 
reduce long-term mortality in survivors with depressed post-MI ventricular function.7 
21
 However, the implementation of these strategies comes at a high cost, precluding 
their universal implementation.8 Therefore, the possibility of preventing (rather than 
treating) post-MI HF by using therapies able to reduce cardiac damage, which will 
eventually result in better heart performance, is of significant clinical and 
socioeconomic value.  
 
1.2 Ischemia/reperfusion injury and cardioprotection 
1.2.1 Concept  
As mentioned before, reperfusion, i.e. blood flow restoration into the ischemic 
territory, is the main available treatment to stop the progression of ischemic damage 
during an acute MI. However, a large body of experimental and clinical literature 
supports the notion that reperfusion induces additional harm to the myocardium, 
known as reperfusion injury.9, 10 Thus, the damage inflicted on the myocardium 
during an MI is better defined as ischemia/reperfusion (I/R) injury, and reperfusion 
injury is nowadays considered “a necessary evil” being responsible for up to 50% of 
the final damage extent.11  
Among others, the main determinants of infarct size are (1) the size of the 
hypoperfused myocardial zone previously perfused by the occluded coronary artery 
(i.e. myocardium at risk, [MaR]); (2) the duration of myocardial ischemia; and (3) the 
implementation of an effective therapy capable of targeting I/R injury and therefore 
reducing cardiac damage. Among the two first determinants, the former is not 
modifiable by definition while the latter has been remarkably reduced and optimized 
over the last decades.2 Consequently, the field of cardioprotection constitutes a 
window of opportunity, and has generated a huge amount of human and economic 
efforts being of scientific and clinical relevance.  
 
1.2.2 Pathophysiology of ischemia/reperfusion injury 
Understanding the pathophysiology and the temporal evolution of events underlying 
myocardial I/R is likely one of the most important first steps before any attempt of 
testing any potential cardioprotective strategy. From a simplistic point of view, the 
typical morphological features of reperfused MI are contraction band necrosis, 
mitochondrial and cardiomyocyte swelling and disruption, accompanied by 
microvascular destruction, interstitial hemorrhage, and inflammation.10 Thus, it has 
22
 been classically described that the infract healing process involves a sequential 
infiltration of neutrophils and macrophages, removal of necrotic myocytes, formation 
of granulation tissue, and collagen deposition intermingled with groups of 
cardiomyocytes.12 The coronary microcirculation plays a critical role in the complex 
processes happening after I/R given that the microcirculatory network is the 
interface between the epicardial coronary artery and the cardiomyocyte.10, 13 Thus, 
no matter how rapidly the blood flow is restored to the culprit epicardial artery; if 
there is microvascular injury, the myocardial tissue will remain without efficient 
perfusion. One of the main contributors to dysfunctional coronary microcirculation is 
the edema that quickly develops in the myocardium within minutes of acute MI. 
Edema induces and external compression to the microcirculation contributing to 
poor perfusion despite patency of the main coronary artery. 
 
1.2.3 Myocardial edema after ischemia/reperfusion 
As with most organs, water is a major component of healthy cardiac tissue. In 
steady-state conditions, myocardial water content is stable and mostly intracellular, 
with only a very small interstitial component. Cardiac edema occurs in numerous 
pathological conditions in which this homeostasis is disrupted, and affects both fluid 
accumulation within cardiomyocytes (intracellular edema) and outside cells 
(interstitial edema).14-16 In the context of I/R, edema appears initially in the form of 
cardiomyocyte swelling during the early stages of ischemia.14 Myocardial edema is 
then significantly exacerbated upon restoration of blood flow to the ischemic area. 
This increase is due to increased cell swelling and, more importantly, to interstitial 
edema secondary to reactive hyperemia and leakage from damaged capillaries 
when the hydrostatic and osmotic pressure is restored upon reperfusion.13  
Finally, the generation of tissue edema following reperfusion can result in external 
compression of the microcirculation, and might be one of the principal causes of 
reduced perfusion capacity of the capillary network after I/R.10 Thus, a profound 
study of the post-MI edematous reaction seems to be crucial in the understanding 
of the complex phenomenon of myocardial I/R and the discovery of effective 
cardioprotective therapies. Likely equally important is the possibility of having 
translational tools able to precisely characterize post-MI tissue composition; 
23
 therefore able to monitor these processes in vivo, quantify the extent of cardiac 
damage and cardioprotection, and predict functional recovery after MI. 
 
1.3 Tissue characterization by cardiac magnetic resonance 
1.3.1 The possibility of performing in vivo pathology 
Histologic evaluation has been classically considered the reference standard for the 
evaluation of myocardial tissue. However, it is poorly suited for serial (or even single) 
measurements into the required follow-up clinical field. Conversely, several non-
invasive imaging modalities have been developed for the characterization of the 
heart, including positron emission tomography, single-photon emission computed 
tomography, and computed tomography. However, it is cardiac magnetic resonance 
(CMR) the tool that probably has captured more attention over the last decades for 
such a purpose given that offers a unique combination of versatility, high spatial 
resolution and high soft tissue contrast with no ionizing radiation.17 Thus, CMR is 
nowadays considered to be able to perform a comprehensive analysis of the post-
MI heart, including in vivo tissue characterization which is considered a surrogate 
for histologic evaluation.  
 
1.3.2 Readouts of ischemia/reperfusion injury and cardioprotection 
Testing the effect of cardioprotective therapies benefits from measuring of MaR and 
infarct size in the same CMR examination session to quantify the amount of 
salvaged myocardium, i.e. % of MaR with no infarction, a theoretical better 
(normalized) surrogate of their effect;18, 19 therefore reducing the sample size 
needed in trials.20 Thus, on the basis of the biological assumptions that (1) an 
intense edematous reaction confined to the post-I/R region appears early after MI 
and persists in stable form for at least 1 week;21, 22 that (2) the entire jeopardized 
myocardium shows a detectable (and homogeneous) edematous reaction, 
regardless of the outcome (death or salvage); and that (3) CMR is able to 
unequivocally detect this edematous reaction retrospectively,23 the use of edema-
sensitive T2-weighted (T2W) CMR sequences to delineate the spatial extent of post-
MI edema was rapidly incorporated as an index of the original occluded coronary 
artery perfusion territory (or MaR).24, 25 Among T2W sequences, dark-blood short-
tau inversion recovery (STIR) methods are well studied and widely used for clinical 
24
 and research purposes.19, 24, 26 Thus, hyperintense areas on T2W-STIR CMR 
imaging have been classically proposed as having a good correlation with post-MI 
edema and, thus, with MaR.25 
On the other hand, and also based on the biological assumption that the necrotic 
tissue extent persists in stable form for at least 1 week, the use of T1-weighted CMR 
sequence with an inversion recovery pre-pulse after the administration of gadolinium 
contrast is an in vivo well stablished reference to measure infarct size,27 with its size 
and distribution being well correlated with remodeling and prognosis.26 
Consequently, CMR-based extent of edema, infarct size and myocardial salvage 
have been and continue to be used as main endpoint in multiple clinical and 
experimental studies at a variety of post-MI time points.28 Finally, there is growing 
evidence that the extent of microvascular injury, i.e. intramyocardial hemorrhage 
(IMH) and microvascular obstruction (MVO), provide important information for 
predicting adverse left ventricular remodeling and clinical events after MI.29-31 
Notably, the degree of IMH and MVO can be quantified as well with CMR, by 
delineating hypointense areas on T2W-STIR and late gadolinium enhancement 
sequences, respectively;32 and are being incorporated progressively in experimental 
research and clinical studies.  
 
1.4 Translational preclinical models of myocardial infarction 
Most of the studies validating CMR against reference histology for in vivo myocardial 
tissue characterization are derived from experimental (preclinical) studies, as it is 
most of the knowledge in regards to the pathophysiology underlying MI and 
cardioprotection.  
Small animal models may help to identify potential mechanisms, but their significant 
anatomic/physiological differences from humans make it challenging to extrapolate 
results to the clinical setting.33 Large animal models exhibit a much closer match to 
human anatomy and physiology making feasible the use of clinically applicable 
imaging technology and methodology; thus, they become a mandatory step before 
initiating human trials.34, 35 For the latter, it is important to select the patients who 
have been shown to derive the most benefit from a cardioprotective strategy applied 
as an adjunct to PCI to reduce MI size; this includes those patients presenting with 
relatively short ischemic time, large MaR, fully occluded coronary artery prior PCI, 
25
 and no significant coronary collaterals.36 Among the larger mammals, pigs and 
primates have little collateral blood flow, whereas cats and especially dogs have a 
sizeable innate collateral circulation; therefore, different species develop myocardial 
necrosis during acute MI at significantly different rates.37 Based on these premises, 
the reperfused acute MI model induced in the swine by closed-chest I/R, via mid left 
anterior descending coronary artery balloon complete occlusion followed by balloon 
deflation and reestablishment of blood flow, has become one of the most 
translational preclinical models of MI.38-41 Nevertheless, tolerance to I/R varies 
notably across different strains or concomitant medication, among others;33 
consequently, it is fair to acknowledge that any preclinical model may have many 
limitations. 
 
1.5 Controversy and research gaps on post-myocardial 
infarction edema 
1.5.1 CMR methods to detect myocardial edema 
As mentioned before, there is particular interest on using T2W CMR to detect and 
track edema since this is a common pathological feature of many cardiovascular 
conditions.14-16 However, it is fair to recognize that dark-blood STIR methods are 
qualitative in nature and present inherent limitations which include variations in 
surface coil sensitivity, motion artifacts, incomplete blood suppression, and the 
subjectivity of image interpretation.42 Adequate slice thickness and some technical 
advances (surface-coil intensity correction algorithms or the use of body coils) may 
help to overcome some of the cons of T2W-STIR imaging.43 However, efforts over 
the last decade have been directed at implementing more robust methods for CMR 
edema imaging.  
In this regard, quantitative T2 mapping methods, which provide direct measurement 
of intrinsic tissue properties in the form of T2 relaxation time that can be compared 
among studies, are less dependent on confounders affecting signal intensity and 
might overthrow some of T2W imaging limitations.44 However, it is noteworthy that 
the relationship between T2 relaxation time and true myocardial water content 
directly quantified in the tissue has been explored in only a few studies conducted 
more than two decades ago.45-49 These studies were performed in low magnetic 
fields or with excised hearts, factors well known to affect T2 relaxation time;50 
26
 therefore the evidence supporting the validity of T2 mapping for the precise 
quantification (degree and spatial extent) of myocardial edema is scarce. In addition, 
some newer mapping methods are either time consuming or require specialized 
software for data acquisition and/or post-processing, factors which limit their routine 
clinical use.  
Based on previous assumptions, we here identified an important gap in knowledge: 
the possibility of validating a CMR T2 mapping method for fast and accurate 
quantification of T2 relaxation time, and consequently myocardial water content, 
which could be easily integrated in daily clinical and research imaging protocols 
would be of great value. 
  
1.5.2 Myocardial edema as marker of the jeopardized myocardium  
As previously mentioned, experimental and clinical studies have relied on the 
pathophysiological assumption that myocardial edema appears early after I/R and 
persists in a stable form for at least 1 week for the use of T2 CMR sequences to 
retrospectively quantify MaR and myocardial salvage.21, 22 Thus, the time chosen for 
the CMR examination varies significantly among studies,28 from several hours or 
days21, 22, 51 to several weeks52 after reperfusion.  
Notably, it is well known that reperfusion, a pre-requisite for myocardial protection 
during infarction, alters post-MI tissue composition and dynamics compared with the 
nonreperfused setting.12 Nonetheless, most current knowledge of the 
pathophysiology and tissue modifications in the post-infarcted myocardium is based 
on observations in nonreperfused hearts. In addition, T2 in the post-ischemic area 
might be affected by the presence of IMH and/or MVO,30, 53 and the implementation 
of cardioprotective therapies able to reduce infarct size like post-conditioning54 and 
remote conditioning.55, 56 Consequently, it is remarkably that despite T2 CMR is 
increasingly used for the detection of myocardial edema, its capacity to 
retrospectively depict the true MaR is a matter of debate.23, 24, 57  
Based on background described before, here we identified another important gap in 
knowledge: the dynamics and pathophysiology of myocardial edema after I/R are 
poorly understood, as they will be the implications of related novel findings for the 
retrospective quantification of MaR and salvage based on edema-based T2 CMR. 
There is therefore a need for a comprehensive myocardial tissue characterization 
27
 study in the context of I/R, comprising both translational CMR imaging methods and 
reference standard measurements. 
 
The work described in this dissertation is focused on the understanding of the above 
mentioned gaps in knowledge, which otherwise we think are essential to make a 
successful translation from the preclinical laboratory to the clinical setting.  
28
  
 
 
 
 
2 OBJECTIVES 
Under the global hypothesis that myocardial edema after I/R is a dynamic 
phenomenon modulated by multiple factors, the main objectives of the present work 
thesis are as follows: 
 
Objective 1. To provide a validation of a CMR method for fast and accurate 
quantification of myocardial edema which could be easily integrated in daily 
protocols. 
 
Objective 2. To study the temporal evolution of myocardial edema, and other 
myocardial tissue components, after I/R in the preclinical setting. 
 
Objective 3. To decipher into the pathophysiology underlying the dynamics of 
myocardial edema after I/R in the preclinical setting. 
 
Objective 4. To study the impact of ischemia duration and protective strategies in 
the temporal dynamics of tissue composition after I/R, and their implications for 
assessing MaR and salvage, in the preclinical setting. 
 
Objective 5. To characterize the temporal evolution of myocardial edema, and its 
implications for assessing MaR and salvage, by CMR in ST-segment elevation MI 
patients undergoing primary PCI. 
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3 MATERIALS, METHODS AND RESULTS 
The doctoral student was first exposed to translational approaches related to I/R, 
cardioprotection and imaging of the post-MI heart by the host institution. This 
capacitation included the opportunity of reviewing literature and writing scientific 
documents, being crucial for a successful achievement of the thesis objectives. 
Outcomes derived from this training phase are reflected as well in this dissertation 
as a key step in the learning process of the scientific research method. Thus, the 
present thesis work has been organized in three chapters as mentioned below. For 
each of the chapters, a brief introduction to the published scientific documents and 
contribution performed by the doctoral student are indicated. 
 
Chapter I. Myocardial infarction: scope, opportunities and challenges. 
 
Chapter II. Translational implementation of cardiac magnetic resonance to the 
post-myocardial infarction heart. 
 
Chapter III. Temporal dynamics and pathophysiology of the edematous response 
after myocardial infarction. 
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 3.1 Chapter I. Myocardial infarction: scope, opportunities and 
challenges  
As an initial step of this research work, a profound review of available literature 
related to the pathophysiology of MI, non-invasive imaging methods for myocardial 
tissue characterization (mainly CMR methods), and translational preclinical models 
of I/R injury and cardioprotection was performed.  
As a result, we have contributed to the literature with 1 review article and 2 editorial 
articles for which I am the first author. For each of the scientific documents, I was 
responsible for reviewing the literature, drafting the manuscript, and elaborating and 
making critical input in the peer review process. 
 
Editorial #1. “Health and cost benefits associated with the use of metoprolol in 
heart attack patients”.58 In this editorial work, a brief overview on the magnitude 
of the MI disease, and current and future socioeconomic challenges are 
discussed in the context of the results from the METOCARD-CNIC trial.51, 59, 60 
This proof-of-concept trial demonstrated that the administration of intravenous 
metoprolol before reperfusion reduces infarct size and the cases of post-MI 
chronic HF, being a promising low-cost an safe therapy likely to have a major 
health and socioeconomic positive impact. The results from this clinical study lead 
by the director of this thesis, Dr Borja Ibanez, constitutes a paradigmatic 
translational success story. Thus, the clinical trial was launched after encouraging 
preclinical results;61 whereas a subsequent journey back to the bench was 
performed after to decipher into the mechanisms behind this protective effect.40, 
62 As it will be shown later, this translational process was replicated in several 
occasions by the doctoral student as part of his research work contained in this 
thesis. 
 
Review article #1. “Animal models of tissue characterization of area at risk, 
edema and fibrosis”.63 This article aims at concisely reviewing recent and 
significant developments in the field of imaging techniques, mainly CMR, in 
relevant animal models of tissue characterization of area at risk, edema, and 
fibrosis. 
32
 Ex vivo histologic analyses of tissue samples have been classically considered 
the gold standard in the study of tissue properties and its composition. However, 
over the past decade, there has been a growing interest in the in vivo myocardial 
characterization with different imaging techniques, which can be potentially 
translated into the clinic in order to make an early diagnosis and evaluate serial 
changes, opening the possibility of dynamic evaluation. Animal models have 
become an essential tool to achieve this goal. Myocardial in vivo tissue 
characterization is of great importance because it can provide translational 
meaningful information to understand pathophysiological processes underlying 
different cardiac diseases.  
 
Editorial #2. “CAESAR: one step beyond in the construction of a translational 
bridge for cardioprotection”.64 Most promising cardioprotective agents have failed 
to replicate the positive results in experimental models in the clinical arena over 
the last decades. In this editorial, a critical discussion on the challenges and 
reasons of such failure are discussed in the context of the initial outcomes from 
the CAESAR initiative.34 Several Working Groups of experts have deeply 
discussed the reasons for the failure to effectively translate potential therapies for 
protecting the heart from I/R, making recommendations to try solving this unmet 
research need.35, 65 The United States of America initiative included the creation 
of a national network of research laboratories with expertise in small and large 
animal models of I/R injury to systematically test a particular cardioprotective 
therapy using a multicenter randomized controlled study approach as a 
checkpoint before jumping into the clinical setting: the CAESAR (Consortium for 
preclinicAl assESsment of cARdioprotective therapies).34 A movement for the 
establishment of a European network of research centers to test cardioprotective 
interventions in an attempt to mimic the pioneer endeavor of the CAESAR’s 
enterprise is ongoing.65 
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 Editorial #1. “Health and cost benefits associated with the use of metoprolol in 
heart attack patients”.58  
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Heart attack (myocardial infarction) is a highly prevalent entity worldwide.
Widespread implementation of reperfusion strategies has dramatically reduced the
mortality associated with infarction. Paradoxically, the mortality reduction has
significantly increased the incidence of chronic heart failure (HF). Treatment of HF,
once present, represents a huge socioeconomic burden on individuals and
healthcare systems. The possibility of preventing rather than treating
post-infarction HF would be of paramount importance. Given that infarct size is
the main determinant of adverse post-infarction outcomes (including chronic HF),
therapies able to reduce infarct size are needed. The single administration of
intravenous metoprolol before reperfusion has been recently shown to reduce
infarct size and reduce the cases of chronic HF in a proof-of-concept trial. If
confirmed in larger trials, this low-cost therapy is expected to have a major health
and socioeconomic impact.
Heart attack, mainly presented as ST-
segment elevation myocardial infarction
(STEMI) due to complete occlusion of
an epicardial coronary artery, is a leading
cause of mortality and morbidity world-
wide [1]. Timely reperfusion and aggres-
sive invasive management (percutaneous
coronary interventions [PCI]) have been
demonstrated as the most effective ther-
apy to reduce the mortality associated
with STEMI. Risk-adjusted in-hospital
mortality had decreased from »30% in
1985 to »5.5% among STEMI patients
treated in routine practice in 2008 [2],
reaching a plateau thereafter [3]. The lat-
ter suggests that additional strategies
beyond reperfusion are needed to further
reduce mortality in this population.
Paradoxically, the significant reduc-
tion in acute mortality during a STEMI,
resulting from the universal implementa-
tion of timely reperfusion, has signifi-
cantly increased the incidence of chronic
heart failure (HF): patients with poor
left ventricular function previously have
died in the acute phase, but with the
advent of reperfusion now survive the
acute episode and continue to live with
a significantly damaged heart [2]. Indeed,
STEMI is a major cause of chronic HF,
with reduced left ventricular ejection
fraction (LVEF) post-infarction being
one of the single principal causes of
chronic HF, both in developed and
other low- to middle-income coun-
tries [4,5]. Because mortality rates for
STEMI patients have declined, attention
has shifted toward reducing post-
infarction HF because this outcome is
thought to reflect the downstream
impact of acute therapies for STEMI.
Immense research efforts have led to
chronic HF interventions (pharmacologi-
cal and device-based) that reduce long-
term mortality in STEMI survivors with
low LVEF [6]. Nonetheless, the imple-
mentation of these strategies comes at a
high cost, which precludes its universal
application [7,8]. Chronic treatment of
HF once present represents a huge social
and economic burden on individuals
and healthcare systems. Moreover, for
chronic HF, frequent hospital readmis-
sions are the main contributors to the
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escalating long-term healthcare costs [9,10]. The possibility of pre-
venting (rather than treating) post-infarction HF would therefore
be of significant clinical and socioeconomic importance.
The size of the infarct after a STEMI has been demonstrated
as the main determinant of adverse post-infarction outcomes
(including chronic HF). Patients with larger infarcts are at the
highest risk since they have chronic severely depressed LVEF and
associated HF [11]. Therefore, cost–effective therapies able to
reduce infarct size are urgently needed since smaller infarctions
will result in better heart performance and translate into fewer
short- and long-term adverse clinical outcomes, helping to allevi-
ate the huge socioeconomic burden of post-infarction HF.
Early intravenous (iv.) b-blocker initiation during a STEMI was
proposed long ago as a therapy to limit infarct, but its real cardio-
protective capacity during STEMI has been controversial [12]. Met-
oprolol tartrate was one of the first b-blockers released for clinical
use and second iv. b-blocker agent clinically approved in the USA
in 1978 [13]. Metoprolol is a b1-selective blocker. In spite of the
availability of other drugs from the same family, metoprolol offers
some potential advantages, like short half-life, easy administration
in bolus injection and potential pleiotropic effects. These advan-
tages, in addition to the clinical benefits here described, makes met-
oprolol the leading drug of its class. Surprisingly, in the current era
of primary PCI as the treatment of choice for STEMI, no random-
ized trials assessing the beneficial effects of pre-reperfusion
b-blocker administration had been reported until the advent of the
METOCARD-CNIC trial [14,15].
In this trial, patients (mean age » 58 years, » 85% males) with
anterior STEMI, Killip I or II, revascularized by PCI within 6 h
from symptom onset with no obvious contraindication for the
administration of b-blockers were randomized to receive up to
three 5-mg iv. boluses of metoprolol tartrate [16] or control. In
this context, early iv. metoprolol administration before reperfu-
sion reduced infarct size (adjusted treatment effect, –6.5 g; 95%
CI, –11.4 to –1.8; p = 0.012) and increased LVEF (adjusted
treatment effect 2.7%; 95% CI, 0.1–5.2; p = 0.045) with no
increase in adverse events in the acute phase (7.1% in the pre-
reperfusion iv. metoprolol group, vs 16 events (12.3%) in the
control group; p = 0.21). Patients receiving iv. metoprolol tar-
trate before reperfusion had a reduced incidence of HF readmis-
sions over a median 2 years follow-up (2.2 vs 7% in iv.
metoprolol and control groups, respectively, p = 0.04) [15]. Of
note, the occurrence of severely depressed LVEF at 6 months was
significantly lower in patients treated with iv. metoprolol (11 and
27% of patients in the iv. metoprolol and control groups, respec-
tively, had an LVEF £35%, p = 0.006). Consequently, the pro-
portion of patients fulfilling class-I indications for implantable
cardioverter defibrillator (ICD) was significantly lower in the
metoprolol group [15,17]. Early b-blockage before reperfusion is
not encouraged in clinical guidelines, mainly due to the results of
the COMMIT trial, which demonstrated no short-term net clini-
cal benefit of early metoprolol in STEMI patients undergoing
thrombolysis [18]. This trial recruited all comers with almost no
restriction. Subgroup analyses suggested that patients fitting the
inclusion criteria of the METOCARD-CNIC benefited from
early iv. metoprolol in terms of mortality reduction. In addition,
the clinical benefits associated with infarct size reduction (and
post-infarction LVEF improvement) are expected to occur late
(months to years) after STEMI. In the COMMIT trial, clinical
follow-up was less than 1 month. It is plausible that longer
follow-up of the COMMIT trial would show additional benefit
of early metoprolol administration in survivors. Thus, an impor-
tant lesson from the COMMIT trial is that not all STEMI
patients benefit from very early b-blockage, a deduction sup-
ported by the results observed in the METOCARD-CNIC
trial [15], following the personalized medicine principle.
ICD devices are of great value in reducing long-term mortal-
ity rates of STEMI patients. However, the enormous economic
burden for health services precludes its universal implementa-
tion [19]. Even in advanced economies, cost considerations pre-
clude universal implementation of ICD therapy in all patients
who fulfill class-I indication [8]. Of note, mean initial implanta-
tion costs including procedure and single-chamber ICD device
have been estimated to be around e30,000 ($40,000 in the
USA or £23,000 in the UK) [20]. This initial estimation does
not include post-discharge costs (tests, follow-up exams), poten-
tial related complications or device replacement. Some studies
addressing cost–effectiveness of ICD therapy for post-infarction
primary prevention have suggested unfavorable results for
device implantation, even for class-I indication patients [21].
Moreover, there are many intangible impacts on psychological
aspects. Fear of death, shock and public embarrassment are
commonly experienced by recipients. The possibility of reduc-
ing the number of patients fulfilling criteria for primary pre-
vention ICD implant would have an impact in the reduction
of costs and also in the increased accessibility of those with a
clinical indication. The cost of iv. metoprolol is less than
e2 (<$3 in the USA or<£4 in the UK), and thus it appears a
highly cost–effective therapy to tackle the huge socioeconomic
burden associated with post-infarction HF.
It is important to highlight that the METOCARD-CNIC
trial was powered to detect differences in infarct size; therefore,
all other promising findings described here should be taken as
hypothesis generating. The ‘Impact of pre-reperfusion Meto-
prolol On clinical eVEnts after myocardial infarctiON’
(MOVE ON!) trial is a European endeavor that will recruit
more than 3000 patients in seven countries. The MOVE ON!
trial will prospectively test the hypothesis that a single adminis-
tration of iv. metoprolol in STEMI patients transferred to PCI
will reduce the incidence of hard clinical endpoints, including
chronic HF and cardiac mortality, and will specifically evaluate
the savings to the healthcare systems by this low-cost therapy.
The cost of chronic HF treatment is estimated to represent
2% of the total healthcare budgets across Europe [5]. This repre-
sents approximately e48 billion for the European member states.
STEMI is the most common cause of chronic HF, accounting
for approximately 35% of all chronic HF cases. Thus, the cost of
treating STEMI and its consequences is approximately
e20 billion/year in Europe. The potential cost savings associated
with early metoprolol administration are speculative at this stage,
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but a plausible scenario can be proposed: assuming that half of
the at-risk population might be able to receive the new therapy
proposed in this application, the 25% reduction in cases of post-
infarction chronic HF might represent a saving of around
e5 billion/year across Europe. The MOVE ON! trial will tell
whether these projections are real. If positive, it may have a major
health and socioeconomic impact on infarcted patients.
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Abstract Myocardial in vivo tissue characterization is of
great importance because it can provide meaningful informa-
tion to understand pathophysiological processes underlying
different cardiac diseases. Ex vivo histologic analyses of
tissue samples have been classically considered the gold stan-
dard in the study of tissue properties and its composition.
However, over the past decade, there has been a growing
interest in the in vivo myocardial characterization with differ-
ent imaging techniques, which can potentially be translated
into the clinics in order to make an early diagnosis and
evaluate serial changes, opening the possibility of dynamic
evaluation. Animal models have become an essential tool to
achieve this goal. This article aims at concisely reviewing
recent and significant developments in the field of imaging
techniques—mostly cardiac magnetic resonance—in relevant
animal models of tissue characterization of area at risk, edema,
and fibrosis.
Keywords Magnetic resonance . Animal model . Area at
risk . Edema . Fibrosis
Introduction
In vitro tissue characterization techniques have been classical-
ly considered as the gold standard for assessment of cardiac
diseases and treatments. Although these methods are very
useful for a profound analysis of tissue composition, they
have limitations such as changes in tissue composition be-
cause of manipulation, poorly suited for serial measurements
and inability to translate it into the required follow-up clinical
field. Conversely, several imaging modalities have been de-
veloped for the in vivo characterization of cardiac tissue
properties such as positron emission tomography (PET) [1]
or computed tomography (CT) [2]. However, cardiac magnet-
ic resonance (CMR) is the technique that has captured most of
the attention in preclinical and clinical research, since it offers
a combination of high spatial resolution and high soft tissue
contrast with no ionizing radiation. These features entitle
CMR as an ideal tool for imaging the heart in terms of
myocardial structure and function, becoming a reference stan-
dardmodality for the tissue characterization in general, and for
evaluation of the heart in particular, in preclinical and clinical
research, including small/large animals and humans [3].
Myocardial tissue characterization in the context of a myo-
cardial infarction or a suspected cardiomyopathy is one of the
most frequent clinical indications to perform a CMR. Specific
MR sequences addressing a comprehensive evaluation of
heart structure and function are currently implemented in most
clinical protocols [4], including late gadolinium enhancement
sequences, which allow visualization and quantification of
macroscopic areas of scar tissue [5]. However, an intense
clinical and research interest is found today in the develop-
ment of CMR sequences, which are dependent on native
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myocardial signal characteristics—because of change in its
composition—rather than in exogenous contrast-based im-
ages, to demonstrate pathophysiology and tissue characteriza-
tion in cardiac disease [6].
Special attention has been focused in distinguishing and
quantifying several main components of myocardial tissue
(water, collagen, fat) that can be altered in different clinical
scenarios, mostly in myocardial infarction and cardiomyopa-
thies. In fact, changes in water content have been demonstrat-
ed after an ischemic event and other myocardial forms of
inflammation such as myocarditis or sepsis, making possible
the identification and delineation of the area of a myocardial
insult [7]. Conversely, increased amounts of fibrosis, main-
ly—but not restricted to—collagen, has been also extensively
shown after myocardial infarction and in other cardiomyopa-
thies in the form of macroscopic areas of fibrosis (scar), as
well as more recently in several cardiac diseases in the form of
diffuse microscopic fibrosis, the former being associated with
poor prognosis and mortality [8-12] and to be better correlated
with actual infarct size than other biomarkers [13]. Finally,
changes in the amount of myocardial, epicardial, or pericardial
fat have been also shown in a wide spectrum of heart and
systemic diseases, being a marker as well of adverse outcomes
[14-16].
Some ex vivo models have been proposed as valid tools for
the development of novel MR sequences in this regard [17].
However, beyond its value in the development of new imag-
ing algorithms, relevant animal models can further provide,
with a human, closer profound understanding of disease-
related mechanisms and pathophysiology, important informa-
tion before experimental-to-clinical leap, and histologic vali-
dation of new imaging methods and sequences. The purpose
of the present review is to bring an updated overview of the
most recent works involving small and large animal models
using imaging technology—mainly CMR—for the in vivo
tissue characterization of myocardial area at risk, edema, and
fibrosis.
Animal Models of Tissue Characterization of Area at Risk
The myocardial territory, which becomes ischemic after oc-
clusion of its supplying coronary artery, defines the region
potentially at risk for necrosis, named as area at risk (thereaf-
ter, AAR). Modern percutaneous revascularization techniques
and pharmacologic interventions aim to salvage areas of re-
versibly acute injured myocardium, thus, limiting infarct size
and improving prognosis [18-21]. Testing the efficacy of
cardioprotective therapies benefits from measuring both in-
farct size and AAR to calculate the normalized amount of
myocardial salvage, which is probably a better measure of
therapeutic efficacy than the absolute infarct size (Fig. 1) [22,
23]. Thus, there is considerable interest in finding a
reproducible in vivo imaging method, which accurately re-
flects the AAR. CMR has become a paradigm of this research
being one of the imaging techniques that have generated more
published articles and controversies over recent past years on
this topic.
Hyperintense areas on T2-weightedMR imaging have been
classically proposed as having good correlation with AAR in
animal models [24••, 26], being among the most popular
sequences used in humans to retrospectively delineate the
ischemic myocardium (ie, to delineate area of former ischemia
after the acute episode). Signal intensity on T2-weighted MR
sequences appears to be linearly related to myocardial water
content, which seems to be increased over the ischemic terri-
tory in the form of myocardial edema [27-29]. However, all
these assumptions come from wide experimental studies and
fewer human studies [30], most of them with small sample
sizes and mixed patient population. As a result of this great
heterogeneity, if these hyperintense areas accurately track the
AAR or just the infarcted region, or merely something related
to it, is still a matter of controversy [31••, 32••]. Moreover, T2-
weighted imaging is often limited by a low signal-to-noise
ratio, motion artifacts, incomplete blood suppression, and coil
sensitivity related-issues of surface coils [33]. On top, no
consensus exists in regards to how this data has to be optimally
acquired and quantitatively analyzed.
Newer quantitative MR methods as T1 and T2 mapping,
which allow direct measurement of intrinsic tissue properties
in the form of T1 and T2 relaxation times, respectively, are
less dependent on confounders affecting signal intensity and
could overcome some of T2-weighted imaging limitations
[34, 35] (Fig. 2). In this way, in a recent animal research in a
dog model of ischemia/reperfusion injury [36], the accuracy
for quantifying AAR with clinically available T1- and T2-
mapping sequences, compared with microsphere blood flow
analysis as a reference standard was demonstrated. However,
pre-reperfusion delineation of AAR is likely the most accurate
approach to delineate the anatomic myocardium at risk in the
Fig. 1 Diagram representing both the AAR (blue delimited region),
defined as the hypoperfused myocardial distal to a coronary occlusion;
and the salvaged myocardium (green area), defined as the difference
between the myocardial AAR and the necrotic area (pink area)
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experimental setting since reperfusion induces tissue changes
after reperfusion that can modify the extension of former
ischemic insult. Pathophysiological responses after acute
myocardial infarction include edema, hemorrhage, and micro-
vascular obstruction along with cellular damage, which prob-
ably have counter-acting effects on T2 and T1 relaxation
times, as recently demonstrated in a porcine model of myo-
cardial infarction [37].
Thus, in a recent experimental work it compared the accu-
racy of early postreperfusion CMR and prereperfusion multi-
detector computed tomography (MDCT) imaging to measure
the size of the AAR, using pathology as a reference technique
in a porcine acute myocardial infarction model [38]. It was
shown that pathology best correlated with measurements
made by MDCT. However, AAR measurements obtained by
several T2-weigthed sequences (T2-STIR and T2-ACUTE)
resulted in a modest correlat ion with pathology
overestimating the anatomic extension of AAR. In our labo-
ratory, we have been able to reproduce prereperfusion MDCT
to measure AAR (Fig. 3, unpublished data) with similar
results. However, this approach is hardly expected to be
translated into humans, and available information suggests
that postreperfusion T2-weighted imaging (or any other
postreperfusion sequence or technique) aimed to measure
AAR may have some limitations depending on the timing of
image acquisition after ischemic insult.
On top, novel CMR methods have been recently added to
the AAR identification and characterization repertoire. MR
spectroscopy (MRS) and MR-based molecular imaging
methods have shown promise for evaluating cardiac metabo-
lism in the setting of ischemia/reperfusion. For example,
phosphorus-31 MRS can assess high-energy phosphate con-
tent and energy reserve in the heart in animal and human
subjects [39]. In a rat model of myocardial infarction, whole
heart PCr content was inversely correlated with infarct size,
whereas ATP distribution provided a profile of viable myo-
cardium around the infarction reflecting remodeling of the
heart [40]. In rats undergoing ligation of the left anterior
descending coronary artery, 1H-MRS proved lower creatine
myocardium content compared with controls [41]. In addition,
dynamic nuclear polarization has been recently shown to
allow a signal increase of more than 10,000-fold, opening
the door to new understanding of the metabolic processes in
the heart [42]. Experiments performed in the globally ische-
mic, isolated rat heart have demonstrated that hyperpolarized
13C-pyruvate can show the glycolytic switch characteristic of
myocardial ischemia [43, 44]. In addition, hyperpolarized
experiments in pig model of ischemia/reperfusion showed
the potential of 13C-bicarbonate and (1-13C) alanine maps
to distinguish between stunned myocardium and not viable
tissue [45]. Modified blood oxygen level-dependent (BOLD)
sequence, which signal intensity changes primarily from
Fig. 2 Direct measurement of intrinsic tissue properties in the form of T1 mapping (Panel A) and T2 mapping (Panel B) in a pig model of ischemia/
reperfusion injury. Note abnormal T1 and T2 relaxation times over anterior ventricular wall
Fig. 3 In vivo delineation of area
at risk at the mid-ventricular level
using prereperfusion multi-
detector computed tomography
(Panel A, white arrows) and
postreperfusion T2-weighted
STIR magnetic resonance
sequence (Panel B, white arrows)
in the same pig submitted to
transient percutaneous occlusion
of the left anterior descending
coronary artery
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alterations in blood oxygen saturation (and so, from changes
in myocardial perfusion) has been just proposed as able to
detect ischemic myocardium in a dog model of severe coro-
nary stenosis, even earlier in time than the appearance of
edema [46]. Tracking of upregulated vascular cell and inter-
cellular adhesionmolecules (VCAM and ICAM, respectively)
following ischemia using targeted microparticles of iron ox-
ide, which shorten T2 and T2* relaxation times, have also
shown promise for the detection and localization of recent
ischemia. Thus, they have been reported as suitable for the
early identification of ischemic/damage organs [47, 48] as
well as myocardial AAR [49] in small animal models, al-
though its translation into the clinic does not seem to be
around the corner. Finally, re-invented balanced steady-state
free precession (bSSFP) sequence with T2 preparation, has
been also recently described as potentially able to detect
myocardial edema in both porcine model and patients with
reperfused acute myocardial infarction, due to its sensitivity to
T1, T2, and magnetization transfer effects [50-52].
Despite all these experiments and some clinical studies
[30], important questions remain unclear. As previously men-
tioned, comprehensive study of the time course of myocardial
edema and its visualization by CMR from the just early
reperfusion is of critical importance and not fully addressed
at the moment. Knowing the optimal time to accurately mea-
sure AAR would allow standardization of experimental and
clinical protocols, avoiding conflicting data published over the
literature. Large animal models of ischemia/reperfusion in-
volving CMR studies become an ideal platform to go in depth
into this phenomenon. Among them, pig is one of the most
translational and reliable model to study ischemia/reperfusion-
related issues since shows, unlike other mammals but similar
to humans, analogous coronary artery anatomy and distribu-
tion [53, 54], and minimal pre-existing coronary collateral
flow [55••, 56].
Animal Models of Tissue Characterization
of Infarction-Unrelated Myocardial Edema
Experimental myocardial edema is mostly generated through
a surgical (small and large animal models) or percutaneous
(only large animal models) ischemia/reperfusion procedure
involving transient occlusion of a coronary artery. This pro-
cedure has been described elsewhere [23], and its edema-
related consequences have been briefly reviewed along previ-
ous section.
Different procedures inducing infarct-independent increase
of myocardial water content in animal models have been also
described, trying to reproduce other forms of myocardial
edema. Sepsis triggered by sublethal injection of lipopolysac-
charide [57, 58] or mechanical-induced peritonitis [59] has
been shown to augment water content in the myocardium due
to increased vascular permeability in mice. Global acute myo-
cardial edema has been induced in a canine model by transient
elevation of coronary sinus pressure [60]; whereas local myo-
cardial edema has been described in the setting of experimen-
tal autoimmune myocarditis in CD69-defficient mice, which
is characterized by an infiltration of inflammatory cells into
the myocardium, fibrosis, edema, and necrosis, leading to
ventricular wall dysfunction and heart failure [61].
Same CMR sequences described in previous section for
AAR identification have been investigated for tissue charac-
terization of noninfarct models of myocardial edema since
share identical target; that is myocardial edema and so, chang-
es in water tissue content. However, some imaging techniques
are briefly pointed in this section since are specifically focused
in tracking changes in the amount and conformation proper-
ties of the tissue water content itself, beyond the ischemic
view.
Diffusion imaging provides information of water mole-
cules displacement using motion sensitive gradients [62]
adding complementary information to T2 weighted for edema
definition (Fig. 4). Although limited experiments have been
reported in animal models, different publications in human
subjects have proposed this technique as a valuable tool for
edema identification mostly using this diffusion information
as a black-blood technique obtaining better blood suppression
than conventional T2-weighted images [63].
Sodium chemical shift imaging (23Na-CSI) has been re-
ported as able to assess the sodium gradient and cell mem-
brane integrity in order to visualize areas of myocardial edema
in isolated rat hearts [64]. Because of expansion of the extra-
cellular space in interstitial edema, imaging intra- and extra-
cellular sodium separately may provide an alternative ap-
proach to assess myocardial edema. In this way, an elevated
total sodium signal has been observed after myocardial infarc-
tion both in small and large animals [65, 66], and humans [67].
In a very recent research, using a noninfarcted isolated heart
model of extracellular edema and 23Na-CSI, it has been shown
that viable edematous myocardium with cell membranes still
intact is characterized by increased extracellular sodium but
normal intracellular sodium since viable cells are able to
maintain a normal sodium gradient [68]. Although promising,
translation into clinically feasible seems to be again further
away.
Animal Models of Tissue Characterization of Myocardial
Fibrosis
Myocardial fibrosis is a common phenomenon that is ob-
served in different stages in a wide variety of heart diseases.
Collagen accumulation and increase in extracellular volume is
basically shown in the myocardium in 2 ways: macroscopic
fibrosis in the form of a visible based scar and microscopic
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fibrosis in the form of diffuse global fibrosis. Myocardial
fibrosis has become one of the hot topics at the moment,
generating a huge amount of publications in animal models
and humans over the last recent years.
Macroscopic fibrosis in the form of a scar (Fig. 5) has been
classically and extensively described after myocardial infarc-
tion, and in other cardiomyopathies [69, 70], based on delayed
enhancement sequences both in CMR and CT [71], being its
size and distribution intimately associated with heart remod-
eling, prognosis, and mortality of patients [69, 71-75]. Small
and large animal models of myocardial infarction are now
being frequently used for precl inical test ing of
cardioprotective therapies [23], development, and progress
in imaging techniques [76], and study of scarring-related
arrhythmias [77, 78]. Moreover, animal models closely repro-
ducing human atrial arrhythmias are becoming a nice platform
Fig. 4 In vivo diffusion-weighted images (Panels A, B, C and D) from a
pig submitted to myocardial infarction. All images show a very bright
region corresponding to edema within the area at risk, with different
diffusion weighted b values (0, 50, 150, 500 s/mm2). Image of the
ventricle at same level using a T2W-STIR sequence for comparison
between both techniques (Panel E)
Fig. 5 Macroscopic fibrosis in
the form of scar localized at the
mid-ventricular anterior wall on
magnetic resonance images using
late gadolinium enhancement
(Panels A and B), which is also
demonstrated on pathological
specimen (Panels C and D)
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to develop and improve new and classic ablation techniques,
which can potentially be translated to clinical trials, along with
going in depth with arrhythmia-related imaging, mechanisms,
and pathophysiology [79-81].
Although conventional late gadolinium enhancement
CMR sequences are able to identify macroscopic fibrosis in
conditions such as myocardial infarction and other cardiomy-
opathies as previously described, they are less suitable for
in vivo detection of microscopic diffuse myocardial fibrosis
since the myocardium is globally affected by smaller collagen
deposits and there may be little normal myocardium to com-
pare with. However, relying on quantification of the T1 relax-
ation times after contrast enhancement equilibrium, the myo-
cardial extracellular volume fraction has been proposed as
having a good correlation with the amount of diffuse fibrosis
[82, 83]. Fibrosis shortens the postcontrast longitudinal relax-
ation time (and so, T1) properties of the myocardium and this
feature may be tracked by specific pulse sequences. Thus, a
shorter myocardial T1 after administration of gadolinium-
based contrast agent indicates extracellular matrix expansion
and is associated with accumulation of connective tissue in the
myocardium. Promising noncontrast CMR methods for the
discrimination of normal and diffusely diseased myocardium
are emerging as the recently described T1 native [84].
Animal models have become critical for validation of
newer CMR methods, and research in fibrosis imaging is not
an exception. Diffuse myocardial fibrosis over the left ventri-
cle has been generated in small and large animals mostly
based on different approaches such as placement of aortic
constrictive banding [85] or drug administration [86, 87],
Fig. 6 Cardiac contrast
computed tomography - sagittal
view showing surgical placement
of a banding at the ascending
aorta (black asterisk) of a pig
(Panel A). Histologic mid-
ventricular short axis slice of the
same animal with Picrosirius red
staining demonstrating left
ventricular hypertrophy and
diffuse interstitial fibrosis (Panel
B, red fibers; courtesy of Damian
Sanchez-Quintana)
Fig. 7 Contrast computed
tomography images showing
normal pulmonary vein anatomy
(Panel A) and a significant
stenosis of the inferior pulmonary
vein (Panel B) in a pig model of
pulmonary hypertension.
Histologic images of the right
ventricle of the same pig using
Picrosirius red (Panel C) and
Masson trichrome (Panel D)
stainings showing myofiber
disarray and diffuse myocardial
fibrosis over the right ventricle
(courtesy of Damian Sanchez-
Quintana)
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overall inducing pressure-overload left ventricular hypertro-
phy (Fig. 6); although other animal models reproducing spe-
cific cardiomyopathies have been also reported [88]. Particu-
lar modified sequences for generating T1 maps, and so de-
tecting diffuse fibrosis, have been developed and are needed
in small animals due to their high heart rates [89]. Although
not so well studied, generation of animal models with diffuse
myocardial fibrosis in the right ventricle (Fig. 7) is an inter-
esting and promising approach for investigating its forgotten
diseases and for achieving new treatments for pulmonary
hypertension [90, 91].
Novel imaging techniques have been recently described
adding new information about myocardial fibrosis. Diffusion
tensor magnetic resonance imaging (DT-MRI) is a diffusion-
weighted technique that uses the directionality information of
water diffusion to track myofibers orientation and organiza-
tion [92] (Fig. 8). This myofiber organization can bemeasured
with a DTI parameter called fractional anisotropy that repre-
sents the capability of water molecules to move more easily in
1 direction compared with the others. Thus, DT-MRI has
demonstrated a reduction of fractional anisotropy values in
the infarcted and border zones compared with the remote
myocardium showing good agreement with histology findings
in a pig model [93, 94]. New approaches using molecular
imaging have emerged to in vivo visualize and quantify in-
flammatory molecules involved in the formation of scar tissue
in the postinfarction myocardium [95]. For example, targeting
myofibroblasts or metalloproteinases using specific ligands
have been proposed for imaging left ventricular remodeling
in a murine model of myocardial infarction [96]. Thus, the
possibility to identify early stages of postinfarction healing
may allow the development of new therapies focused in
preventing irreversible changes.
Conclusions
Characterization of myocardial tissue changes with CMR
represents a valuable tool to define the presence and stage of
a particular heart disease, and to serially and noninvasively
monitor both animal models and patients for progression of
disease or therapeutic efficacy. However, despite great devel-
opment in the last years, this topic is far from been closed,
remaining important questions to be answered. Early detection
as well as timing and mechanistics of these tissue changes are
of great importance and interest, although little and controver-
sial information only is published at present. Full animal
models become the ideal tool for the in vivo development of
newer imaging methods, which would potentially allow an-
swering these questions since ability for follow-up acquisi-
tions and feasibility of validation and translation to the clinic.
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Editorial
Timely reperfusion is known as the best therapeutic strat-egy for limiting the extent of myocardial damage during 
an ST-segment–elevation myocardial infarction (STEMI).1,2 
The concept of reperfusion as a means to limit necrosis during 
an STEMI was established in an experimental large animal 
(dog) model 4 decades ago.3,4 Noteworthy, the translation of 
the reperfusion concept in STEMI is one of the most success-
ful stories of therapies ever. This example highlights the criti-
cal relevance of using preclinical models similar to humans 
for efﬁcient translational research. Further research in the ﬁeld 
identiﬁed that reperfusion is not a free lunch, and it can come at 
the price of inducing additional damage to the myocardium, a 
phenomenon known as reperfusion injury.5 The ﬁnal extent of 
myocardial necrosis after a STEMI, resulting from both isch-
emic and reperfusion injuries, is a major determinant of mor-
tality and morbidity after infarction.6 Therefore, huge efforts 
have been dedicated for exploring cardioprotective therapies 
that might limit ischemia/reperfusion injury beyond timely 
reperfusion. Opposed to what occurred with the reperfusion 
concept, the translation of therapies aiming to ameliorate re-
perfusion injury has been more disappointing than the former. 
With the exception of a few therapies succeeding in translat-
ing experimental results into positive proof of concept clini-
cal trials demonstrating reduction in infarct size and increase 
in myocardial salvage,7–11 most promising cardioprotectives 
agents/interventions have failed to replicate the positive re-
sults in experimental models in the clinical arena over the last 
decades.8,12 It is important to note that failure in translation is 
not restricted to the cardioprotection ﬁeld, and similar frustrat-
ing ﬁndings have been observed in other areas.13,14
Article, see p 572
What are the reasons responsible for this loss in translation? 
Inadequate experimental data and overoptimistic erroneous 
conclusions resulting from methodological ﬂaws in animal 
studies might be one of the main reasons accounting for this 
scientiﬁc inconsistency.15 Like in any formal clinical trial, 
animal studies testing the efﬁcacy of a given (cardioprotec-
tive) therapy/intervention should be based on a well-designed 
prespeciﬁed protocol paying rigorous attention to design 
(including expected effect size), conduct, statistical, and re-
porting-style aspects. Unfortunately, critical methodological 
elements such as blinding, randomization, or a priori sample 
size calculation are too frequently neglected in the experimen-
tal setting, increasing the chances of biased and hyped posi-
tive results.16 In the case of cardioprotective therapies, speciﬁc 
aspects directly related to the ultimate myocardial damage, 
such as animal species, strain differences, anesthetic agents, 
duration of ischemia, drug administration, manner and dura-
tion of reperfusion, and methodology and timing of end point 
(myocardial damage/salvage) evaluation,17–19 may be decisive 
in the outcome of the study as well. Having all these vari-
ables as potential sources of variability, it is not so surprising 
that the replication and reproducibility of experimental results 
among different laboratories are alarmingly low.20 Several 
Working Groups of experts have deeply discussed the reasons 
for the failure to effectively translate potential therapies for 
protecting the heart from ischemia/reperfusion, making rec-
ommendations to try solving this unmet research need.17,19,21 
The US initiative further included the creation of a national 
network of research laboratories with expertise in small and 
large animal models of ischemia/reperfusion injury to sys-
tematically test a particular cardioprotective therapy using a 
multicenter randomized controlled study approach as a check-
point before jumping into the clinical setting: the CAESAR 
(Consortium for preclinicAl assESsment of cARdioprotec-
tive therapies) Cardioprotection Consortium22 (http://www.
nihcaesar.org/). Recently, the European Society of Cardiology 
Group in Cellular Biology of the Heart have proposed the es-
tablishment of a European network of research centers to test 
cardioprotective interventions17 in an attempt to mimic the 
pioneer endeavor of the CAESAR’s enterprise.
Two highly relevant papers on the topic of translating pre-
clinical results into clinics in the ﬁeld of cardioprotection 
during STEMI appear in this issue of the Journal. Jones et 
al23 report the initial validation of the CAESAR initiative by 
testing the protection afforded by preconditioning, and Prof 
Heusch24 presents an outstanding comprehensive review of 
the mechanisms and signal transduction pathways in ischemic 
conditioning. The landmark CAESAR validation23 is based on 
the principles of detailed conduct of experimental protocols, 
randomization, researcher blinding, a priori sample size calcu-
lation and exclusion criteria, appropriate statistical analyses, 
and assessment of reproducibility. For such proof of concept 
validation, authors decided to test ischemic (local) precondi-
tioning as the intervention to reduce infarct size in 3 species 
CAESAR
One Step Beyond in the Construction of a Translational Bridge  
for Cardioprotection
Rodrigo Fernández-Jiménez, Borja Ibanez
(Circ Res. 2015;116:554-556. 
DOI: 10.1161/CIRCRESAHA.115.305841.)
© 2015 American Heart Association, Inc.
Circulation Research is available at http://circres.ahajournals.org 
DOI: 10.1161/CIRCRESAHA.115.305841
The opinions expressed in this article are not necessarily those of the 
editors or of the American Heart Association.
From the Centro Nacional de Investigaciones Cardiovasculares Carlos 
III (CNIC), Madrid, Spain (R.F.-J., B.I.); and Hospital Universitario 
Clínico San Carlos, Madrid, Spain (R.F.-J., B.I.).
Correspondence to Borja Ibanez, MD, PhD, Myocardial Pathophysiology 
Program, Centro Nacional de Investigaciones Cardiovasculares Carlos III 
(CNIC), Melchor Fernández Almagro, 3, 28029, Madrid, Spain. E-mail 
bibanez@cnic.es
50
Fernández-Jiménez and Ibanez  CAESAR: Bridge of Translation  555
(mouse, rabbit, and pig) at 3 different centers of the consor-
tium (2 sites/species). Authors wisely chose ischemic precon-
ditioning as a protective intervention because it is probably 
the most robust and reproducible cardioprotective intervention 
known to date. The mechanisms of protection during ischemic 
preconditioning are extensively presented in the review paper 
appearing in the same issue of the journal.24
The CAESAR authors and institutions involved in this work 
should be congratulated for their innovative and huge effort 
to achieve a rigorous experimental setting. Overall, this ap-
proach should result in a reduction of potential biases and 
consequently in an increase in the conﬁdence of attributing 
the differences observed between groups of animals allocated 
to different interventions to the treatment under investigation 
rather than to confounding factors or to just random error. 
However, there are potential shortcomings in the implemen-
tation and universalization of the CAESAR methodology. 
Counterintuitively, the excessive protocol standardization to 
reduce data variance can come at a negative price in some cas-
es. It has been postulated that highly environmental standard-
ized conditions may reveal restricted conclusions to a concrete 
experimental setting with little external validity being a cause, 
rather than a cure, of poor study reproducibility25 something 
that has been previously referred to as the standardization fal-
lacy.26 External validity of experimental studies can be also af-
fected by inevitable species differences. Therefore, even with 
rigorous design and conduct of an experimental study, such 
as the one elegantly presented by CAESAR, the translation 
of animal results to the clinics may fail because of disparities 
between the model and the real-world patient. CAESAR tries 
to overcome this limitation by using >1 laboratory for each 
species, but in the end 2 laboratories closely associated and 
following the exact same methodology are virtually a single 
hyperspecialized unit. The adding of more laboratories, even-
tually using slight different approaches (eg, different strain of 
animals, different anesthetics, different methods for outcome 
assessment, etc.), can serve to further improve the salutary 
long-term beneﬁts of CAESAR.
Even the best animal models are approximations to human 
physiology/pathophysiology, and it is fair to acknowledge that 
in most cases they are only partially resembling what is seen 
in a more complex human diseased system. As an example, 
aging and multiple comorbid conditions seen in patients in-
cluded in regular clinical trials are barely present in the exper-
imental setting. Obviously, the intrinsic limitations inherent 
to animal models do not invalidate the use of laboratory re-
search. We are convinced that animal models are useful tools 
in biomedical research, but a call for rigor in experimental 
investigation as presented by CAESAR initiative is necessary 
to improve translation. In this regard, it is noteworthy that in 
the paper by Jones et al,23 there seems to be a species-related 
effect size gradient: infarct size reduction by the applied pre-
conditioning intervention was largest in mice, intermediate in 
rabbits, and smallest in pigs. This anecdotic ﬁndings highlight 
that the extrapolation of animal results into clinics highly de-
pends on the species evaluated.
Another relevant aspect close to the topic here discussed 
is the positive results publication bias. The report of negative 
preclinical studies is an extremely hard endeavor, and many 
times animal studies yielding neutral results are never report-
ed. CAESAR is certainly an endeavor of such relevance that 
a room for the report of negative preclinical studies should be 
identiﬁed. In this regard, it is noteworthy that Jones et al23 ac-
knowledge in their paper that 2 other agents have been tested 
by CAESAR, sodium nitrite and sildenaﬁl citrate, and both 
failed to limit infarct size despite prior experimental studies 
reporting beneﬁcial effects with these therapies. The best ven-
ue for reporting these negative ﬁndings in CAESAR is to be 
decided by the implicated institutions.
What is the ultimate translational relevance of the CAESAR 
initiative? This enterprise will certainly help in the better iden-
tiﬁcation of therapies/interventions with chances to be tested 
in pilot clinical trials. Early identiﬁcation of therapies with 
no (or limited) beneﬁts will be of massive help for the scien-
tiﬁc and pharmaceutical communities. The personal and eco-
nomical costs associated with clinical trials is humongous and 
the proper early identiﬁcation of potential failures is capital. 
There are some interventions that have already shown positive 
results in pilot clinical trials (for more details, we refer to the 
accompanying review paper by G. Heusch24). It is noteworthy 
that these positive experiences were always preceded by thor-
ough preclinical studies.9,11,27
Emulating Julius Caesar and his legionaries, who built the 
ﬁrst 2 bridges across the Rhine River to defeat Germanic tribes 
during the Gallic War in 53 BC, the CAESAR initiative23 has 
built a new bridge that will help the translation expansion in 
the ﬁeld of cardioprotection during STEMI.
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 3.2 Chapter II. Translational implementation of cardiac magnetic 
resonance to the post-myocardial infarction heart 
As a next step, the doctoral student was trained and capacitated by the host 
research group in the pig model of closed-chest MI and translational imaging 
methods to assess the post-MI heart. For such purpose, the doctoral student 
elaborated on a clinical observation done during his cardiology fellowship training: 
upon an acute MI, the systemic release of troponins seems to be disproportionately 
higher than that of total creatine kinase in patients with left ventricular hypertrophy. 
As a consequence, the prediction of infarct size based on the circulating levels of 
troponin might be confounded by the presence of left ventricular hypertrophy.66 
Although retrospective in nature, this was the first time that a different pattern of 
creatine kinase and troponin release was shown in MI patients with left ventricular 
hypertrophy. 
This clinical observation was translated then to the preclinical laboratory at CNIC. A 
pig model of left ventricular hypertrophy secondary to pressure-overload by surgical 
banding of the ascending aorta was developed, and CMR used to assess left 
ventricular outcomes after MI. The hypothesis was then tested in the experimental 
setting, and translated again to the bedside by replicating the results in the 
METOCARD-CNIC trial; therefore completing a success translational journey. As a 
result, we have contributed to the literature with the following original research article 
for which I am the first author.  
 
Original research article #1. “Impact of left ventricular hypertrophy on troponin 
release during acute myocardial infarction: new insights from a comprehensive 
translational study”.67 
 
The lessons learned before about imaging of the post-MI heart were again applied 
in the clinical setting. Specifically, the association between the red blood cell content 
of marine omega-3 fatty acids and CMR measurements of MaR, infarct size, 
myocardial salvage and left ventricular ejection fraction was prospectively evaluated 
by using the METOCARD-CNIC data set. As a result, we have contributed to the 
literature with the following original research article for which I am the co-first author. 
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 Original research article #2. “Nutritional preconditioning by marine omega-3 fatty 
acids in patients with ST-segment elevation myocardial infarction: A 
METOCARD-CNIC trial substudy”.68 
 
For the scientific documents published and contained in this chapter, I contributed 
as doctoral student in the following: design and plan the preclinical experiments, 
recruitment and follow-up of patients within the METOCARD-CNIC trial, perform the 
model of MI in the pig, collect and process blood and myocardial tissue samples for 
subsequent analysis, CMR imaging acquisition and analysis, statistical analysis, 
draft the manuscript, and elaborate and make critical input in the peer review 
process. 
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 Original research article #1. “Impact of left ventricular hypertrophy on troponin 
release during acute myocardial infarction: new insights from a comprehensive 
translational study”.67 
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Impact of Left Ventricular Hypertrophy on Troponin Release During
Acute Myocardial Infarction: New Insights From a Comprehensive
Translational Study
Rodrigo Fernandez-Jimenez, MD; Jacobo Silva, MD, PhD; Sara Martınez-Martınez, PhD; Mª Dolores Lopez-Maderuelo, PhD;
Mario Nuno-Ayala, PhD; Jose Manuel Garcıa-Ruiz, MD; Ana Garcıa-Alvarez, MD, PhD; Leticia Fernandez-Friera, MD, PhD;
Tech Gonzalo Pizarro, MD; Jaime Garcıa-Prieto, BSc; David Sanz-Rosa, PhD; Gonzalo Lopez-Martin; Antonio Fernandez-Ortiz, MD, PhD;
Carlos Macaya, MD, PhD; Valentin Fuster, MD, PhD; Juan Miguel Redondo, PhD; Borja Ibanez, MD, PhD
Background-—Biomarkers are frequently used to estimate infarct size (IS) as an endpoint in experimental and clinical studies. Here,
we prospectively studied the impact of left ventricular (LV) hypertrophy (LVH) on biomarker release in clinical and experimental
myocardial infarction (MI).
Methods and Results-—ST-segment elevation myocardial infarction (STEMI) patients (n=140) were monitored for total creatine
kinase (CK) and cardiac troponin I (cTnI) over 72 hours postinfarction and were examined by cardiac magnetic resonance (CMR) at
1 week and 6 months postinfarction. MI was generated in pigs with induced LVH (n=10) and in sham-operated pigs (n=8), and
serial total CK and cTnI measurements were performed and CMR scans conducted at 7 days postinfarction. Regression analysis
was used to study the inﬂuence of LVH on total CK and cTnI release and IS estimated by CMR (gold standard). Receiver operating
characteristic (ROC) curve analysis was performed to study the discriminatory capacity of the area under the curve (AUC) of cTnI
and total CK in predicting LV dysfunction. Cardiomyocyte cTnI expression was quantiﬁed in myocardial sections from LVH and
sham-operated pigs. In both the clinical and experimental studies, LVH was associated with signiﬁcantly higher peak and AUC of
cTnI, but not with differences in total CK. ROC curves showed that the discriminatory capacity of AUC of cTnI to predict LV
dysfunction was signiﬁcantly worse for patients with LVH. LVH did not affect the capacity of total CK to estimate IS or LV
dysfunction. Immunoﬂuorescence analysis revealed signiﬁcantly higher cTnI content in hypertrophic cardiomyocytes.
Conclusions-—Peak and AUC of cTnI both signiﬁcantly overestimate IS in the presence of LVH, owing to the higher troponin
content per cardiomyocyte. In the setting of LVH, cTnI release during STEMI poorly predicts postinfarction LV dysfunction. LV mass
should be taken into consideration when IS or LV function are estimated by troponin release. ( J Am Heart Assoc. 2015;4:
e001218 doi: 10.1161/JAHA.114.001218)
Key Words: creatine kinase • hypertrophy • magnetic resonance imaging • myocardial infarction • troponin
S ystemic release of cardiac biomarkers is commonly usedto quantify the extent of cardiac damage after an acute
myocardial infarction (AMI). Peak and area under the curve
(AUC) of total creatine kinase (CK) and cardiac troponin (cTn)
have been consistently shown to correlate with infarct size
(IS) measured by reference standards: cardiac magnetic
resonance (CMR),1–3 single-photon emission computed
tomography (SPECT),4,5 and postmortem analysis.6 Accurate
quantiﬁcation of IS is of value given that it correlates closely
with long-term left ventricular (LV) performance and, more
important, with clinical outcomes.7 However, reference stan-
dard techniques for IS quantiﬁcation (CMR or SPECT) are not
widely available. Infarct size is therefore commonly estimated
from the levels of cardiac biomarkers in peripheral blood,
especially in clinical trials in which IS is used as an
endpoint.8,9
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We recently reported on a retrospective observational
analysis showing that patients with LV hypertrophy (LVH) who
suffer an ST-segment elevation myocardial infarction (STEMI)
can have disproportional blood concentrations of cardiac
troponin I (cTnI)/total CK, compared with STEMI patients with
no LVH.10 Given the high prevalence of LVH in the general
population11,12 and the importance of accurate IS quantiﬁca-
tion, unequivocal demonstration of the inﬂuence of LVH on
biomarker release is of clinical and research value.
In the present study, we conducted a prospective analysis
to determine whether LV mass inﬂuences cardiac biomarker
release after STEMI. Biomarker estimates of IS were com-
pared with state-of-the-art CMR, a gold standard for IS
quantiﬁcation, in STEMI patients from a prospective clinical
trial, and a similar analysis was conducted in a controlled
experimental pig STEMI model (with/without LVH) to gain
insight into the underlying mechanisms. The main aims of the
present study were to (1) analyze the inﬂuence of LVH on the
cTnI/total CK release pattern after STEMI, (2) study the
impact of LVH on IS quantiﬁcation and LV ejection fraction
(LVEF) prediction by these biomarkers, and (3) study the
effect of LVH on cTnI expression in myocardial tissue samples
from LVH and control pigs.
Methods
Clinical Study
Patients with ﬁrst anterior STEMI presenting early
(<6 hours) and undergoing primary angioplasty were
recruited within the METOCARD-CNIC trial.13,14 A prespec-
iﬁed analysis within this trial was the study of the
association between cTnI/total CK and CMR-measured
LVH, IS, and LVEF. Inclusion/exclusion criteria can be
found elsewhere.15 Serial cTnI and total CK measurements
were taken in 140 patients, and data from these patients
were used for the current analysis. All patients underwent
CMR studies at 5 to 7 days (1 week)13 and 6 months14
after STEMI. This study was approved by the ethics
committee, and patients signed informed consent.
CMR protocol
A detailed description of the CMR protocol and methods for
imaging analysis has been reported elsewhere15 and is
detailed below. A comprehensive CMR study was performed
with dedicated sequences to evaluate cardiac function and
myocardial necrosis. Scans were performed with a 3.0-T
magnet (Achieva Tx; Philips Medical Systems, Best, the
Netherlands), with vectorcardiographic gating and a dedi-
cated cardiac 32-channel phased-array surface coil. All
sequences were acquired during expiration breath-hold
mode. After standard localizer scan, contiguous short-axis
slices were acquired to cover the whole LV. For functional
cine imaging, we ﬁrst ran a balanced turbo ﬁeld echo steady-
state free precession (SSFP) with a sensitivity encoding fast
parallel imaging technique sequence. Typical parameters
were voxel size 1.692 mm, slices 13, slice thickness 8 mm,
gap 0 mm, cardiac phases 30, repetition time (TR) 3.5 ms,
echo time (TE) 1.7 ms, ﬂip angle (FA) 40°, sensitivity
encoding 1.5, averages 1, and ﬁeld of view (FOV)
3609360 mm. Delayed enhancement images to assess
necrotic myocardium were acquired with a T1-weighted
two-dimensional (2D) segmented inversion recovery turbo
ﬁeld echo (2D IR-TFE) sequence performed 10 to 15 minutes
after intravenous administration of 0.20 mmol of gadopen-
tate dimeglumine contrast agent (Magnevist; Schering AG,
Berlin, Germany) per kg body weight.16 The delayed
enhancement images were thus acquired in short-axis slices
that matched function imaging and had the following
parameters: voxel size 1.591.5 mm; slices 13; slice thick-
ness 8 mm; gap 0; TR 6.1; TE 3.0; inversion time 250 to 350
(optimized to null normal myocardium); FA 25°; TFE factor
20; averages 1; and FOV 3609360 mm.
CMR data analysis
Blinded analyses were undertaken by the core laboratory at
the Centro Nacional de Investigaciones Cardiovasculares
Carlos III (CNIC). Data were quantiﬁed with dedicated
software (QMass MR 7.5; Medis, Leiden, the Netherlands).
LV mass, LVEF, and extent of necrosis were determined. LV
mass was normalized to body surface area according to Du
Bois’ formula.17 Myocardial necrosis (IS), expressed as a
percentage of LV mass (the gold standard for IS quantiﬁca-
tion), was deﬁned according the extent of delayed gadolinium
enhancement.18
Measurement of cTnI and total CK
Blood samples (3 mL) were taken from a peripheral vein
into clot activator tubes for serum total CK analysis and
into lithium-heparin tubes for analysis of plasma cTnI.
Samples were prepared from blood by centrifugation
following standard procedures. Total-CK was assessed with
a standard enzymatic method on an Olympus AU2700
analyzer (Beckman Coulter Clinical Diagnostics, Nyon,
Switzerland). cTnI was assessed by a chemoluminescence
immunoassay on a Dimension Vista system (Siemens
Healthcare Diagnostics, Deerﬁeld, IL) or the AccuTnI
paramagnetic chemoluminescence immunoassay on an
Access-2 analyzer (Beckman Coulter Clinical Diagnostics)
with reagents provided by the manufacturer. Blood samples
for biomarkers were obtained on admission, every 4 hours
during the ﬁrst 12 hours post-STEMI, and then every
12 hours up to 72 hours post-STEMI.
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Animal Study
Experimental procedures were performed in castrated male
Large-White pigs. The study protocol was approved by the
institutional animal research committee and conducted in
accord with recommendations of the Guide for the Care and
Use of Laboratory Animals.
Generation of pressure-overload LVH
Pressure-overload LVH was induced in 10 four-week-old
Large-White pigs (10 to 14 kg) by surgical banding of the
ascending aorta. Sedation was induced by intramuscular
injection of ketamine (20 mg/kg), xylazine (2 mg/kg), and
midazolam (0.5 mg/kg) and then maintained with sevoﬂura-
ne. Continuous intravenous infusion of fentanyl served as an
analgesic during surgery and a single dose of prophylactic
antibiotic with cefuroxime was administered just before the
procedure. Mechanical endotracheal ventilation was con-
trolled by external respirator. A minimally invasive right lateral
thoracotomy was performed in the fourth intercostal space.
Through a small pericardiotomy, the ascending aorta was
constricted 3 cm above the aortic valve with a rigid
polyethylene band adjusted to 70% of the measured perimeter
of the aorta. In all cases, the band was tied to ﬁt snugly
around the aorta, but did not create a palpable thrill. The small
pericardiotomy was left open, the pneumothorax evacuated
with a chest tube, and the chest wall and skin incisions were
closed. After surgery and before the animals recovered from
anesthesia, intramuscular (0.01 mg/kg) buprenorphine was
administered as a postoperative analgesia. In 8 sham-
operated animals, the same procedure was followed, but
the band was not tightened. All animals were returned to the
farm to grow for an average of 16 weeks before myocardial
infarction (MI) procedure.
MI procedure
AMI was induced in all pigs 4 to 5 months after surgery when
animals reached a weight of 60 to 70 kg. The protocol of AMI
induction has been detailed elsewhere.19,20 In summary,
anesthesia was induced in all animals as described above and
maintained by continuous intravenous infusion of ketamine
(2 mg/kg/h), xylazine (0.2 mg/kg/h), and midazolam
(0.2 mg/kg/h). All animals were intubated and mechanically
ventilated with oxygen (fraction of inspired O2: 28%). Central
venous and arterial lines were placed and a single bolus of
unfractioned heparin (300 mg/kg) was administered imme-
diately before introduction of the catheter. A continuous
infusion of amiodarone (300 mg/h) was maintained during
the procedure in all pigs to prevent malignant ventricular
arrhythmias. The left anterior descending coronary artery
immediately distal to the origin of the ﬁrst diagonal branch
was occluded for 60 minutes with an angioplasty balloon
introduced with a catheter inserted by the percutaneous
femoral route. Balloon location and state of inﬂation were
monitored angiographically. After balloon deﬂation, a coro-
nary angiogram was recorded to conﬁrm patency of the
coronary artery. In cases of ventricular ﬁbrillation, a biphasic
deﬁbrillator was used to deliver nonsynchronized shocks.
During their recuperation, animals were cared for by ded-
icated veterinarians and technicians at the CNIC.
CMR protocol
A baseline CMR scan was performed in each pig immediately
before AMI induction to assess baseline LV mass and LVEF. A
second CMR study was performed 7 days after AMI in order
to assess IS and LV performance. Pigs were anesthetized by
intramuscular injection of ketamine, xylacine, and midazolam
as described above, and anesthesia was maintained by
continuous intravenous infusion of midazolam (0.2 mg/kg/h).
All studies were performed using a Philips 3-Tesla Achieva Tx
whole-body scanner (Philips Medical Systems) equipped with
a 32-element cardiac phased-array surface coil. To evaluate
global LV motion, segmented cine SSFP sequences were
performed to acquire 13 to 15 contiguous short-axis slices
covering the heart from the base to the apex (FOV of
2809280 mm; slice thickness of 8 mm without gap; TR
2.8 ms; TE 1.4 ms, FA 45°; cardiac phases 25; voxel size
1.891.8 mm; and 3 NEX [number of excitations]). Delayed
enhancement imaging of infarct size was performed 10 to
15 minutes after intravenous administration of 0.20 mmol of
gadopentate dimeglumine contrast agent per kg of body
weight16 using an inversion-recovery spoiled turbo ﬁeld echo
sequence (FOV of 2809280 mm; 13 to 15 short-axis slices
with a thickness of 8 mm and no gap; TR 5.6 ms; TE 2.8 ms;
voxel size 1.691.6 mm; time interval optimized to null normal
myocardium; trigger delay longest; bandwidth, 304 Hz per
pixel; and 2 NEX).
CMR data analysis
All CMR images were analyzed using dedicated software
(QMass MR 7.5; Medis) by 2 observers experienced in CMR
analysis and blinded to the LVH induction procedure. LV
cardiac borders were traced in each cine image to obtain LV
end-diastolic volume (LVEDV), end-systolic volume (LVESV),
and LVEF. In the tracing convention used, the papillary
muscles were included as part of the LV cavity volume. LVEDV
and LVESV were determined using a summation of disks
(“Simpson’s rule”) method. Ejection fraction (EF) was com-
puted as EF=(LVEDVLVESV)/LVEDV. LV epicardial borders
were also traced on the end-diastolic images, with LV mass
computed as the end-diastolic myocardial volume (ie, the
difference between the epicardial and endocardial volumes)
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multiplied by myocardial density (1.05 g/mL). Values of LV
volume and LV mass normalized to body surface area were
calculated with Brody’s formula.21 Myocardial necrosis (IS),
expressed as a percentage of LV mass (the gold standard for
IS quantiﬁcation), was deﬁned according the extent of delayed
gadolinium enhancement.18 Necrosis was identiﬁed as hyper-
intense regions, deﬁned as >50% of maximum myocardial
signal intensity (full width at half maximum), with manual
adjustment when needed. If present, a central core of
hypointense signal within the area of increased signal was
included in the late gadolinium enhancement analysis.
Measurement of cTnI and total CK
Blood samples (3 mL) were taken from the femoral vein into
clot activator tubes for serum total CK analysis and into
lithium-heparin tubes for analysis of plasma cTnI. Samples
were prepared from blood by centrifugation separation. Total
CK was measured by an enzymatic method, according to the
manufacturer’s recommendations, and cardiac TnI was
assayed using an automated colorimetric immunoassay with
reagents provided by the manufacturer. Both biomarkers were
determined on a Dimension RxL Max system (Siemens
Healthcare Diagnostics). Blood samples for biomarker mea-
surement were obtained from a femoral vein at baseline
(before AMI procedure), minute 0 (just before coronary
occlusion), minute 60 (immediately before reperfusion), and
every hour over 6 hours following reperfusion.
Immunoﬂuorescence Analysis of cTnI in
Myocardial Tissue Samples
MI greatly inﬂuences myocardial protein tissue content,22
prompting us to measure myocardial tissue content of cTnI in
an additional set of 8 pigs (n=4 banded-LVH; n=4 sham-
operated controls). When they reached the target weight (60
to 70 kg), these pigs underwent the baseline CMR scan and
were sacriﬁced (they did not undergo AMI induction).
Myocardial samples were collected within minutes of eutha-
nasia from the anterior and posterolateral mid-ventricular
wall, ﬁxed in formalin, embedded in parafﬁn, and analyzed by
immunoﬂuorescence to measure expression of cTnI and
cardiomyocyte perimeter. A detailed description is given
below.
Heart samples from banded LVH (n=4) and normal pigs
(n=4) were ﬁxed in 10% formalin at 4°C for 24 hours and
embedded in parafﬁn. For epitope unmasking, heart sections
(5 lm) were treated with 10 mmol/L of trisodium citrate
0.05% Tween 20 (pH 6.0) for 3 minutes at 125°C. Sections
were then permeabilized with 0.25% Triton X-100 in PBS for
10 minutes and blocked with 2% BSA in PBS (blocking buffer)
for 1 hour at room temperature. Blocked sections were
incubated with a mouse monoclonal anti-cardiac troponin I
antibody (2 lg/mL, ab19615; Abcam, Cambridge, MA) or
control mouse IgG (sc2025; Santa Cruz Biotechnology, Santa
Cruz, CA) in blocking buffer for 2 hours at room temperature.
After incubation with secondary anti-mouse Alexa-647 anti-
body (Invitrogen, Carlsbad, CA) for 45 minutes at room
temperature, sections were stained with ﬂuorescein isothio-
cyanate-conjugated lectin from wheat (FITC-WGA; 100 lg/mL
in PBS, L-4895; Sigma-Aldrich, St. Louis, MO) overnight at 4°C
to delineate the perimeter of cardiomyocytes. Finally, nuclei
were stained by incubating slides with 40,6-diamidino-2-
phenylindole, and slides were mounted with Mowiol-Dabco
mounting medium. Images were captured with a ﬂuorescence
confocal microscope (Leica SPE, DM 2500; Leica Microsys-
tems, Buffalo Grove, IL) ﬁtted with an 940 objective. ImageJ
software (National Institutes of Health, Bethesda, MD) was
used to quantify mean ﬂuorescence intensities corresponding
to cTnI and cardiomyocyte cross-sectional area. The captured
images of 20 random ﬁelds in a section from each pig (4 pigs
per group) were quantiﬁed, and an average value was
calculated for each pig.
Statistical Analysis
For quantitative variables, data are expressed as meanSD
and compared by parametric methods. Non-normal data are
reported as medians and interquartile range (IQR) and were
compared by nonparametric methods. Owing to the small
sample size in the experimental study, all data were compared
using nonparametric methods irrespective of the normality
test. For categorical data, percentages were compared using
exact methods.
Multiple linear regression analysis was used to study the
inﬂuence of indexed LV mass on total CK and cTnI values,
adjusted for infarct size measured by CMR. Variance of data
on peak and AUC of total CK and cTnI release tends to be
proportional to the mean; therefore, we used a square-root
transformation for these variables when included in the
regression analysis. Indexed LV mass was analyzed either as a
continuous or as a categorical variable. For the experimental
study, pigs were categorized according the presence or
absence of LVH (yes/no) at baseline (before MI), which
perfectly coincided with banding or sham operation, respec-
tively. In the clinical study, patients were classiﬁed into 3
categories (LVH tertiles) according to indexed LV mass and
sex.23 Nonparametric ROC (receiver operating characteristic)
curve analyses were performed in the clinical study to assess
the discriminatory capacity of AUC of cTnI and total CK to
predict LV dysfunction at 1 week and 6 months after STEMI.
In addition, several predictive multiple regression models
were estimated based on our human data to correct infarct
sizing for troponin when LVH is present (upper tertile of
indexed LV mass), being the ﬁnal model selected according to
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parsimonious criteria and predictive capacity. All statistical
analyses were performed using commercially available soft-
ware (Stata 12.0; StataCorp LP, College Station, TX).
Results
Clinical Study
Baseline characteristics and CMR data are presented in
Table 1. Patients in the upper LVH tertile showed a 50%
higher CMR-measured absolute and indexed LV mass, com-
pared with those in the lower LVH tertile (Figure 1). Infarct
size (% of LV mass) and LVEF on 1-week CMR did not differ
between the lower and upper LVH tertiles (Figure 2).
Peak cTnI (median [IQR]) was 154.0 ng/mL (90.4 and
266.3 ng/mL) in the upper LVH tertile versus 98.1 ng/mL
(36.2 and 191.3 ng/mL) in the lower LVH tertile (P=0.02;
Figure 3A). AUC of cTnI (median [IQR]) was 3640 ng/mL
(2335 and 5143 ng/mL) in the upper LVH tertile versus
2539 ng/mL (995 and 4616 ng/mL) in the lower LVH tertile
(P=0.03; Figure 3B). In contrast, no signiﬁcant differences
were found in peak and AUC of total CK between the upper
and lower LVH tertiles (Figure 4). Biomarker release data in
the 3 population tertiles are summarized in Table 2.
In the regression analysis, higher LV mass was associated
with signiﬁcantly higher peak and AUC cTnI, after adjustment
for IS evaluated by the gold standard (% of LV mass on 1-week
CMR). This difference was observed both when indexed LV
mass was categorized (upper versus lower LVH tertiles;
P=0.009 and P=0.01 for peak and AUC cTnI, respectively;
Figure 5A and 5B) and when it was evaluated as a continuous
variable (P<0.001 and P=0.003 for peak and AUC cTnI,
respectively; see Table 3). In contrast, indexed LV mass
showed no signiﬁcant association with peak or AUC of total
CK, either when it was categorized or when it was evaluated
as a continuous variable.
The discriminatory capacity of AUC of cTnI to predict post-
STEMI LV dysfunction (LVEF ≤40%) on 1-week CMR was
signiﬁcantly worse for patients with LVH (upper LVH tertile,
0.71; 95% conﬁdence interval [CI], 0.55 to 0.87; lower LVH
tertile, 0.92; 95% CI, 0.84 to 0.99; P=0.02; Figure 6A). A
sensitivity analysis using other clinically relevant LVEF cutoffs
showed similar results (Figure 6B). AUC of cTnI was similarly
poor at predicting long-term (6 months post-STEMI) severe
Table 1. Characteristics and Cardiac Magnetic Resonance Data in the Clinical Study
Lower Tertile of Indexed LV Mass
(n=47)
Middle Tertile of Indexed LV Mass
(n=46)
Upper Tertile of Indexed LV Mass
(n=47) P Value* P Value†
Age, y 58.7 (11.9) 59.7 (12.0) 56.7 (10.6) 0.45 0.23
Male, % 89.4 89.1 89.4 1.00 1.00
Hypertension, % 40.4 45.7 31.9 0.41 0.40
Dyslipidemia, % 53.2 44.4 36.2 0.26 0.15
Diabetes, % 12.8 30.4 14.9 0.08 1.00
Smoking (active), % 51.1 50.0 55.3 0.91 0.84
Body mass index, kg/m2 27.9 (3.1) 28.3 (3.7) 28.0 (4.4) 0.86 0.94
Body surface area, m2 1.93 (0.15) 1.90 (0.14) 1.89 (0.17) 0.40 0.20
Symptom-onset-to-balloon time,
minute
190.8 (61.1) 186.0 (57.7) 212.7 (77.3) 0.12 0.13
TIMI grade 3 post-PTCA, % 68.1 69.6 76.6 0.67 0.49
Prereperfusion i.v. metoprolol, % 46.8 54.3 44.7 0.49 1.00
LV mass, g 93.1 (12.9) 110.1 (13.6) 136.6 (22.2) <0.0001 <0.0001
Indexed LV mass, g/m2 48.1 (5.1) 57.7 (4.5) 72.3 (10.9) <0.0001 <0.0001
Infarct size (% of LV) at day 5 to 7 21.4 (12.6) 19.7 (11.1) 23.0 (10.7) 0.37 0.52
LVEF (%) at day 5 to 7 44.4 (9.7) 47.4 (9.4) 44.2 (7.3) 0.17 0.92
LVEF (%) at 6 months 47.18 (10.85) 50.8 (10.0) 46.48 (9.90) 0.11 0.75
Continuous variables are reported as means (SD) and compared by parametric methods (1-way ANOVA for comparison between all tertiles, and 2-tailed Student t test for comparison
between upper and lower tertile of indexed LV mass). Categorical variables are reported as percentages and compared by Fisher’s exact test. LV indicates left ventricle;
LVEF, left ventricular ejection fraction; PTCA, percutaneous transluminal coronary angioplasty; TIMI, thrombolysis in myocardial infarction.
*P value for comparison between all tertiles.
†P value for comparison between upper and lower tertile of indexed LV mass.
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LVEF depression (≤35%) for patients with LVH (upper LVH
tertile, 0.74; 95% CI, 0.59 to 0.90; lower LVH tertile, 0.92; 95%
CI, 0.84 to 1.00; P=0.04). In contrast, the discriminatory
capacity of AUC of total CK to predict LV dysfunction did not
differ signiﬁcantly between LVH tertiles at any cutoff or time
point.
Animal Study
Six pigs (4 of 10 banded, and 2 of 8 sham-operated) died
during AMI induction as a result of refractory ventricular
ﬁbrillation. The ﬁnal population for analytical purposes was
thus 12 pigs (6/group). Baseline characteristics and CMR
data are presented in Table 4. Banded pigs had 30% higher
absolute and indexed LV mass (Figure 7). Infarct size (% of LV
mass) and LVEF on day 7 CMR did not differ between banded
and sham-operated groups (Figure 8).
Peak cTnI (median [IQR]) was 183.4 ng/mL (171.4 and
194.3 ng/mL) in the banded group versus 153.1 ng/mL
(132.6 and 169.7 ng/mL) in sham-operated controls (P=0.04;
Figure 9A). AUC of cTnI (median [IQR]) was 55 230 ng/mL
(52 537 and 57 598 ng/mL) in the banded group versus
45 817 ng/mL (41 998 and 50 365 ng/mL) in sham-
operated controls (P=0.04; Figure 9B). In contrast, peak and
A B
Figure 1. Left ventricular mass differences in patients presenting with STEMI. Patients in the upper tertile
showed 50% higher absolute LV mass (A) and indexed LV mass (B): 136.622.2 g and 72.310.9 g/m2
in the upper tertile versus 93.112.9 g and 48.15.1 g/m2 in the lower tertile, respectively (P<0.0001 for
both comparisons). Bars represent mean and SEM. LV indicates left ventricular; STEMI, ST-segment
elevation myocardial infarction.
A B
Figure 2. Distributional plots of infarct size (A) and left ventricular ejection fraction (B) measured by
magnetic resonance in STEMI patients 1 week after infarction and classiﬁed in upper and lower tertiles of
indexed LV mass. No between-tertile differences were detected: infarct size 23.01.6% in the upper LVH
tertile versus 21.41.8% in the lower tertile; LVEF 44.21.1% in the upper tertile versus 44.41.4% in the
lower tertile (P>0.50 for both comparisons). Box plots show median values and interquartile range (Tukey’s
method); crosses represent mean values. LV indicates left ventricular; LVEF, LV ejection fraction; LVH, LV
hypertrophy; STEMI, ST-segment elevation myocardial infarction.
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AUC of total CK did not differ signiﬁcantly between banded
and sham-operated groups.
In the regression analysis, higher LV mass was associated
with a signiﬁcantly higher peak and AUC cTnI, after
adjustment for IS evaluated by the gold standard (% of LV
mass on day 7 CMR). This difference was observed both
when indexed LV mass was categorized (yes/no; P<0.001
and P=0.001 for peak and AUC cTnI, respectively; Figure 10A
A B
Figure 3. Differences in peripheral blood concentrations of cTnI between lower and upper tertiles of
indexed LV mass in patients presenting with STEMI. A, Box plots of peak cTnI, showing median values and
interquartile range (Tukey’s method); crosses represent mean values. B, Time proﬁle of cTnI readings after
STEMI (meanSEM). cTnI indicates cardiac troponin I; LV, left ventricular; STEMI, ST-segment elevation
myocardial infarction.
A B
Figure 4. A, Peak total CK in STEMI patients in the lower and upper LVH tertiles in the clinical study. Box
plots show median values and interquartile range (IQR; Tukey’s method) of total CK; crosses represent
mean values. The median (IQR) of the peak in the upper tertile was 4003 (2064 to 5065) versus 2829 UI/L
(1348 to 4720) in the lower tertile (P>0.10). B, AUC of total CK in the lower and upper LVH tertiles. Data are
presented as meanSEM. The median (IQR) AUC of total CK in the upper tertile was 67 841 (40 759 to
99 692) versus 54 365 UI/L (28 573 to 83 894) in the lower tertile (P>0.10). AUC indicates area under
the curve; CK, creatine kinase; LVH, left ventricular hypertrophy; STEMI, ST-segment elevation myocardial
infarction.
Table 2. Biomarker Release Data in the Clinical Study
Lower Tertile of Indexed LV Mass (n=47) Middle Tertile of Indexed LV Mass (n=46) Upper Tertile of Indexed LV Mass (n=47)
Peak of cTnI, ng/mL 98.1 (36.2 to 191.3) 98.3 (29.4 to 200.3) 154.0 (90.4 to 266.3)
AUC of cTnI, ng/mL 2539 (995 to 4616) 2021 (741 to 4913) 3640 (2335 to 5143)
Peak of total CK, UI/L 2829 (1348 to 4720) 2176 (897 to 4471) 4003 (2064 to 5065)
AUC of total CK, UI/L 54 365 (28 573 to 83 894) 45 573 (21 230 to 74 260) 67 841 (40 759 to 99 692)
Data are presented as median (interquartile range). Data are not adjusted by actual infarct size as measured by cardiac magnetic resonance. AUC indicates area under the curve;
CK, creatine kinase; cTnI, cardiac troponin I; LV, left ventricle.
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and 10B) and when it was evaluated as a continuous variable
(P=0.023 and P=0.035 for peak and AUC cTnI, respectively;
see Table 5). In contrast, indexed LV mass showed no
signiﬁcant association with peak or AUC of total CK, either
when it was categorized or when it was evaluated as a
continuous variable.
A
B
Figure 5. A, Scatter plots and ﬁtted values of transformed (square-root) peak cTnI in STEMI patients
versus infarct size evaluated by the gold standard (% of LV mass on 1-week CMR). Plots are shown for
patients in the lower tertile of indexed LV mass (white circles and dash line) and in the upper tertile (gray
squares and solid line). B, Differences in transformed peak and AUC of cTnI between the upper and lower
indexed LV mass tertiles, adjusted for infarct size as assessed by the CMR gold standard. AUC indicates
area under the curve; CI, conﬁdence interval; CMR, cardiac magnetic resonance; cTnI, cardiac troponin I; LV,
left ventricle; STEMI, ST-segment elevation myocardial infarction.
Table 3. Elevated LV Mass in STEMI Patients in the Clinical Study Is Signiﬁcantly Associated With High Peak and AUC of cTnI,
After Adjustment for Infarct Size
Adjusted Difference 95% CI P Value
Transformed peak of cTnI 0.87 0.41 to 1.33 <0.001
Transformed AUC of cTnI 2.59 0.87 to 4.30 0.003
The table shows adjusted differences in transformed peak and transformed AUC of cTnI for every 10-g/m2 increase in indexed LV mass, adjusted for infarct size as assessed by the gold
standard (% of LV mass on 1-week CMR). AUC indicates area under the curve; CI, conﬁdence interval; CMR, cardiac magnetic resonance; cTnI, cardiac troponin I; LV, left ventricle;
STEMI, ST-segment elevation myocardial infarction.
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Histological evaluation showed that ventricular cardiomyo-
cytes from banded pigs were signiﬁcantly larger than those of
sham-operated pigs (P=0.021; Figures 11 and 12A). Quanti-
ﬁcation of total cTnI per cardiomyocyte on immunostained
sections revealed signiﬁcantly higher cTnI content per cell in
banded pigs (P=0.043; Figures 11 and 12B).
Discussion
The present study shows that, for a given infarct size
determined by CMR, peak and AUC of cTnI are unusually
high in patients with LVH and in pigs with induced LVH. In
contrast, LVH had no effect on peak or AUC of total CK.
A
B
Figure 6. A, Discriminatory capacity of AUC of cTnI to predict LV dysfunction (LVEF ≤40%) on 1-week
CMR in STEMI patients in the lower and upper indexed LV mass tertiles. B, Sensitivity analysis performed
according to clinically relevant LVEF cut-offs. AUC indicates area under the curve; CI, conﬁdence interval;
CMR, cardiac magnetic resonance; cTnI, cardiac troponin I; LV, left ventricle; LVEF, LV ejection fraction;
ROC, receiver operating characteristic; STEMI, ST-segment elevation myocardial infarction.
Table 4. Characteristics and Cardiac Magnetic Resonance Data of the Animal Study Population
Sham-Operated Group (n=6) Banded Group (n=6) P Value
Weight, kg 63.8 (6.1) 66.9 (2.8) 0.23
Body surface area, m2 1.12 (0.07) 1.16 (0.03) 0.23
LV mass, g 81.7 (8.3) 107.4 (16.7) 0.004
Indexed LV mass, g/m2 72.9 (3.4) 92.8 (13.8) 0.004
Baseline LVEF, % 54.9 (5.2) 57.6 (3.9) 0.42
Infarct size (% of LV) 27.8 (5.0) 25.0 (3.3) 0.42
LVEF (%) at day 7 38.2 (8.0) 39.7 (6.3) 0.87
Continuous variables are reported as means (SD) and compared by a nonparametric test (Wilcoxon’s rank-sum test). LV indicates left ventricle; LVEF, left ventricular ejection fraction.
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ROC analysis shows that cTnI release during a STEMI is a
less-accurate predictor of short- and long-term LV impair-
ment in the presence of LVH. Moreover, cardiomyocytes
from pigs with LVH have a higher cTnI content compared
with cardiomyocytes from nonhypertrophied hearts. The
same ﬁndings were consistently found in patients enrolled
in a contemporary clinical trial and in a controlled large-
animal study.
Quantiﬁcation of the extent of myocardial necrosis after
STEMI is of clinical and research interest. CMR has become
the gold standard for accurate in vivo quantiﬁcation of IS.1
However, CMR is not widely available and is logistically
challenging. Biomarkers of cardiac damage released to the
systemic circulation after STEMI have, for many years, been
used as surrogate markers of IS. For several decades, peak
and AUC of total CK was the preferred biomarker. The more
speciﬁc cardiac troponins were introduced later and are
increasingly used. Peak and AUC of total CK and cTnI have
been shown to correlate well with IS measured by gold-
standard techniques. Owing to their cardiac speciﬁcity,
troponins have become the reference biomarker for estimat-
ing IS and thus for predicting long-term clinical outcomes
A B
Figure 7. LV mass differences between sham-operated pigs and pigs with banding of the aorta to induce
LVH. Absolute (A) and indexed (B) LV mass were 30% higher in the banded pigs: 107.416.7 g and
92.813.8 g/m2 in the banded group versus 81.78.3 g and 72.93.4 g/m2 in the sham-operated group
(P<0.01 for both comparisons). Bars represent mean and SEM. LV indicates left ventricle; LVH, left
ventricular hypertrophy.
A B
Figure 8. Distributional plots of infarct size (A) and LVEF (B) measured by magnetic resonance in sham-
operated and banded pigs 1 week after infarction. No differences were detected between groups for either
parameter: infarct size, 25.03.3% banded versus 27.85.0% sham-operated; LVEF, 39.76.3% banded
versus 38.28.0% sham-operated (P>0.40 for both comparisons). Box plots show median values and
interquartile range (Tukey’s method); crosses represent mean values. LV indicates left ventricle; LVEF, LV
ejection fraction.
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after STEMI,4,24 and, consequently, many experimental stud-
ies and clinical trials use cardiac troponins as the primary
outcome measure.8,25,26 It is therefore important to identify
confounders that affect the release and quantiﬁcation of
cardiac troponins. Given the high prevalence of LVH in the
general population (20% to 25%),11,12 and especially in the MI
population (50%),27 it is of great importance to know whether
LV mass affects the systemic release of biomarkers after an
AMI. Notably, stratiﬁcation according to hypertension—the
most frequent cause of LVH—may be insufﬁcient to control
the effect of LV mass on biomarker release, given that
approximately one third of patients with hypertension are
unaware that they are hypertensive.28
Our analysis of total CK and cTnI showed that whereas
hypertrophied hearts release more cTnI than control hearts
upon AMI, hypertrophy does not affect total CK release. The
CK system is important for intracellular energy production
and utilization and is abundantly present in tissues with high
metabolic demand. There are 4 electrophoretically distinct
CK isoenzymes—BB, MB, MM, and the mitochondrial forms
(mi-CK)—with CK-MB predominating in the adult heart.29
Animal models of LVH consistently show that hypertrophic
cardiomyocytes switch to a fetal CK isoenzyme pattern,
increasing expression of CK-MB and CK-BB at the expense of
reduced expression of CK-MM and mi-CK in order to
increase energy yield; these changes balance out so that
total CK levels in the hypertrophied myocardium are
unaltered.30–35 In contrast, it is intuitive to argue that
cardiomyocyte content of troponin would increase with
hypertrophy as part of the general increase in cardiomyocyte
content of contractile units and associated contractile
proteins. Thus, in the setting of LVH, the release of
troponins will be disproportionally high after STEMI, whereas
total CK release will not be affected. Regarding this speciﬁc
issue, we estimated a ﬁnal predictive model to correct
infarct sizing for troponin when LVH is present. Thus, it was
estimated that, in patients with LVH (upper tertile of indexed
LV mass), peak of cTnI overestimates infarct size by 30%, as
measured on CMR. Most research on the CK system took
place in the 1980s and 1990s, when the troponins were still
A B
Figure 9. Postinfarction differences in peripheral blood concentrations of cTnI between sham-operated
and pigs with banding of the aorta to induce LVH. A, Box plots of peak cTnI, showing median values and
interquartile range (Tukey’s method); crosses represent mean values. B, Time proﬁle of cTnI readings after
induced MI (meanSEM). cTnI indicates cardiac-troponin I; LVH, left ventricular hypertrophy; MI, myocardial
infarction.
Table 5. Experimentally Increased LV Mass in Pigs Is Signiﬁcantly Associated With High Peak and AUC of cTnI, After Adjustment
for Infarct Size
Adjusted Difference 95% CI P Value
Transformed peak of cTnI 0.67 0.12 to 1.22 0.023
Transformed AUC of cTnI 9.62 0.82 to 18.42 0.035
Transformed peak of total CK 2.72 27.06 to 32.51 0.841
Transformed AUC of total CK 72.18 446.31 to 590.68 0.760
On the other hand, increased LV mass in pigs is not associated with higher peak and AUC of total CK. The table shows adjusted differences in transformed peak and transformed AUC of
cTnI and total CK for every 10-g/m2 increase in indexed LV mass, adjusted for infarct size as assessed by the gold standard (% of LV mass on 1-week CMR). AUC indicates area under the
curve; CK, creatine kinase; CMR, cardiac magnetic resonance; cTnI, cardiac troponin I; LV, left ventricle.
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unknown. The subsequent development of speciﬁc methods
to accurately quantify troponins has established the use of
this biomarker, and the high sensitivity and speciﬁcity of
troponins for detecting even mild cardiac damage has
represented a big step forward in the early triage of patients
with chest pain. The inﬂuence of LVH on cTnI release after
myocardial damage reported here does not invalidate the
use of troponins as surrogate markers, but shows the need
to take LV mass into account as an important potential
confounding factor in clinical and research evaluations.
These considerations could be especially important in
determining the signiﬁcance of small increases in circulating
troponin in patients presenting to the emergency depart-
ment, given that troponin readings in patients with LVH may
give a false-positive diagnosis of MI.36 In this regard, mild
increases in troponin-I37–40 or troponin-T41 have been
reported in patients with LVH in the absence of chest pain
or any other acute condition. In addition, it has been recently
reported that cardiac troponin concentrations correlate with
LV mass index independent of coronary artery disease status
in patients with aortic valve stenosis.42,43 Presence of a
dynamic pattern (rise and/or fall) in cardiac troponin values
along with clinical evidence of ischemia can be of help to
conﬁrm the diagnosis of MI in these contexts. Although the
aims of our study were beyond these important issues, our
data support that, for a given small stress to the myocar-
A
B
Figure 10. A, Scatter plots and ﬁtted values of transformed (square-root) peak postinfarction cTnI versus
infarct size evaluated by the gold standard (% of LV mass on 1-week CMR). Plots are shown for sham-
operated (white circles and dash line) and banded pigs (gray squares and solid line). B, Differences in
transformed peak and AUC of cTnI between sham-operated and banded pigs, adjusted for infarct size as
assessed by the CMR gold standard. AUC indicates area under the curve; CI, conﬁdence interval; CMR,
cardiac magnetic resonance; cTnI, cardiac-troponin I; LV, left ventricle.
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dium, troponin release in patients with LVH might be larger
than in patients with normal LV mass.
In summary, our results show that LVH inﬂuences troponin
release upon cardiac damage both in STEMI patients and in a
controlled large-animal study, associated with higher expres-
sion of cTnI in cardiomyocytes from LVH hearts. These data
have clinical implications given that many clinical trials use
troponin release as a surrogate endpoint of the extent of
cardiac damage and IS.
Limitations
Total CK circulating levels are potentially inﬂuenced by
skeletal muscle trauma (including animal handling, intramus-
Figure 11. Representative immunoﬂuorescence images of cTnI (pink, center) and cell membrane stained
with FITC-WGA (green, left) in heart sections from sham-operated pigs (top) and hypertrophic (banded) pigs
(bottom). Merged images are shown on the right. Nuclei are stained blue. cTnI indicates cardiac troponin I;
FITC-WGA, ﬂuorescein-isothiocyanate–conjugated lectin from wheat.
A B
Figure 12. A, Cardiomyocyte area in banded and sham-operated pigs with no induced myocardial
infarction. Box plots (Tukey’s method) represent individual data (all random analyzed ﬁelds) from all pigs
(4 pigs/group). Median (IQR) cardiomyocyte size was 579.3 lm2 (516.9 to 685.7) in banded pigs and
326.2 lm2 (271.0 to 420.0) in sham-operated pigs (P=0.021). B, Immunoﬂuorescence of cardiac troponin I
in banded and sham-operated pigs with no induced myocardial infarction. Box plots (Tukey’s method)
represent individual data (all random analyzed ﬁelds) from all pigs (4 pigs/group). Median (IQR)
immunoﬂuorescence intensity was 80 arbitrary units/ﬁeld (62 to 96) in the banded pigs and 55.5 a.u./ﬁeld
(49.5 to 65) in sham-operated pigs (P=0.043). IQR indicates interquartile range.
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cular injections, or surgical procedures).44,45 Although we
cannot completely exclude a signiﬁcant inﬂuence of animal
manipulation in total CK release, baseline total CK values
were not different among groups. Of note, blood sample
collections for biomarker measurement were performed 4 to
5 months after thoracotomy, thus unlikely to interfere in
total CK release.
CK-MB was not systematically measured in the clinical
study because it is no longer routinely evaluated in our
environment. Similarly, CK-MB was not assessed in the animal
study owing to lack of speciﬁcity of available antibodies and
species differences in detected CK-MB activity.46 In addition,
activity of CK-MB has been shown to be very low in pigs,47
thus being much less cardiac speciﬁc of myocardial damage
than expected in humans owing to a very low CK-MB/total CK
ratio in the cardiac muscle.48 Of note, because of previously
mentioned increase expression of CK-MB during ventricular
hypertrophy,30–35 we can speculate that CK-MB measurement
overestimates actual infarct size similar to cTn. Although
CK-MB has been used for years as the cardiac-speciﬁc
biomarker of myocardial damage, cTn is currently the
preferred biomarker because of its signiﬁcantly higher cardiac
tissue speciﬁcity.9,49
None of the cTnI assays used in this study are considered
ultrasensitive. However, the conclusions from the present
work are not likely to be affected by this fact given that high
sensitivity is not needed to measure the levels observed both
in pigs and humans in the context of STEMI.
The Siemens Dimension RxL assay was designed for
detection of human cTnI. However, several ﬁndings anticipate
its acceptable use in blood samples derived from pigs: (1)
There is an almost perfect match between pigs and humans
regarding amino acid sequences of the residues (epitopes)
recognized by the antibodies of this kit (see www.ifcc.org/
ifcc-scientiﬁc-division/documents-of-the-sd/troponinassay-
analyticalcharacteristics2013/) when performing a Basic
Local Alignment Search Tool (BLAST) test; (2) this assay has
been shown to have good cTnI immunoreactivity in serum
collected from rats and dogs,50 which have identical amino
acid sequence in these epitopes to pigs; and (3) blood and
cardiac tissue collected from pigs has been shown to have
good cross-reactivity to the antibodies used in a previous ﬁrst-
generation kit from the same manufacturer, which recognized
the same epitopes with the same method.51,52
Conclusions
Peak and AUC of cTnI signiﬁcantly overestimate infarct size in
the presence of LVH, a phenomenon probably owing to the
increased cTnI content in hypertrophied cardiomyocytes.
Consistent with these ﬁndings, the discriminatory capacity
of cTnI to predict LV dysfunction is signiﬁcantly worse for
patients with LVH. LV mass should therefore be considered
when infarct size and LV function are estimated by troponin
release.
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(6months) follow-up. Infarct size (delayed gadoliniumenhancement) and cardiac function (left ventricular ejec-
tion fraction [LVEF]) were correlated with exposures of interest by multivariate regression analysis.
Results:AA:EPA ratio directly related to acute infarct size (coefﬁcient [95%CI]: 6.19 [1.68 to 10.69], P=0.008) and
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1. Introduction
Ischemic heart disease (IHD), the leading cause of death worldwide
[1], can be prevented by a variety of dietary components [2]. Among
them, intake of long-chain omega-3 polyunsaturated fatty acids
(LCn3PUFA), mainly eicosapentaenoic acid (C20:5n-3, EPA) and
docosahexaenoic acids (C22:6n-3, DHA), is associated with a lower
risk of IHD, particularly sudden cardiac death, in individuals without
prior cardiovascular disease [3]. The link is controversial for secondary
prevention [4], which can be mostly explained by the universal statin
treatment aftermyocardial infarction and by the fact thatmyocardial in-
farction survivors are no longer deﬁcient in LCn3PUFA, as recently
pointed out [5]. Based on large epidemiologic studies, the American
Heart Association recommended consuming at least two servings per
week of ﬁsh, preferably fatty ﬁsh [6].
Dietary LCn3PUFA readily displace the omega-6 arachidonic acid
(C20:4n-6, AA) from membranes [7]. Such replacement modiﬁes the
production of eicosanoids and other lipid mediators by the cyclooxy-
genase, lipoxygenase, and cytochrome P450 pathways [8,9]. Myocardial
ischemia triggers the release of free AA and the ensuing formation of
pro-inﬂammatory eicosanoids, which are believed to amplify ischemic
tissue damage in animal models and in patients with myocardial
infarction [10,11]. In contrast, the release of EPA from cardiac
membranes under ischemic conditions leads to the generation of anti-
inﬂammatory eicosanoids [7–9].
Long-termdiet-induced displacement of AA of cardiomyocytemem-
branes by EPA may thus have beneﬁcial effects in the event of ST-
segment elevation myocardial infarction (STEMI), protecting the myo-
cardium during the ischemia/reperfusion process and improving post-
infarction ventricular function and remodeling. This strategy would be
of interest in public health, given that infarct size and chronic left ven-
tricular ejection fraction (LVEF) are major determinants of post-STEMI
mortality and morbidity [12,13]. Experimental models have consistent-
ly reported a nutritional preconditioning-like effect of diets supple-
mented with LCn3PUFA in the heart [14–19], but clinical data are
conﬁned to a recent study reporting that treatment with doses of
4 g/d of LCn3PUFA after myocardial infarction improves cardiac remod-
eling [20]. The issue of whether regular ﬁsh eaters who sustain a ﬁrst
STEMImayhave less extensive cardiac damage than non-eaters remains
to be explored. In observational studies, the optimal approach to ad-
dress this issue is by using the fatty acid composition of body tissues,
given the difﬁculties of accuratelymeasuring fat intake from the diet re-
cords [21].
We therefore hypothesized that cardiomyocite membrane AA re-
placement by EPA supplied by the usual diet, in the absence of omega-
3 supplementation,would relate to smallermyocardial injury and result
in better chronic left ventricle contractile function at the time of a ﬁrst
STEMI. Given that routine myocardial biopsy is not safe in the acute
phase of STEMI, we measured the AA:EPA ratio in red blood cells
(RBC) – a well validated surrogate for cardiomyocyte membrane fatty
acid content [22,23] unaffected in the subacute phase of a cardiac
event [24] – at the time of STEMI and studied its association with
acute infarct size and long-term cardiac function as assessed by state-
of-the-art cardiac magnetic resonance (CMR) [25].
2. Material and methods
This observational study is a substudy of the METOCARD-CNIC clinical trial (http://
www.clinicaltrials.gov. Unique identiﬁer: NCT01311700. EUDRACT number: 2010-
019939-35) [26–28].
2.1. Design and study participants
TheMETOCARD-CNIC trial showed that in patients suffering a ﬁrst STEMI, early intra-
venous metoprolol administration prior to primary percutaneous coronary intervention
reduces acute infarct size [27] and preserves long-term LVEF, thereby reducing the inci-
dence of severe left ventricle systolic dysfunction and lowering heart failure admissions
[28]. The study protocol has been described in detail elsewhere [26]. Participants were
recruited between November 2010 and October 2012. Inclusion criteria were age 18 to
80 years, Killip class ≤ II anterior STEMI, and anticipated symptom onset-to-reperfusion
time ≤ 6 h. Aside from allocation to pre-reperfusion intravenous metoprolol or control,
all patients received state-of-the-art treatment according to clinical guidelines, including
long-term oral treatment with β-blockers. The study, which complied with the Declara-
tion ofHelsinki,was approved by the institutional reviewboards of each participating cen-
ter, and all eligible candidates provided written informed consent. Complete information
was available in 100 STEMI patients (n=50, treatedwith intravenousmetoprolol admin-
istration prior to primary percutaneous coronary intervention; and n=50 controls, no re-
ceiving metoprolol) who agreed to participate in this substudy (Supplementary Fig. 1).
2.2. RBC membrane fatty acid analysis
Overnight fasting period (N10 h) blood samples were drawn during hospital admis-
sion and were stored at−80 °C until fatty acid analysis. The RBC fatty acid proﬁle was de-
termined as described [29]. In brief, whole blood cells were hemolysed and the pellet
(N99.5% RBC membranes) was obtained by centrifugation. After that, the cell membrane
pellet was dissolved in 1 ml BF3 methanol solution and transferred to a screw-cap test-
tube, which was heated for 10 min at 100 °C to hydrolyze and methylate
glycerophospholipid fatty acids. The extracts were cooled and fatty acid methyl esters
were isolated by adding 300 μl of n-hexane. The tubes were centrifuged and an aliquot
of the upper layer was transferred into an automatic injector vial equipped with a 300 μl
volume adapter. Fatty acid methyl esters were separated by gas-chromatography using
an Agilent HP 7890 Gas Chromatograph equipped with a 30 m × 0.25 μm × 0.25 mm
SupraWAX-280 capillary column (Teknokroma, Barcelona, Spain), an autosampler, and a
ﬂame ionization detector. The amount of each fatty acid is expressed as a percentage of
the total identiﬁed fatty acids in the sample.
2.3. Dietary assessment
To assess the consumption of foods rich in the fatty acids of interest (seafood) in the
months prior to the STEMI, a random subsample (n= 36) underwent an adaptation of a
validated semiquantitative food-frequency questionnaire [30] at baseline in a face-to-
face interview. Information on seafood products was collected in eight items (uncanned
fatty ﬁsh; lean ﬁsh; smoked/salted ﬁsh; molluscs; shrimp, prawn and crayﬁsh; octopus,
baby squid and squid; fatty ﬁsh canned in oil; fatty ﬁsh canned in salted water). EPA
and DHA intake was estimated by multiplying the frequency of each item for the fatty
acid composition of the servings consumed and averaging intake to daily amounts. Nutri-
ent composition was estimated from Spanish food composition tables [31].
2.4. CMR procedure
A detailed description of the CMR protocol and analytical methods is reported else-
where [26]. Analyses were undertaken by the core laboratory at the Centro Nacional de
Investigaciones Cardiovasculares Carlos III (CNIC). Data were quantiﬁed with dedicated
software (QMass MR 7.5; Medis, Leiden, the Netherlands). Main CMR outcomes included
the extent of edema (myocardium at risk) deﬁned by high signal intensity on T2-weighted
imaging; the extent of necrosis (infarct size) deﬁned by the degree of abnormal delayed
gadolinium enhancement on T1 inversion-recovery sequences; and LVEF. Acute CMR
was scheduled to be performed 5 to 7 days after infarction, and patients underwent
follow-up CMR 6 months after the index event.
2.5. Statistical analysis
Normal distribution of eachdata subsetwas assessed using graphicalmethods and the
Shapiro–Wilk test. Levene's test was performed to test the homogeneity of variances. For
quantitative variables following a normal distribution, data are expressed as mean and
standard deviation (SD), while non-normal data are reported asmedians and interquartile
range. For categorical variables, data are expressed as frequencies and percentages. Multi-
ple linear regression analysis was used to study the association between RBC fatty acids
(AA:EPA ratio, AA, and EPA) and CMR outcomes (infarct size at 5–7 days after infarction,
and LVEF at 6 months after infarction). In addition to unadjusted models, we constructed
models adjusted for area at risk,which is themain determinant of infarct size, and by early
intravenous metoprolol administration (yes/no), given that it has been shown to reduce
infarct size [27] and improve long-term LVEF [28]. Potential confounding factors (age,
sex, body mass index, diabetes, dyslipidemia, and hypertension) were investigated, and
the ﬁnal model was selected according to parsimonious criteria and no relevant change
in the precision of the estimation. Any explored fatty acid variable followed a normal dis-
tribution; therefore in the regression analysis these variables were processed by a loga-
rithmic transformation (EPA and the AA:EPA ratio) or a square transformation (AA).
Standard diagnostic checks on the residuals from the ﬁtted models showed no evidence
of any failure of the assumption of normality and homogeneity of the residual variance.
Sperman's correlation coefﬁcientwas used to study the association between the calculated
intake of EPA + DHA and the RBC proportions of EPA and AA:EPA ratio at the time of
STEMI. Statistical signiﬁcance was set at an alpha value of 0.05. All statistical analyses
were performed using commercially available software (Stata 12.0).
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3. Results
Baseline clinical characteristics and treatment regimens of the study
population are shown in Table 1. Demographic, anthropometric, and
clinical characteristics of patients included in this substudy were
similar to those of the overall study cohort (data not shown). 15% of par-
ticipants were treated with statins before STEMI, while the full cohort
received statin treatment at 6 months. RBC membrane fatty acid com-
position at hospital admission is presented in Table 2. Acute and
follow-up CMR data are summarized in Table 3.
In a randomly selected subset of subjects at baseline (n = 36), the
mean (SD) of fatty ﬁsh, lean ﬁsh, and total ﬁsh was 38.3 g/d (22.1),
27.7 g/d (16.2) and 101.4 g/d (45.8), respectively. The calculated
mean EPA+DHA intake was 1006mg/d (502). Attesting to the validity
of the questionnaire, the Spearman's correlation coefﬁcient between
calculated intake of EPA + DHA and AA:EPA ratio in RBC at the time
of STEMI was−0.384 (P= 0.021), while the value for EPA in RBC was
0.392 (P= 0.018).
Univariate associations between CMR-assessed acute infarct size
were−0.141 (P = 0.161); 0.112 (P = 0.269), and 0.173 (P = 0.086)
for RBC EPA, AA, and AA:EPA ratio, respectively. The values for long-
term LVEF were 0.130 (P = 0.198),−0.225 (P = 0.024), and−0.185
(P = 0.065), respectively. Multivariate associations are shown in
Tables 4, 5, and eTable 1. The AA:EPA ratio showed a signiﬁcant direct
association with acute infarct size (coefﬁcient: 6.19; 95% CI: 1.68 to
10.69; P = 0.008; Table 4) and a signiﬁcant inverse association with
LVEF at 6 months (coefﬁcient: −4.02; 95% CI: −7.15 to −0.89; P =
0.012; Table 4). Signiﬁcant associations were found for EPA (inverse
with infarct size at baseline [coefﬁcient: −6.58; 95% CI: −11.46 to
−1.70; P = 0.009], and direct with LVEF at follow-up [coefﬁcient:
3.67; 95% CI: 0.25 to 7.08; P=0.036]) (Table 5). AA showed a signiﬁcant
inverse association with long-term LVEF (coefﬁcient: −0.02; 95% CI:
−0.03 to 0.00; P= 0.022) (eTable 1).
4. Discussion
In this substudy of theMETOCARD-CNIC trial, we found that reduced
AA:EPA ratio in RBC membranes at the time of STEMI was associated
with smaller infarctions and improved long-term LVEF. Despite its ob-
servational design, our study investigated the preconditioning-like
properties of omega-3 fatty acids in humans, a notion only explored in
animal models heretofore. We determined the LCn3PUFA proﬁle in
RBC, which is known to mirror dietary LCn3PUFA intake [21,29] and it
is a validated surrogate for cardiac fatty acid status in humans, as previ-
ously demonstrated in studies undertaken in heart transplant recipients
[23] and in patients undergoing cardiac bypass surgery [24]. Our un-
precedented ﬁndings suggest that replacement of AA with EPA in the
phospholipids of cell membranes (including cardiomyocytes), which
can be achieved through the regular intake of fatty ﬁsh or ﬁsh oil,
might contribute improving prognosis in the event of a STEMI.
Advances in reperfusion have reduced the acutemortality associated
with STEMI, the leading cause of death worldwide, and attention has
since turned to the improvement of survivors' quality of life and life ex-
pectancy [14]. In this regard, declining cardiac function emerged as an
important and powerful predictor of clinical outcomes in post-
infarction patients [13]. As a result, pharmacological and device-based
therapies have been implemented to reduce long-term mortality
Table 1
Clinical characteristics and treatment regimens at baseline in 100 patients with anterior
STEMI.
Variable Mean (SD) Range
Age, y 58.1 (11.5) 34.3 to 80.8
Male sex, n (%) 86 (86.0) –
Body mass index, kg/m2 27.4 (3.5) 21.1 to 40.4
Hypertension, n (%) 40 (40.0) –
Smoking status, n (%) –
Current 54 (54.0)
Ex-smoker (0–10 y before) 7 (7.0)
Dyslipidemia, n (%) 44 (44.0) –
Treatment with statins, n (%) 15 (15.0) –
Diabetes mellitus, n (%) 20 (20.0) –
Ischemia duration, mina 190.6 (62.9) 60 to 345
Killip class I at admission, n (%) 94 (94.0) –
Infarct artery lesion location, n (%) –
Proximal LAD 21 (21.0)
Mid LAD 67 (67.0)
Distal LAD 7 (7.0)
Diagonal 2 (2.0)
Other 3 (3.0)
TIMI grade 0–1 ﬂow before PCI, n (%) 83 (83.0) –
Successful PCI, n (%)b 98 (98.0) –
Treatment at the time of PCI, n (%) –
Heparin 95 (95.0)
Aspirin 100 (100.0)
Thienopyiridine 98 (98.0)
Thrombus aspiration 89 (89.0)
GP IIb/IIIa during PCI 66 (66.0)
a Time from symptom onset to reperfusion.
b Deﬁned as TIMI grade 2 to 3 ﬂow after percutaneous coronary intervention.
Table 2
Red blood cell fatty acids at hospital admission.
Fatty acid (% of total fatty acids) Median (interquartile range)
C14:0 1.86 (1.00 to 2.76)
C16:0 20.63 (19.93 to 21.48)
C18:0 10.51 (9.85 to 11.56)
C20:0 0.10 (0.08 to 0.12)
C22:0 0.14 (0.11 to 0.17)
C24:0 0.29 (0.22 to 0.35)
Sum of saturated fatty acids 33.79 (32.77 to 34.84)
C16:1n-7 cis 0.67 (0.54 to 0.88)
C18:1n-9 cis 14.78 (14.11 to 16.34)
C18:1n-9 trans 1.26 (1.15 to 1.34)
C20:1n-9 0.19 (0.16 to 0.23)
C24:1n-9 0.37 (0.27 to 0.45)
Sum of monounsaturated fatty acids 17.41 (16.50 to 18.97)
C18:2n-6 12.70 (11.56 to 14.07)
C18:3n-6 0.17 (0.12 to 0.22)
C20:2n-6 0.25 (0.22 to 0.30)
C20:3n-6 1.89 (1.64 to 2.20)
C20:4n-6 (AA, arachidonic acid) 20.13 (18.63 to 22.04)
C22:4n-6 2.44 (2.10 to 2.78)
C22:5n-6 0.46 (0.38 to 0.56)
Sum of n-6 polyunsaturated fatty acids 38.21 (36.60 to 41.18)
C18:3n-3 0.12 (0.10 to 0.16)
C20:5n-3 (EPA, eicosapentaenoic acid) 0.83 (0.62 to 1.13)
C22:5n-3 1.85 (1.67 to 2.04)
C22:6n-3 (DHA, docosahexaenoic acid) 6.67 (5.79 to 7.58)
Omega-3 index (C20:5n-3 + C22:6n-3) 7.70 (6.52 to 8.64)
AA:EPA ratio 24.97 (18.14 to 32.74)
Table 3
Baseline and long-term magnetic resonance imaging data.
Variable
Baseline
(5 to 7 days after infarction)
Long-term
(6 mo after infarction)
Mean (SD) Range Mean (SD) Range
LVEDV, mL 173.9 (36.7) 100.2 to 301.6 190.1 (43.1) 108.7 to 327.7
LVESV, mL 94.9 (32.1) 33.3 to 217.7 101.7 (41.0) 39.9 to 229.2
LV mass, g 110.8 (25.8) 57.7 to 186.1 85.8 (20.0) 40.5 to 139.4
Edema, g 35.4 (16.5) 0 to 75.7 – –
Edema, % LV 28.2 (11.7) 0 to 52.0 – –
Infarct size, g 24.7 (17.7) 0 to 79.8 14.8 (10.8) 0.0 to 42.4
LVEF, % 46.4 (9.7) 26.7 to 67.2 48.0 (10.8) 26.8 to 68.4
LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume;
LV, left ventricle; LVEF, left ventricular ejection fraction.
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associated with low LVEF. The cost of these treatment strategies, how-
ever, precludes their universal implementation, particularly in develop-
ing countries [32]. By showing that long-term LVEF relates to the cell
membrane fatty acid proﬁle at the time of infarction, which is known
to be modulated by dietary habits during the preceding weeks [21,33],
we add on the notion of ﬁsh-derived LCn3PUFA as healthy fat for the
heart.
The associations found for EPA and for the AA:EPA ratio, a surro-
gate of AA displacement by EPA, are mechanistically supported by
the opposite effects on ischemia of recently discovered cytochrome
P450-derived metabolites of AA and EPA [9,10]. Of note, an EPA-
derived compound, resolvin E1, has been found to protect rat
cardiomyocytes against ischemia-reperfusion injury and to limit in-
farct size when administered intravenously before reperfusion [34].
Our ﬁnding adds plausibility to the hypothesis linking cardiovascular
risk to the relative proportions of precursors of harmful and protec-
tive lipid mediators (AA and EPA, respectively), which was raised
by Dyerberg more than 30 years ago in an attempt to explain the
low incidence of myocardial infarction among the Inuit of Greenland
despite their high dietary intake of marine fat [35]. In line with our
results, three studies from Japan, a country in which ﬁsh consump-
tion is customarily high, reported that serum AA/EPA ratio directly
related to hampered cardiac stability [36] and to an increased inci-
dence of major adverse cardiac events after an ischemic insult [37,
38]. However, the use of fatty acid composition of total serum,
which does not reﬂect long-term intake as accurately as adipose
tissue or RBC do [21], precludes the attribution of observed effects
to membrane changes upon long-term EPA intake. In contrast, the
turnover of RBC (120-day lifespan) makes RBC a suitable sample
for objective assessment of LCn3PUFA status, with stability docu-
mented over a 6-week period [33] and importantly, in a subacute
phase of a cardiac event [24]. This guarantees that the RBC fatty
acid composition during hospital admission is representative of the
fatty acid proﬁle at the time of STEMI.
In linewith the knownnotion that LCn3PUFA content in body tissues
mirrors dietary intake of EPA andDHA,we inquired about ﬁsh and shell-
ﬁsh consumption in a subset (36%) of our population. To address this,
we adapted a validated food-frequency questionnaire [30] previously
used to relate dietary estimate EPA+DHA intake to RBC LCn3PUFA sta-
tus in a Spanish population [29].Accordingly, we found a signiﬁcant as-
sociation between RBC AA:EPA ratio and estimated LCn3PUFA intake,
with a Spearman's correlation coefﬁcient concurring with previous lit-
erature [21]. The subset providing dietary data reported a mean
EPA+DHA intake of 1006mg/d, which largely exceeds the recommen-
dation for the primary prevention of IHD [6]. This, in turn, is due to the
high consumption of fattyﬁsh (mean38 g/d)within themonths prior to
STEMI in our study, a ﬁgure that concurs with reports from other Span-
ish populations [39].
Our study has limitations, such as the relatively small number of
study subjects and the related low statistical power to detect clinical
events during follow-up. The reason for a lack of a pre-speciﬁed sample
size is that this is a study conducted in a subset of a clinical trial explor-
ing changes in infarct size and LVEF after early intravenous metoprolol
administration, and ours was an exploratory study with a sample
large enough to detect a link between dietary determinants prior to
admission and LVEF 6 months after infarction. A second limitation is
that the food-frequency questionnaire was only administered to a
subgroup of patients, and dietary intakes could not be adjusted
for total energy intake because only seafood-derived items were
investigated. Finally, a cause-effect relationship would only be
established by a randomized clinical trial involving a nutritional inter-
vention in a large population at high risk of STEMI followed for several
years. The study also has strengths, such as the use of state-of-the-art
CMR technology to evaluate heart anatomy and function, the use of an
Table 4
Independent determinants of acute infarct size (grams of LV tissue) and long-term left ventricular ejection fraction (%), including the ratio of C20:4n-6 to C20:5n-3 (AA:EPA ratio) in red
blood cells at baseline.
Acute infarct size
Variable Coef. (95% CI) P F (3, 96) Prob N F Adj R-squared
Edema, % of LV 1.08 (0.88 to 1.29) b0.001 42.58 b0.001 0.56
Metoprolol, yes −5.12 (−9.79 to−0.44) 0.032
AA:EPA ratioa 6.19 (1.68 to 10.69) 0.008
Long-term left ventricular ejection fraction
Variable Coef. (95% CI) P F (3, 96) Prob N F Adj R-squared
Edema, % of LV −0.58 (−0.72 to−0.44) b0.001 25.97 b0.001 0.43
Metoprolol, yes 2.59 (−0.65 to 5.83) 0.116
AA:EPA ratioa −4.02 (−7.15 to−0.89) 0.012
CI, conﬁdence interval; LV, left ventricle.
a Logarithmic-transformed variable.
Table 5
Independent determinants of acute infarct size (grams of LV tissue) and long-term left ventricular ejection fraction (%), including the proportion of EPA (C20:5n-3) in red blood cells at
baseline.
Acute infarct size
Variable Coef. (95% CI) P F (3, 96) Prob N F Adj R-squared
Edema, % of LV 1.10 (0.90 to 1.30) b0.001 42.40 b0.001 0.56
Metoprolol, yes −4.92 (−9.60 to−0.24) 0.040
EPAa −6.58 (−11.46 to−1.70) 0.009
Long-term left ventricular ejection fraction
Variable Coef. (95% CI) P F (3, 96) Prob N F Adj R-squared
Edema, % of LV -0.59 (−0.73 to−0.45) b0.001 24.85 b0.001 0.42
Metoprolol, yes 2.48 (−0.80 to 5.75) 0.136
EPAa 3.67 (0.25 to 7.08) 0.036
CI, conﬁdence interval; LV, left ventricle.
a Logarithmic-transformed variable.
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objective and stable biomarker of long-term fatty acid intake
(reinforced by the association with calculated intake of EPA + DHA in
a subset of our sample), and the adjustment for well-known
confounders in multivariable analyses.
In conclusion, we report that a low AA:EPA ratio in RBCmembranes
at the time of STEMI is associated with presumed protection against
myocardial injury, as reﬂected by reduced infarct size and improved
long-term LVEF. Our results, which are consistent with the current
model of the pathogenesis of myocardium damage upon ischemia/re-
perfusion, add plausibility to a hypothesis only tested in experimental
models heretofore. The ﬁndings might contribute to explain also the
primary prevention of fatal IHD, particularly sudden cardiac death, as-
cribed to the anti-arrhythmic properties of LCn3PUFA fatty acids. This
overall supports the notion that consumption of seafood, fatty ﬁsh in
particular, is a valid strategy for improving cardiovascular health, as rec-
ommended by several scientiﬁc society guidelines [6,40].
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ijcard.2016.11.214.
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 3.3 Chapter III. Temporal dynamics and pathophysiology of the 
edematous response after myocardial infarction 
A similar translational strategy as described before was followed for the research 
work performed to study the temporal dynamics and pathophysiology of the 
edematous response after MI. The overall research hypothesis emerged after the 
preliminary observation that the visualization of the post-MI edema qualitatively 
varied among individuals in the experimental setting. 
In this process, we initially performed an in vivo validation of a CMR sequence for 
fast and accurate myocardial T2 mapping (T2 gradient-spin-echo [GraSE]) that 
could be easily integrated in routine protocols, and used in our subsequent 
experimental and clinical work for an accurate quantification and tracking of 
myocardial edema. This study represents the first validation of any parametric T2 
sequence for myocardial water quantification against the gold standard. As a result, 
we have contributed to the literature with the following original research article for 
which I am the first author. 
 
Original research article #3. “Fast T2 gradient-spin-echo (T2-GraSE) mapping for 
myocardial edema quantification: first in vivo validation in a porcine model of 
ischemia/reperfusion”.69 
 
Then, we challenged the accepted view of the development of post-I/R myocardial 
edema in the preclinical setting. Through state-of-the-art CMR analysis and 
histological validation in a pig model of I/R, we showed for the first time that the 
edematous reaction during the first week after reperfusion is not stable, instead 
follows a bimodal pattern. As a result, we have contributed to the literature with the 
following original research article for which I am the first author. 
 
Original research article #4. “Myocardial edema after ischemia/reperfusion is not 
stable and follows a bimodal pattern: imaging and histological tissue 
characterization”.70 
 
Later, we studied the pathophysiology underlying the bimodal edematous reaction 
after MI in the preclinical setting. For such a purpose, a series of experiments were 
79
 designed including (1) a variety of strategies to modulate post-MI tissue composition 
(short-duration ischemia, permanent coronary occlusion, systemic administration of 
steroids, and coronary pre- and post-conditioning); (2) in-depth tissue 
characterization by CMR; (3) different time points for imaging and sample collection 
within the first week after MI; and (4) myocardial characterization at the cellular and 
molecular level by the use of histology, immunohistochemistry and proteomic tissue 
analysis. As a result, we have contributed to the literature with 3 original research 
articles for which I am first or co-first author. The work on proteomic myocardial 
tissue analysis after MI is only mentioned here and the manuscript is not included 
as part of this dissertation since the doctoral candidate is co-first author as second 
position in the manuscript.71 
 
Original research article #5. “Pathophysiology underlying the bimodal edema 
phenomenon after myocardial ischemia/reperfusion”.72 
 
Original research article #6. “Effect of ischemia duration and protective 
interventions on the temporal dynamics of tissue composition after myocardial 
infarction”.73 
 
Finally, we challenged the accepted view of the development of post-I/R myocardial 
edema in the clinical setting in a collaborative effort with researchers located at the 
Hospital Universitario de Salamanca. Thus, we were able to demonstrate for the first 
time that post-MI edema in patients follows a bimodal pattern that affects CMR 
estimates of MaR and salvage. Remarkably, CMR scans timing and sequences 
were designed as per protocol of our previous preclinical studies, becoming the first 
comprehensive evaluation of patients with ST-segment elevation MI by serial CMR 
to include the hyperacute postreperfusion period (i.e. the first 3 hours after primary 
PCI). During the analysis and writing phases of this work, the doctoral student 
performed a multidisciplinary training program that included the use and post-
processing of cardiovascular imaging techniques at Mount Sinai Hospital (New 
York, United States of America) which complemented the skills and knowledge 
previously acquired. As a result, we have contributed to the literature with the 
following original research article for which I am the first author. 
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Original research article #7. “Dynamic edematous response of the human heart 
to myocardial infarction: implications for assessing myocardial area at risk and 
salvage”.74 
 
The results presented in this thesis work have received great attention. Thus, part 
of the work described here has been presented by the doctoral student in renowned 
international scientific congresses. Similarly, the demonstration of a bimodal edema 
phenomenon in the post-ischemic myocardium in pigs, and then in humans, has 
generated an ongoing intense controversy in the scientific community as it will be 
discussed later. As a result, we have contributed to the literature with 4 letters to the 
editor so far for which I am the first author. 
 
Letter to the Editor #1. “Reply: myocardial edema should be stratified according 
to the state of cardiomyocytes within the ischemic region”.75 
  
Letter to the Editor #2. “Reply: myocardial salvage, area at risk by T2W CMR: the 
resolution of the retrospective radio wave paradigm?”.76 
  
Letter to the Editor #3. “Reply: waves of edema seem implausible”.77 
 
Letter to the Editor #4. “Letter by Fernandez-Jimenez et al regarding article, 
Protective effects of ticagrelor on myocardial injury after infarction”.78 
 
For the scientific documents published and contained in this chapter, I contributed 
as doctoral student in the following: design and plan the preclinical experiments and 
clinical study, develop and perform the different models of MI in the pig, collect and 
process myocardial tissue samples for subsequent analysis, CMR imaging 
acquisition and analysis, statistical analysis, draft the manuscript, and elaborate and 
make critical input in the peer review process. 
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 Original research article #3. “Fast T2 gradient-spin-echo (T2-GraSE) mapping for 
myocardial edema quantification: first in vivo validation in a porcine model of 
ischemia/reperfusion”.69 
 
 
Part of this work was presented by the doctoral student at the 64th American College 
of Cardiology´s Annual Scientific Sessions, in San Diego (March 2015; California, 
USA). The communication received the Best Abstract Award: “the American College 
of Cardiology and the Spanish Society of Cardiology recognized Rodrigo 
Fernandez-Jimenez as first author of the highest ranking abstract submitted from 
Spain and accepted for presentation at the American College of Cardiology´s Annual 
Scientific Sessions in San Diego (March 2015; California, USA)”.  
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Background: Several T2-mapping sequences have been recently proposed to quantify myocardial edema by
providing T2 relaxation time values. However, no T2-mapping sequence has ever been validated against actual
myocardial water content for edema detection. In addition, these T2-mapping sequences are either time-
consuming or require specialized software for data acquisition and/or post-processing, factors impeding their
routine clinical use. Our objective was to obtain in vivo validation of a sequence for fast and accurate myocardial
T2-mapping (T2 gradient-spin-echo [GraSE]) that can be easily integrated in routine protocols.
Methods: The study population comprised 25 pigs. Closed-chest 40 min ischemia/reperfusion was performed in
20 pigs. Pigs were sacrificed at 120 min (n = 5), 24 h (n = 5), 4 days (n = 5) and 7 days (n = 5) after reperfusion, and
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Conclusions: We present the first in vivo validation of T2-mapping to assess myocardial edema. Given its shorter
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mapping of the myocardium offers an attractive alternative to current CMR sequences for T2 quantification.
Keywords: Cardiovascular magnetic resonance, T2-mapping, Imaging, Myocardial infarction, Edema, Water content
* Correspondence: bibanez@cnic.es
†Equal contributors
1Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC),
Madrid, Spain
5Department of Cardiology, Instituto de Investigación Sanitaria, Fundación
Jiménez Díaz Hospital, Madrid, Spain
Full list of author information is available at the end of the article
© 2015 Fernández-Jiménez et al. Open Access This article is distributed under the terms of the Creative Commons Attribution
4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Fernández-Jiménez et al. Journal of Cardiovascular Magnetic Resonance  (2015) 17:92 
DOI 10.1186/s12968-015-0199-9
83
Background
Cardiovascular magnetic resonance (CMR) has emerged
as a popular and useful tool for noninvasive myocardial
tissue characterization [1]. CMR provides valuable ana-
tomical and functional information through high spatial
resolution images and soft tissue contrast, without
exposing patients to ionizing radiation. There is particu-
lar interest in using CMR to detect and track myocardial
water content, because edema is a feature of many car-
diovascular conditions [2–4]. T2-weighted (T2W) CMR
sequences have been used for this task [5], but several
problems inherent to these sequences have limited the
widespread acceptance of this sequence to detect edema
[6]. New T2-mapping sequences have recently been pro-
posed to overcome some of these limitations [7–10] and
provide absolute quantification of myocardial T2 relax-
ation times that can be compared among studies, the
reference standard being T2 turbo-spin-echo (T2-TSE)
[11, 12]. However, these methods are either time-
consuming or require specialized software for data
acquisition and/or post-processing, factors which limit
their routine clinical use.
It is noteworthy that no T2-mapping sequence has
ever been validated for quantification of myocardial
water content against direct measurement by a gold
standard technique. The validity of T2-mapping sequences
for this task has been assumed based on their ability to
retrospectively delineate the hypoperfused myocardial ter-
ritory supplied by the occluded coronary artery (the area
at risk). However, regional T2 relaxation time in the post-
ischemia/reperfusion area is affected by tissue characteris-
tics [13, 14], the application of cardioprotective therapies
[15, 16], and the timing of image acquisition [17], and
therefore the evidence supporting the validity of T2-
mapping for myocardial edema quantification is weak.
In this study, we sought to provide in vivo validation
of a sequence for fast and accurate T2-mapping of the
myocardium using the gradient-spin-echo (GraSE) tech-
nique [18], which could be rapidly and easily integrated
in daily protocols as it is commercially available from
many vendors. To achieve this goal, we used a closed-
chest pig model of ischemia/reperfusion in which ani-
mals were serially scanned and sacrificed at different
time-points after reperfusion for direct quantification of
myocardial water content.
Methods
General considerations and study design
Experimental procedures were performed in castrated
male Large-White pigs weighing 30 to 40 kg. The study
population comprised a total of 25 pigs. The experimen-
tal protocol was approved by the Institutional Animal
Research Committee and conducted in accordance with
recommendations of the Guide for the Care and Use of
Laboratory Animals. The study design is summarized in
Fig. 1. Briefly, reperfused acute myocardial infarction
was induced in 20 pigs by closed-chest 40-min left an-
terior descending coronary artery occlusion followed by
reperfusion. Pigs were sacrificed at 120 min (n = 5,
Group 2), 24 h (n = 5, Group 3), 4 days (n = 5, Group 4)
and 7 days (n = 5, Group 5) after reperfusion. CMR scans,
including T2-TSE mapping (current standard) and T2-
GraSE mapping sequences were performed at every
follow-up until sacrifice (animals sacrificed at day 7
thus underwent baseline, 120 min, 24 h, day 4, and
day 7 CMR). Five pigs (Group 1) were sacrificed with
no other intervention than baseline CMR, and served as
controls (healthy non-infarcted heart). Animals were
sacrificed immediately after the last follow-up CMR, and
myocardial tissue samples from ischemic and remote areas
were rapidly collected for determination of water content.
Myocardial infarction procedure
The protocol of ischemia/reperfusion has been detailed
elsewhere [17]. In summary, anesthesia was induced by
intramuscular injection of ketamine (20 mg/kg), xylazine
(2 mg/kg), and midazolam (0.5 mg/kg) and maintained by
continuous intravenous infusion of ketamine (2 mg/kg/h),
xylazine (0.2 mg/kg/h) and midazolam (0.2 mg/kg/h). All
animals were intubated and mechanically ventilated with
oxygen (inspired O2 28 %). Central venous and arterial
lines were placed and a single bolus of unfractioned hep-
arin (300 mg/kg) was administered before any further
procedure. The left anterior descending coronary artery
immediately distal to the origin of the first diagonal
branch was occluded for 40 min with an angioplasty
balloon introduced thorough a catheter inserted via the
percutaneous femoral route. Balloon location and state of
inflation were monitored angiographically. After balloon
deflation, a coronary angiogram was recorded to confirm
patency of the coronary artery. A continuous infusion of
amiodarone (300 mg/h) was maintained during the pro-
cedure in all pigs to prevent malignant ventricular ar-
rhythmias. In cases of ventricular fibrillation, a biphasic
defibrillator was used to deliver non-synchronized shocks.
At intermediate follow-up time points, animals were re-
covered and cared for by a dedicated team of veterinarians
and technicians.
CMR protocol
Baseline CMR was performed immediately before myocar-
dial infarction and subsequently repeated at post-infarction
follow-up time points until sacrifice. All scans were
performed during free breathing in a Philips 3-T
Achieva Tx whole body scanner (Philips Healthcare,
Best, the Netherlands) equipped with a 32-element
phased-array cardiac coil. The imaging protocol included
a standard segmented cine steady-state free-precession
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(SSFP) sequence to provide high quality anatomical refer-
ences, a T2- turbo spin multi-echo mapping sequence
(T2-TSE), and a T2- gradient spin echo mapping sequence
(T2-GraSE). The imaging parameters for the SSFP se-
quence were FOV of 280x280, slice thickness of 6 mm
with no gap, TR 2.8 ms, TE 1.4 ms, flip angle 45°, cardiac
phases 30, voxel size 1.8×1.8 mm2, and 3 NEX. The im-
aging parameters for the T2-TSE mapping were FOV
300×300 with and acquisition voxel size of 1.8×1.8 mm2
and slice thickness 8 mm, TR 2 heartbeats, and ten echo
times ranging from 4.9 to 49 ms. The imaging parameters
for the T2-GraSE mapping were FOV 300×300 with an ac-
quisition voxel size of 1.8×2.0 mm2 and slice thickness
8 mm, TR 2 heartbeats, and eight echo times ranging from
6.7 to 53.6 ms, EPI factor 3. Both T2 mapping sequence
where black blood triggered with a trigger delay placed at
mid-diastole. Both T2-mapping sequences are schema-
tized in Fig. 2. SSFP was performed to acquire 13–15 con-
tiguous short axis slices covering the heart from the base
to the apex, whereas T2-maps were acquired in a mid-
apical ventricular short axis slice corresponding to the
same anatomical level in all studies, in order to track T2
relaxation time changes across time.
CMR data analysis
CMR images were analyzed using dedicated software
(MR Extended Work Space 2.6, Philips Healthcare, The
Netherlands). T2-maps were automatically generated on
the acquisition scanner by fitting the SI of all echo times
to a monoexponential decay curve at each pixel with a
maximum likelihood expectation maximization algo-
rithm. T2 relaxation maps were quantitatively analyzed
by placing a wide transmural region of interest (ROI) at
the ischemic and remote areas of the corresponding slice
in all studies. The masking was defined in the first echo
image to improve the contrast between the cardiac
muscle and the cavity. Higher T2 values in this interface
can be found due to slow flow artifact; therefore, ROIs
were carefully placed avoiding those areas from the ana-
lysis to minimize contamination on the reported T2
values. Hypointense areas suggestive of microvascular
obstruction or hemorrhage were included in the ROI for
T2 quantification purposes.
Quantification of myocardial water content
Paired myocardial samples were collected within the first
5 min of sacrifice from the infarcted and remote myo-
cardium of all pigs. Tissue samples were immediately
blotted to remove surface moisture and introduced into
glass containers previously weighed on a high-precision
scale. The containers were weighed before and after
drying for 48 h at 100 °C in a desiccating oven. Tissue
water content was calculated as follows: water content
(%) = [(wet weight − dry weight)/wet weight] × 100. An
empty container was weighed before and after desicca-
tion as an additional calibration control.
Statistical analysis
Normal distribution was checked using graphical methods
and a Shapiro-Wilk test. For quantitative variables
showing a normal distribution, data are expressed as
mean ± standard deviation. For quantitative variables
showing a non-normal distribution, data are reported
as medians with first and third quartiles. Agreement
of T2 relaxation time measurements between T2-TSE
and T2-GraSE mapping techniques was evaluated by
the square of Pearson’s correlation coefficient, the
intraclass correlation coefficient for two-way random
effect models, and Bland-Altman analysis [19]. Association
between T2 relaxation time measurements performed by
T2-TSE and T2-GraSE, and water content was evaluated
by the square of Pearson’s correlation coefficient. The
significance of the difference between these correlation co-
efficients was performed using the Fisher r-to-z transform-
ation and the cortesti user-written command for Stata.
Statistical significance was set at a two-tailed probability
Fig. 1 Study design. The study population comprised 5 groups of pigs (n = 5/group). Groups 2 to 5 were subjected to 40 min ischemia/reperfusion
(I/R) and were sacrificed at different time-points during the first week after reperfusion and heart tissue extracted for direct quantification of myocardial
water content. Five pigs (Group 1) were sacrificed with no intervention other than baseline cardiovascular magnetic resonance (CMR), and served as
controls. CMR scans including T2-TSE and T2-GraSE mapping sequences were performed at all follow-up stages until sacrifice, so that animals sacrificed
at day 7 underwent baseline, 120 min, 24 h, day 4 and day 7 CMR
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level of 0.05. All statistical analyses were performed using
commercially available software (Stata 12.0). The authors
had full access to the data and take responsibility for
its integrity.
Results
Duration of sequence acquisition and T2 relaxation time
measurements performed by T2-TSE and T2-GraSE mapping
Mean study acquisition length was 189 ± 19 s for T2-TSE
mapping and 65 ± 8 s for T2-GraSE mapping (p < 0.001).
T2 relaxation time measurements obtained by T2-TSE
and T2-GraSE mapping at different follow-up points in
the ischemic and remote myocardium are summarized in
Table 1 and Table 2, respectively.
Agreement of T2 relaxation time measurements
performed by T2-TSE and T2-GraSE mapping
T2 relaxation time measurements obtained by T2-TSE
mapping and T2-GraSE mapping showed almost perfect
correlation (R2 = 0.99, Fig. 3a). Intraclass correlation
coefficients (ICC) evaluating absolute agreement and
consistency of agreement between both T2 mapping
techniques showed an excellent concordance between
sequences (ICC > 0.96 for all evaluations, Table 3).
Bland-Altman analysis showed a good agreement between
sequences (Fig. 3b). Representative T2-mapping images
obtained by T2-TSE and T2-GraSE from the same pig
subjected to 40 min of ischemia and 7 days of reperfusion
are shown in Fig. 4.
Fig. 2 Detail of T2-TSE and T2-GraSE mapping sequences. General scheme of Turbo Spin Echo (TSE) and Gradient Spin Echo (GraSE) mapping sequences.
For the TSE a single k-space line is acquired for every excitation requiring as many excitations as k-space lines in the image (a). Conversely, for the GraSE
sequence an echo planar imaging (EPI) readout is interleaved between each refocusing pulse, so that as many k-space lines are acquired as there are EPI
factors, thus allowing shorter scan times (b). RF: radiofrequency pulse. MR: magnetic resonance signal. Meas.: measurement encoding
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Association between T2 relaxation time measurements
and directly measured water content
Directly determined myocardial water content showed a
good correlation with T2 relaxation time measurements
performed by T2-TSE mapping (R2 = 0.75, p < 0.001;
Fig. 5a) and by T2-GraSE mapping (R2 = 0.73, p < 0.001;
Fig. 5b). No statistically significant differences between
these correlations were observed.
Discussion
In this study we present an in vivo validation of a CMR
sequence for fast and accurate T2-mapping of the heart
using the gradient-spin-echo (GraSE) technique that can
be easily integrated in routine protocols, overcoming
some of the limitations of current CMR mapping se-
quences for myocardial T2 quantification. For this en-
deavor we developed a closed-chest large animal model
of ischemia/reperfusion in which animals had serial
CMR scans and were sacrificed at serial time-points after
reperfusion for direct quantification of myocardial water
content. Two mapping sequences were used to quantify
myocardial T2 relaxation time: the well-established ref-
erence T2-TSE technique and the newer T2-GraSE tech-
nique, which further speeds up the TSE sequence [18].
Table 1 T2 relaxation time (ms) in the ischemic myocardium measured by T2-TSE and T2-GraSE mapping sequences at different
time-points during the first week after ischemia/reperfusion
T2 relaxation time (ms)
Baseline R-120 min R-24 h R-Day4 R-Day7
Group 1 (Control) TSE 47.7 (4.0)
GraSE 48.0 (4.7)
Group 2 (I/R-120 min) TSE 48.7 (0.6) 73.3 (10.0)
GraSE 49.9 (2.5) 76.5 (7.8)
Group 3 (I/R-24 h) TSE 46.5 (1.9) 72.4 (12.3) 45.9 (5.3)
GraSE 48.3 (4.8) 73.9 (10.0) 42.9 (4.5)
Group 4 (I/R-4 days) TSE 45.9 (1.6) 73.5 (4.2) 42.7 (9.3) 55.1 (13.2)
GraSE 45.0 (3.7) 78.7 (10.8) 42.6 (8.5) 54.3 (14.1)
Group 5 (I/R-7 days) TSE 47.2 (3.5) 72.6 (14.2) 47.0 (2.9) 64.9 (7.9) 78.4 (10.6)
GraSE 46.5 (3.0) 74.8 (14.4) 46.7 (4.9) 66.4 (8.3) 78.9 (11.7)
Pooled TSE 47.2 (2.6) 72.9 (9.9) 45.2 (6.2) 60.0 (11.5) 78.4 (10.6)
GraSE 47.6 (3.9) 76.0 (10.3) 44.1 (6.1) 60.4 (12.6) 78.9 (11.7)
Values are mean (standard deviation). I/R: ischemia/reperfusion. TSE: turbo spin echo. GraSE: gradient spin echo. CMR T2 relaxation times measured by T2-TSE
mapping in the ischemic myocardium of these pigs have been reported [17]
Table 2 T2 relaxation time (ms) in the remote myocardium measured by T2-TSE and T2-GraSE mapping sequences at different
time-points during the first week after ischemia/reperfusion
T2 relaxation time (ms)
Baseline R-120 min R-24 h R-Day4 R-Day7
Group 1 (Control) TSE 46.1 (1.5)
GraSE 45.7 (1.8)
Group 2 (I/R-120 min) TSE 46.8 (1.8) 47.0 (1.0)
GraSE 47.2 (1.6) 48.4 (2.0)
Group 3 (I/R-24 h) TSE 46.2 (2.6) 48.6 (3.0) 45.2 (0.6)
GraSE 46.8 (1.9) 47.2 (5.2) 44.8 (1.2)
Group 4 (I/R-4 days) TSE 45.5 (0.8) 48.3 (4.0) 47.5 (3.1) 48.2 (2.9)
GraSE 44.8 (1.1) 45.5 (4.6) 45.9 (3.9) 49.1 (1.4)
Group 5 (I/R-7 days) TSE 46.7 (1.5) 48.5 (3.7) 51.4 (5.0) 50.1 (1.8) 50.0 (3.3)
GraSE 44.6 (2.3) 46.5 (2.9) 51.0 (3.5) 49.0 (1.5) 49.3 (5.0)
Pooled TSE 46.3 (1.7) 48.1 (3.0) 48.0 (4.1) 49.1 (2.5) 50.0 (3.3)
GraSE 45.8 (1.9) 47.0 (3.7) 47.2 (4.0) 49.0 (1.4) 49.3 (5.0)
Values are mean (standard deviation). I/R: ischemia/reperfusion. TSE: turbo spin echo. GraSE: gradient spin echo. CMR T2 relaxation times measured by T2-TSE
mapping in the remote myocardium of these pigs have been reported [17]
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The translational pig model of myocardial infarction
used in this study allows examination of a wide range of
myocardial T2 relaxation times and myocardial water
content [17], and produced values that closely mimic
those clinically observed in several pathological condi-
tions, strengthening the present validation.
Accurate noninvasive detection and quantification of
myocardial edema is of great scientific and clinical inter-
est given the occurrence of edema in several cardiovas-
cular diseases and its usefulness for diagnosis and its
correlation with ventricular remodeling and prognosis
[20–22]. Many studies over the past decades have inves-
tigated the use of CMR with T2-weighted (T2W) se-
quences to monitor in the post-ischemic myocardium,
since this approach is considered especially suited to the
detection of high water content in this setting [23].
However, several problems inherent to T2W-CMR have
limited the widespread uptake of this sequence for the
detection of edema [6]. These problems include varia-
tions in surface coil sensitivity, motion artifacts, incom-
plete blood suppression, and the subjectivity of image
interpretation [24].
A number of T2-mapping sequences have been re-
cently proposed as a route to overcoming some of these
limitations [7–9] and providing absolute quantification
of regional T2 relaxation times that can be compared
across studies. However, these methods are either time-
consuming or require specialized software for data ac-
quisition and/or post-processing, factors that impede
their clinical routine use. Compared with these other
approaches, T2-GraSE mapping has many advantages,
including an acceptable acquisition time for integration
into daily clinical CMR protocols, reduced energy re-
quirements, and the use of standard post-processing
methods. In this study, T2-GraSE mapping was 3-times
faster than conventional reference standard T2-TSE
mapping due to the interleaving of the EPI readout be-
tween two consecutive 180° pulses. The applicability of
myocardial T2-mapping using the GraSE technique in
humans has been reported recently [12, 25]; however,
these studies mostly examined healthy hearts and there-
fore a narrow range of myocardial T2 relaxation times,
and did not validate the sequence against directly deter-
mined tissue water content. Our study provides robust
validation of T2-GraSE over a wide spectrum of myocar-
dial T2 relaxation times and water contents that reflect a
range of potential clinical scenarios.
Descriptions of previous T2-mapping sequences have
relied on their ability to retrospectively identify the hypo-
perfused myocardial territory supplied by the occluded cor-
onary artery—the area at risk—and there are no published
data validating these techniques against true myocardial
water content. Regional T2 relaxation time in the ischemic
area can be altered depending on tissue characteristics
[13, 14], the application of cardioprotective therapies
Fig. 3 Assessment of agreement between T2 relaxation times measured by T2-TSE and T2-GraSE mapping. (a) Scatter plot showing almost perfect
linear correlation (R2 = 0.99) of T2 relaxation times measured by T2-TSE and T2-GraSE mapping. (b) Bland-Altman analysis demonstrated excellent
agreement between T2 relaxation readings from both T2-mapping sequences. The mean T2 relaxation time difference (T2-GraSE – T2-TSE) was
0.1 ms (agreement interval 95 %: −6.2 to 6.3 ms). The percentages of cases above and below the limits were 2.0 % and 2.7 %. The Spearman correlation
coefficient between T2 relaxation time differences (T2-GraSE – T2-TSE) and mean T2 relaxation times (T2-GraSE & T2-TSE) was 0.33 (p < 0.001)
Table 3 Absolute agreement and consistency of agreement
between T2 relaxation times measured by T2-TSE and T2-GraSE
mapping
ICC 95 % CI
Absolute agreement Individual 0.967 0.954–0.976
Average 0.982 0.976–0.988
Consistency of agreement Individual 0.966 0.954–0.976
Average 0.983 0.977–0.988
ICC: intraclass correlation coefficient. CI: confidence interval. TSE: turbo spin
echo. GraSE: gradient spin echo
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[15, 16] or the timing of imaging acquisition [17],
highlighting the need of establishing the relationship
between T2-mapping and true myocardial water con-
tent directly quantified in the tissue. This question
has been explored in only a few studies conducted
over 20 years ago [26–30], and these studies were
performed in low magnetic fields or with excised
hearts, factors well known to affect T2 relaxation
time [31]. The present study is thus the first to pro-
vide in vivo validation of T2-mapping against actual
tissue myocardial water content in magnetic fields
used in current clinical practice. We believe it is
important to assess the association between actual
water content and T2 relaxation time at 3 Tesla since
no clear relationship has been established between
these parameters at different field strength. In this
regard, in vitro analysis have demonstrated an in-
crease on myocardial T2 at 3 Tesla systems com-
pared to 1.5Tesla [32], while in-vivo studies suggest
equivalent T2 values at 3-Tesla with those previously
reported at 1.5 Tesla [33].
Our data demonstrate similarly good correlation be-
tween myocardial water content and both T2-mapping
techniques examined. In our study ≈ 25-30 % of T2
Fig. 4 Representative images of serial T2-TSE and T2-GraSE mapping. Representative T2-mapping images for all time-points from the same pig
subjected to 40 min I/R and sacrificed at day 7 after reperfusion. a T2-TSE images. b T2-GraSE images. All T2 maps were scaled between 30 and 120 ms.
All sequences were acquired with black-blood preparation prepulse. For better visualization, generated T2 maps were masked to remove background
signal. The masking was defined in the first echo image to improve the contrast between the cardiac muscle and the cavity. R: Reperfusion
Fig. 5 Association between T2 relaxation time and directly measured water content. a Scatter plot demonstrating good correlation between T2
relaxation times measured by T2-TSE mapping and directly measured myocardial water content. b Scatter plot demonstrating similarly good correlation
between T2 relaxation times measured by T2-GraSE mapping and directly measured myocardial water content. For each panel, individual data represent
values from pigs sacrificed at baseline (black circles), 120 min (navy squares), 24 h (red triangles), 4 days (green diamonds) and 7 days (blue triangles) after
reperfusion. Solid symbols represent data for ischemic myocardium and hollow symbols represent data for remote myocardium. Therefore, a total of 50
individual points for each correlation are shown which corresponds to two samples per pig (ischemic and remote myocardium) from 5 groups of 5 pigs
each sacrificed at the different time-points
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relaxation time variance was not completely explained by
water content changes, highlighting the influence on T2
values of other tissue characteristics and components
[6, 17] including the proportion of free/bound water as
well as its location (intracellular/extracellular) in the tissue
[34]. These data should be taken into account when inter-
preting clinical studies using these sequences.
In summary, we provide in vivo validation of a CMR
sequence for fast and accurate T2-mapping of the heart
using the gradient-spin-echo (GraSE) technique. This
approach can be easily integrated in routine protocols
since it is available for all equipment, and overcomes
some of the limitations of current CMR mapping
sequences for T2 quantification.
Limitations
Although tissue changes in the post-I/R myocardium in
pigs are similar to those in humans, we cannot rule out the
existence of subtle histological differences between human
and pig after infarction. As a consequence, the ≈ 30 % of T2
relaxation time variance that was not completely explained
by water content changes in the present study might differ
slightly from the value in humans. However, experimental
studies allow validation, as shown here with the direct
quantification of myocardial water content.
The pig is one of the most clinically translatable large
animal models for the study of myocardial infarction
and related issues due to its anatomical and functional
similarities to humans [35], and also shows similar T2
values in the ischemic and remote myocardium to those
seen in humans [8, 12].
In this study the ROIs for T2 relaxation time quantifi-
cation covered the entire wall thickness and were indi-
vidually adjusted by hand to carefully avoid the right and
left ventricular cavities. The ROIs therefore might in-
clude different myocardial states (e.g., hemorrhage,
microvascular obstruction, collagen) given that reperfused
myocardium is a very heterogeneous condition [36]. How-
ever, we adopted this approach to match the analysis of
water content, which was evaluated in the entire wall
thickness. Both T2 mapping sequences did not apply any
correction for respiratory motion. However, all scans were
performed during free breathing; therefore animals had an
abdominal breathing pattern with minimal chest move-
ment in antero-posterior direction minimizing the ghost-
ing artefacts in short axis view. Three-dimensional (3D)
T2-mapping sequences have been very recently described
and might benefit from higher spatial resolution, therefore
reducing partial-volume averaging effects and misreg-
istration between images [37, 38]. However, the pro-
posed implementation of the T2-GraSE mapping can
be performed in many modern scanners in a reasonable
acquisition time, while 3D T2-mapping normally take
longer acquisition times.
Conclusions
We provide the first in vivo validation of T2-mapping
for the assessment of myocardial edema. Given its
shorter acquisition time, high accuracy in quantifying T2
relaxation time and no requirement for specific software
for data acquisition or post-processing, fast T2-GraSE
mapping of the heart is an attractive alternative to
current CMR sequences for T2 quantification.
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Myocardial Edema After
Ischemia/Reperfusion Is Not Stable
and Follows a Bimodal Pattern
Imaging and Histological Tissue Characterization
Rodrigo Fernández-Jiménez, MD,*y Javier Sánchez-González, PHD,*z Jaume Agüero, MD,* Jaime García-Prieto, BSC,*
Gonzalo J. López-Martín, TECH,* José M. García-Ruiz, MD,* Antonio Molina-Iracheta, DVM,* Xavier Rosselló, MD,*
Leticia Fernández-Friera, MD, PHD,*x Gonzalo Pizarro, MD,*k Ana García-Álvarez, MD, PHD,*
Erica Dall’Armellina, MD, DPHIL,{ Carlos Macaya, MD, PHD,y Robin P. Choudhury, DM,{ Valentin Fuster, MD, PHD,*#
Borja Ibáñez, MD, PHD*y
ABSTRACT
BACKGROUND It is widely accepted that edema occurs early in the ischemic zone and persists in stable form for at
least 1 week after myocardial ischemia/reperfusion. However, there are no longitudinal studies covering from very early
(minutes) to late (1 week) reperfusion stages conﬁrming this phenomenon.
OBJECTIVES This study sought to perform a comprehensive longitudinal imaging and histological characterization
of the edematous reaction after experimental myocardial ischemia/reperfusion.
METHODS The study population consisted of 25 instrumented Large-White pigs (30 kg to 40 kg). Closed-chest 40-min
ischemia/reperfusion was performed in 20 pigs, which were sacriﬁced at 120 min (n ¼ 5), 24 h (n ¼ 5), 4 days (n ¼ 5), and
7 days (n ¼ 5) after reperfusion and processed for histological quantiﬁcation of myocardial water content. Cardiac
magnetic resonance (CMR) scans with T2-weighted short-tau inversion recovery and T2-mapping sequences were
performed at every follow-up stage until sacriﬁce. Five additional pigs sacriﬁced after baseline CMR served as controls.
RESULTS In all pigs, reperfusion was associated with a signiﬁcant increase in T2 relaxation times in the ischemic region.
On 24-h CMR, ischemic myocardium T2 times returned to normal values (similar to those seen pre-infarction). Thereafter,
ischemic myocardium-T2 times in CMR performed on days 4 and 7 after reperfusion progressively and systematically
increased. On day 7 CMR, T2 relaxation times were as high as those observed at reperfusion. Myocardial water content
analysis in the ischemic region showed a parallel bimodal pattern: 2 high water content peaks at reperfusion and at day 7,
and a signiﬁcant decrease at 24 h.
CONCLUSIONS Contrary to the accepted view, myocardial edema during the ﬁrst week after ischemia/reperfusion
follows a bimodal pattern. The initial wave appears abruptly upon reperfusion and dissipates at 24 h. Conversely, the
deferred wave of edema appears progressively days after ischemia/reperfusion and is maximal around day 7 after
reperfusion. (J Am Coll Cardiol 2015;65:315–23) © 2015 by the American College of Cardiology Foundation.
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T issue characterization after myocar-dial ischemia/reperfusion (I/R) is ofgreat scientiﬁc and clinical value. Af-
ter myocardial I/R, there is an intense ede-
matous reaction (due to abnormal ﬂuid
accumulation in the interstitial and/or cardio-
myocyte compartments) in the post-ischemic
myocardium (1–5). Cardiac magnetic reso-
nance (CMR) is a noninvasive technique that
allows accurate tissue characterization of the
myocardium (6). In particular, T2-weighted
(T2W) and T2-mapping CMR sequences have
the potential to identify tissues with high wa-
ter content (7). Few experimental studies
have correlated post-I/R T2-CMR data with myocar-
dial water content (2,8), and these validations were
undertaken at different times after reperfusion.
Many recent experimental and clinical studies have
used these CMR sequences to retrospectively eval-
uate post-myocardial infarction edema on the basis
of the assumptions that myocardial edema appears
early after I/R, persists in a stable form for at least
1 week (9,10), and is accurately visualized by CMR.
However, the time chosen for the CMR examination
varies signiﬁcantly among studies, from 1 day (9,10)
up to several weeks (9–16) after reperfusion. In addi-
tion, post-I/R T2W signal intensity and T2 relaxation
time are affected by other factors besides water con-
tent: T2-CMR results can be modulated indepen-
dently by hemorrhage (17,18), microvascular
obstruction (19), and even cardioprotective therapies
(20–22). There is, therefore, intense debate about the
accuracy of CMR-based methods for detecting, quan-
tifying, and tracking the post-infarction edematous
reaction (7,23). Given the growing use of CMR tech-
nology to quantify post-I/R edema in clinical trials
(24,25), a comprehensive characterization of the
time course of post-I/R myocardial edema, including
evaluation of both CMR and histological reference
standards, is needed (22–24,26–28).
The present study aimed to comprehensively
characterize myocardial edema and reperfusion-
related tissue changes after I/R, covering from early
to late reperfusion stages. For this, we performed a
full CMR and histopathological study in a large animal
(pig) model of I/R.
METHODS
STUDY DESIGN. Experiments were performed in
castrated male Large-White pigs weighing 30 kg to
40 kg. A total of 25 pigs completed the full protocol
and comprised the study population. The study was
approved by the Institutional Animal Research Com-
mittee and conducted in accordance with the rec-
ommendations of the Guide for the Care and Use of
Laboratory Animals. The study design is summarized
in Figure 1. Five pigs (Group 1) served as controls and
were sacriﬁced with no intervention other than
baseline CMR. In 20 pigs, reperfused acute myocar-
dial infarction (I/R) was induced experimentally by
closed-chest 40-min left anterior descending coro-
nary artery occlusion. These pigs were sacriﬁced at
120 min (n ¼ 5, Group 2), 24 h (n ¼ 5, Group 3), 4 days
(n ¼ 5, Group 4), and 7 days (n ¼ 5, Group 5) after
reperfusion. CMR scans, including T2W short-tau
inversion recovery (STIR), T2-mapping, and delayed
enhancement sequences, were performed at every
follow-up stage until sacriﬁce (i.e., animals sacriﬁced
on day 7 underwent CMR examinations at baseline,
120 min, 24 h, day 4, and day 7). After the last follow-
up CMR scan, animals were immediately euthanized,
and myocardial tissue samples from ischemic and
remote areas were rapidly collected for evaluation of
water content by histology.
MYOCARDIAL INFARCTION PROCEDURE. The I/R
protocol has been detailed elsewhere (29). Anesthesia
was induced by intramuscular injection of ketamine
(20 mg/kg), xylazine (2 mg/kg), and midazolam
(0.5 mg/kg), and maintained by continuous intrave-
nous infusion of ketamine (2 mg/kg/h), xylazine
(0.2 mg/kg/h), and midazolam (0.2 mg/kg/h). Animals
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ABBR EV I A T I ON S
AND ACRONYMS
CMR = cardiac
magnetic resonance
FOV = ﬁeld of view
I/R = ischemia/reperfusion
NEX = number of excitations
ROI = region of interest
STIR = short-tau
inversion recovery
TE = echo time
TR = repetition time
T2W = T2 weighted
Next Generation Training in Cardiovascular Research and Innovation–Cardionext. This study forms part of a Master Research
Agreement between CNIC and Philips Healthcare. QMass software use was partially supported by a scientiﬁc collaboration with
Medis Medical Imaging Systems BV. The Spanish Ministry of Economy and Competitiveness and the Pro-CNIC Foundation
support the CNIC. Dr. Fernández-Jiménez is a recipient of a Rio Hortega fellowship from the Ministry of Economy and
Competitiveness through the Instituto de Salud Carlos III; and has received an FICNIC fellowship from the Fundació Jesús Serra,
the Fundación Interhospitalaria de Investigación Cardiovascular, and the CNIC. Dr. Sánchez-González is an employee of Philips
Healthcare. Dr. Aguero is an FP7-PEOPLE-2013-ITN-Cardionext fellow. All other authors have reported that they have no re-
lationships relevant to the contents of this paper to disclose. Derek Yellon, PhD, DSc, served as Guest Editor for this paper.
Listen to this manuscript’s audio summary by JACC Editor-in-Chief Dr. Valentin Fuster.
You can also listen to this issue’s audio summary by JACC Editor-in-Chief Dr. Valentin Fuster.
Manuscript received October 19, 2014; revised manuscript received November 5, 2014, accepted November 6, 2014.
Fernández-Jiménez et al. J A C C V O L . 6 5 , N O . 4 , 2 0 1 5
Bimodal Edema After I/R F E B R U A R Y 3 , 2 0 1 5 : 3 1 5 – 2 3
316
94
were intubated and mechanically ventilated with ox-
ygen (fraction of inspired O2: 28%). Central venous and
arterial lines were inserted, and a single bolus of
unfractionated heparin (300 mg/kg) was administered
at the onset of instrumentation. The left anterior
descending coronary artery, immediately distal to the
origin of the ﬁrst diagonal branch, was occluded for 40
min with an angioplasty balloon introduced via the
percutaneous femoral route using the Seldinger tech-
nique. Balloon location and maintenance of inﬂation
were monitored angiographically. After balloon
deﬂation, a coronary angiogram was recorded to
conﬁrm patency of the coronary artery. A continuous
infusion of amiodarone (300 mg/h) was maintained
during the procedure in all pigs to prevent malignant
ventricular arrhythmias. In cases of ventricular ﬁbril-
lation, a biphasic deﬁbrillator was used to deliver
nonsynchronized shocks.
CMR PROTOCOL. A baseline CMR scan was performed
immediately before myocardial infarction and subse-
quent CMR scans were performed at post-infarction
follow-up time points until sacriﬁce. All studies were
performed in a Philips 3-T Achieva Tx whole-body
scanner (Philips Healthcare, Best, the Netherlands)
equipped with a 32-element phased-array cardiac coil.
The imaging protocol included a standard segmented
cine steady-state free-precession (SSFP) sequence to
provide high-quality anatomical references, a T2-
weighted triple inversion-recovery (T2W-STIR)
sequence, a T2-turbo spin echo (TSE) mapping
sequence, and a late gadolinium enhancement
sequence. The imaging parameters for the SSFP
sequence were ﬁeld of view (FOV) of 280  280 mm,
slice thickness 6mmwith no gaps, repetition time (TR)
2.8 ms, echo time (TE) 1.4 ms, ﬂip angle 45, cardiac
phases 30, voxel size 1.8  1.8 mm, and 3 number of
excitations (NEX). Imaging parameters for the T2W-
STIR sequence were FOV 280  280 mm, slice
thickness 6 mm, TR 2 heartbeats, TE 80 ms, voxel size
1.4  1.95 mm, delay 210 ms, end-diastolic acquisition,
echo-train length 16, and 2 NEX. The imaging param-
eters for the T2-TSEmapping were FOV 300 300mm,
slice thickness 8 mm, TR 2 heartbeats, and 10 echo
times ranging from 4.9 to 49.0 ms. Delayed enhance-
ment imaging was performed 10 to 15 min after intra-
venous administration of 0.20 mmol of gadopentetate
dimeglumine contrast agent per kg of body weight (30)
using an inversion-recovery spoiled turbo ﬁeld echo
(IR-T1TFE) sequence with the following parameters:
FOV of 280  280 mm, voxel size 1.6  1.6 mm, end-
diastolic acquisition, thickness 6 mm with no gap, TR
5.6 ms, TE 2.8 ms, inversion delay time optimized to
null normal myocardium, and 2 NEX. SSFP, T2W-STIR,
and IR-T1TFE sequences were performed to acquire 13
to 15 contiguous short-axis slices covering the heart
from the base to the apex. To track T2 relaxation time
changes across time, T2 maps in all studies were ac-
quired in midapical ventricular short-axis slices cor-
responding to the same anatomical level.
CMR DATA ANALYSIS. CMR images were analyzed
using dedicated software (MR Extended Work Space
2.6, Philips Healthcare, and QMass MR 7.5, Medis,
Leiden, the Netherlands) by 2 observers experienced
in CMR analysis. T2 maps were automatically gener-
ated on the acquisition scanner by ﬁtting the signal
intensity of all echo times to a monoexponential
decay curve at each pixel with a maximum likelihood
expectation maximization algorithm. T2 relaxation
maps were quantitatively analyzed by placing a wide
transmural region of interest (ROI) at the ischemic
and remote areas of the corresponding slice in all
studies. Hypointense areas suggestive of microvas-
cular obstruction or hemorrhage were included in
the ROI for T2 quantiﬁcation purposes. Delayed
gadolinium-enhanced regions were deﬁned as >50%
of maximum myocardial signal intensity (full width at
FIGURE 1 Study Design
CMR CMR CMR CMR CMR
BASELINE
n = 25
Group 1
(n = 5)
Group 2
(n = 5)
Group 3
(n = 5)
Group 4
(n = 5)
Group 5
(n = 5)
n = 20
n = 20 n = 15 n = 10 n = 5
120 min 24 hours Day 4 Day 7
40 min Ischemia/
Reperfusion
Sacrifice
Sacrifice Sacrifice Sacrifice Sacrifice
The study population comprised 5 groups of pigs (n ¼ 5/group) used to characterize myocardial edema during the ﬁrst week after ischemia/
reperfusion. Cardiac magnetic resonance (CMR) scans, including T2-weighted short-tau inversion recovery and T2-mapping sequences, were
performed at every follow-up until sacriﬁce (i.e., animals sacriﬁced on day 7 underwent baseline, 120-min, 24-h, day 4, and day 7 CMR).
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half maximum) with manual adjustment when
needed. If present, a central core of hypointense
signal within the area of increased signal was
included as late gadolinium-enhanced myocardium.
Regional transmurality of contrast enhancement was
evaluated in the same segments where ROIs for T2
quantiﬁcation were placed with a scheme on the basis
of the spatial extent of delayed enhancement tissue
within each segment (31). Segments with more than
75% hyperenhancement were considered segments
with transmural enhancement.
QUANTIFICATION OF MYOCARDIAL WATER CONTENT
BY HISTOLOGY. Paired myocardial samples were
collected within minutes of euthanasia from the
infarcted and remote myocardia of all pigs. Tissue
samples were immediately blotted to remove surface
moisture and introduced into laboratory crystal con-
tainers previously weighed on a high-precision scale.
The containers were weighed before and after drying
for 48 h at 100C in a desiccating oven. Tissue water
content was calculated as follows: water content
(%) ¼ ([wet weight  dry weight]/wet weight) 100.
An empty container was weighed before and after
desiccation as an additional calibration control.
STATISTICAL ANALYSIS. Normal distribution of each
data subset was checked using graphical methods
and a Shapiro-Wilk test. For quantitative variables
showing a normal distribution, data are expressed as
mean  SD. Leven’s test was performed to check the
homogeneity of variances. A 1-way analysis of vari-
ance was conducted for comparison of myocardial
water content among groups (from animals sacriﬁced
at different time points). To take repeated measures
into account, a generalized mixed model was con-
ducted for comparison of T2 relaxation times among
different time points. As this study was exploratory,
all pairwise comparisons were explored, adjusting
p values for multiple comparisons using the Holm-
Bonferroni method. In all cases, data from the
ischemic and remote myocardium (i.e., myocardial
water content and T2 relaxation time values) were
separately analyzed. All statistical analyses were
performed using commercially available software
(Stata version 12.0, StataCorp, College Station, Texas).
RESULTS
NATURAL EVOLUTION OF MYOCARDIAL EDEMA
DURING THE FIRST WEEK AFTER I/R. CMR imag ing.
Baseline (i.e., before ischemia) mean T2 relaxation
times were 47.2  2.6 ms and 46.3  1.7 ms for the
midapical anteroseptal and posterolateral left ven-
tricular walls, respectively. In all pigs, early
FIGURE 2 Time Course of CMR T2 Relaxation Time and Corresponding
Myocardial Water Content During the First Week After I/R
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Note the parallel courses of cardiac magnetic resonance (CMR) ﬂuctuations and
histologically determined edema (dashed red lines). (A) Time course of absolute T2 relax-
ation time values (ms) in the ischemic myocardium during the ﬁrst week after ischemia/
reperfusion (I/R). Bars represent means and standard errors of the means. The top of the
panel shows representative images from1 animal that underwent 40-min/7-day I/R andCMR
T2-weighted short-tau inversion recovery and T2-mapping examinations at all time points.
All T2mapswere scaled between 30 and 120ms. (B) Time course of absolute differences (%)
in water content between ischemic (midapical anteroseptal left ventricular wall) and remote
(posterolateral left ventricular wall) zones during the ﬁrst week after I/R. Bars represent
means and standard errors of the means. Absolute differences were 0.0 0.2% for group 1
(sacriﬁced at baseline with no other intervention than CMR), 5.20.6% for group 2 (I/R 120
min), 1.10.7% for group 3 (I/R 24 h), 2.4 1.3% for Group 4 (I/R 4 days), and 5.1 1.0% for
group 5 (I/R 7 days). All pairwise comparisons for the absolute differences in myocardial
water content were explored, adjusting the p values for multiple comparisons using the
Holm-Bonferroni correction. Comparisons between different groups remained statistically
signiﬁcantwith the exception of the following: group 1 (control) vs. group 3 (I/R 24 h), group
3 (I/R 24 h) vs. group 4 (I/R 4 days), and group 2 (I/R 120 min) vs. group 5 (I/R 7 days).
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reperfusion (120-min CMR) was associated with a
sharp and signiﬁcant increase in T2 relaxation time
above baseline, in the former ischemic area (mid-
apical anteroseptal ventricular wall). T2 relaxation
times returned to baseline values at 24 h post-I/R in
all animals, but subsequently increased progres-
sively, reaching post-I/R values on day 7 similar to
those observed during early reperfusion. Albeit
slight, a linear trend for a progressive increase in T2
relaxation times across different time points was
observed in the remote myocardium. Figure 2A shows
mean changes in T2 relaxation time in the ischemic
myocardium as well as a representative example of 1
animal serially scanned at all time points. Measure-
ments of T2 relaxation time in the ischemic and
remote myocardium at different time points after I/R
are summarized in Table 1. Changes observed in T2W-
STIR and T2-TSE mapping were consistent in all
animals, as seen in Figure 3, which shows images from
8 pigs scanned at the different time points. The
transmural extent of infarction was >80% in all
evaluated segments containing the ROIs for T2
relaxation time quantiﬁcation.
Myocard ia l water content . Myocardial water con-
tent in noninfarcted myocardium (from animals in
group 1) was 79.4  0.6% and 79.4  0.7% for
the midapical anteroseptal and posterolateral left
ventricular walls, respectively. In the ischemic
myocardium, an abrupt increase in water content was
detected at early reperfusion. Consistent with the CMR
data, therewas a systematic and signiﬁcant decrease in
tissue water content in the formerly ischemic region at
24 h, followed by a subsequent increase over the
following days to reach values on day 7 similar to those
observed at early reperfusion. A linear trend for a
slight, but progressive increase in water content across
different time points was observed in the remote
myocardium. Time courses for absolute differences in
water content between ischemic and remote myocar-
dium are shown in Figure 2B. Table 2 summarizes
measurements of water content in the ischemic and
remote myocardium at different time points after I/R.
DISCUSSION
The present experimental study challenges the
accepted view of the development of post-ischemia/
reperfusion myocardial edema. Through state-of-
the-art CMR analysis and histological validation in a
pig model of I/R, we show that the edematous reac-
tion during the ﬁrst week after reperfusion is
not stable, instead following a bimodal pattern
(Central Illustration). The ﬁrst wave appears abruptly
upon reperfusion and dissipates at 24 h. Conversely,
the second wave of edema appears progressively days
after I/R and increases to a maximum on post-
reperfusion day 7. To the best of our knowledge,
this is the ﬁrst study to comprehensively characterize
the time course of myocardial edema during
the ﬁrst week after I/R, covering from very early to
late reperfusion stages. Because edema has been
perceived as both stable and persistent during at least
1 week after myocardial I/R, it has been used
increasingly both clinically and in the setting of
clinical trials as a marker of “ischemic memory.”
Therefore, our ﬁndings that neither of these as-
sumptions is accurate will have important trans-
lational implications.
As with most organs, water is a major component
of healthy cardiac tissue. In steady-state conditions,
myocardial water content is stable and mostly intra-
cellular, with only a very small interstitial component
contained within the extracellular matrix. Cardiac
TABLE 1 Measurements of T2 Relaxation Time in the Ischemic and Remote Myocardium
at Different Time Points During the First Week After Ischemia/Reperfusion
Baseline
T2 Relaxation Times (ms)
R-120 min R-24 h R-Day 4 R-Day 7
Group 1 (Control) IM 47.7  4.0
Rem 46.1  1.5
Group 2 (I/R-120 min) IM 48.7  0.6 73.3  10.0
Rem 46.8  1.8 47.0  1.0
Group 3 (I/R-24 h) IM 46.5  1.9 72.4  12.3 45.9  5.3
Rem 46.2  2.6 48.6  3.0 45.2  0.6
Group 4 (I/R-4 days) IM 45.9  1.6 73.5  4.2 42.7  9.3 55.1  13.2
Rem 45.5  0.8 48.3  4.0 47.5  3.1 48.2  2.9
Group 5 (I/R-7 days) IM 47.2  3.5 72.6  14.2 47.0  2.9 64.9  7.9 78.4  10.6
Rem 46.7  1.5 48.5  3.7 51.4  5.0 50.1  1.8 50.0  3.3
Pooled IM 47.2 ± 2.6 72.9 ± 9.9 45.2 ± 6.2 60.0 ± 11.5 78.4 ± 10.6
Rem 46.3 ± 1.7 48.1 ± 3.0 48.0 ± 4.1 49.1 ± 2.5 50.0 ± 3.3
Values are mean  SD. All pairwise comparisons for pooled serial T2 relaxation times were explored, adjusting p
values for multiple comparisons using the Holm-Bonferroni correction. Comparisons between different time
points in the ischemic myocardium remained statistically signiﬁcant with the exception of the following: baseline
vs. R-24 h, and R-120 min vs. R-day 7. Bold values are those that were compared and are also represented in
Figure 2A.
IM ¼ ischemic myocardium; Rem ¼ remote myocardium.
TABLE 2 Measurements of Myocardial Water Content in the Ischemic and Remote
Myocardium at Different Time Points During the First Week After I/R
Water Content (%)
Group 1
(Control)
Group 2
(I/R-120 min)
Group 3
(I/R-24 h)
Group 4
(I/R-4 days)
Group 5
(I/R-7 days)
IM 79.4  0.6 84.5  0.5 81.2  0.5 82.5  1.4 85.2  0.9
Rem 79.4  0.7 79.4  0.4 80.0  0.4 80.1  0.4 80.1  0.3
Values are mean  SD. All pairwise comparisons for myocardial water content were explored, adjusting p values
for multiple comparisons using the Holm-Bonferroni correction. Comparisons between different groups in
the ischemic myocardium remained statistically signiﬁcant with the exception of the following: group 2
(I/R-120 min) vs. group 5 (I/R-7 days).
Abbreviations as in Table 1.
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edema occurs in numerous pathological conditions in
which this homeostasis is disrupted, and affects both
ﬂuid accumulation outside cells (interstitial edema)
and within cardiomyocytes (cellular edema). In the
context of myocardial infarction, edema appears
initially in the form of cardiomyocyte swelling during
the early stages of ischemia (5). Myocardial edema is
then signiﬁcantly exacerbated upon restoration of
blood ﬂow to the ischemic region. This increase is due
to increased cell swelling (3) and, more importantly,
to interstitial edema secondary to reactive hyperemia
and leakage from damaged capillaries when the hy-
drostatic pressure is restored upon reperfusion (1,4).
CMR has emerged as a noninvasive technology that
allows characterization of cardiac tissue after I/R (6),
with T2-weighted (T2W) CMR sequences especially
suited to detecting high water content in post-
ischemic edematous cardiac muscle (7). Under the
accepted dogma that myocardial edema appears early
after I/R and is present for at least 1 week (9,10,24),
numerous experimental and clinical studies have
used T2W-CMR to retrospectively evaluate the ede-
matous reaction associated with myocardial infarc-
tion. Although visually attractive, T2W imaging is
subject to several technical limitations and does not
offer quantitative T2 measurements that would allow
for comparisons between different studies (32,33).
Recently developed quantitative T2 relaxation maps
(T2 mapping) have been proposed to overcome at
least some of the limitations for the detection and
quantiﬁcation of myocardial edema (34,35). However,
T2-mapping sequences have inherent limitations, are
time-consuming, and are thus mostly used as a
research tool and require further validation. Large
animal models of I/R offer an ideal platform for such a
validation (36), and, due to its anatomical and phys-
iological similarities to the human heart, the pig
is one of the most reliable models for studying
I/R-related processes.
The disparate time points examined in different
experimental and clinical studies are an important
source of confusion in CMR evaluation of post-I/R
FIGURE 3 CMR T2W-STIR and T2 Mapping Images From Different Animals During the 1-Week Time Course After I/R
I-40min/R-120 min
(Group 2)
I-40min/R-24 hours
(Group 3)
I-40min/R-4 days
(Group 4)
I-40min/R-7 days
(Group 5)
1
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Serial CMR scans reveal highly consistent bimodal changes in image-determined myocardial edema during the ﬁrst week after I/R, both in T2-weighted short-tau
inversion recovery (T2W-STIR) imaging (A) and T2 mapping (B). Images from 8 pigs at different time points are shown. All T2 maps were scaled between 30 and 120 ms.
Abbreviations as in Figure 2.
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edema. As demonstrated in the present study,
because T2 values in the ischemic myocardium
ﬂuctuate signiﬁcantly during the ﬁrst week after
reperfusion, the timing of post-infarction imaging is
critically important for noninvasive assessment of
myocardial edema. In a previous study, Foltz et al.
(37,38) suggested a similar myocardial T2 relaxation
time course in a pig model of I/R, with CMR scans at
days 0, 2, and 7 after reperfusion. However, this study
lacked histological validation of myocardial water
content, and the observed T2 value ﬂuctuations were
interpreted as reﬂecting the oxidative denaturation of
hemoglobin to methemoglobin (17,39) rather than
ﬂuctuations in myocardial water content. The histo-
logical validation in the present study demonstrates
the consistent appearance of 2 consecutive waves of
edema during the ﬁrst week after I/R, a ground-
breaking concept in the ﬁeld.
The ﬁrst wave of edema appears soon after reper-
fusion and dissipates at 24 h. Interestingly, water
content within the ischemic myocardium did not
return to normal values, whereas T2 relaxation time
in the ischemic ventricular wall dropped to baseline
values. It is plausible that the decrease in T2 relaxa-
tion time observed at 24 h is due to at least 2
components: the classically described paramagnetic
effect of hemoglobin denaturation products and the
sharp decrease in myocardial water content at 24 h
post-reperfusion reported here.
The second wave of edema appeared progressively
in the days after I/R and was maximal at day 7.
Interestingly, T2 abnormalities and increased water
content in the ischemic region were ultimately as
impressive as those observed at early reperfusion.
Further studies are needed to elucidate the phy-
siopathology underlying this bimodal edematous
reaction after I/R. It is intuitive to argue that the ﬁrst
and second waves of post-I/R edema are related to
different pathological phenomena, although this has
not been demonstrated in the present work. Whereas
the ﬁrst wave seems to be directly related to reper-
fusion, the pathophysiology underlying the second
wave is more challenging to decipher. We speculate
that tissue changes during the ﬁrst week of infarction
(removal of cardiomyocyte debris from the extra-
cellular compartment and its replacement by water,
collagen homeostasis, and healing of tissue/inﬂam-
mation, among others) could play a role in this second
edematous reaction.
The data presented here might have implications
for understanding the role of CMR in retrospective
quantiﬁcation of the post-infarction area at risk.
Given that this study was not designed to corre-
late the actual anatomical area at risk (perfusion
defect during ischemia) with the extension of
CMR-visualized edema, any conclusions in this re-
gard are speculative and distract from this study’s
main objective. Future studies should speciﬁcally
evaluate the impact of the dual edema phenomenon
on the role of CMR to accurately quantify area at
risk.
The identiﬁcation of the time course of post-I/R
myocardial edema has important biological, diag-
nostic, prognostic, and therapeutic implications, and
opens a route to further exploration of factors inﬂu-
encing this phenomenon.
STUDY LIMITATIONS. Extrapolation of the results
of this experimental study to the clinic should be
done with caution. The intensity and time course
of bimodal post-I/R edema may be modiﬁed by
several factors, such as the duration of ischemia, pre-
existence of collateral ﬂow, and even the application
of peri-reperfusion therapies to attenuate I/R dam-
age. Nonetheless, the use of a large animal model is of
CENTRAL ILLUSTRATION Edematous Reaction After Ischemia/Reperfusion
Follows a Bimodal Pattern: The Bimodal Edema Phenomenon
The development of myocardial edema is a well known phenomenon occurring after
ischemia/reperfusion (myocardial infarction). This edematous reaction was long assumed
to be stable for at least 1 week, but the post-ischemia/reperfusion phase was not previ-
ously tracked in a comprehensive serial study. In the present study, analysis of advanced
cardiac magnetic resonance and histopathology showed that post-ischemia/reperfusion
edema is bimodal. An initial wave of edema abruptly appears upon reperfusion and almost
completely disappears at 24 h. A deferred wave appears later and increases progressively
until day 7. STIR ¼ short-tau inversion recovery.
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great translational value, especially considering the
difﬁculty of performing such a comprehensive serial
CMR study (including 1 examination immediately
upon reperfusion) in patients. The data presented in
this study are robust and consistent, and the pig is
one of the most clinically translatable large animal
models for the study of I/R issues, because (unlike
other mammals) its coronary artery anatomy and
distribution are similar to those of humans (40) and it
has minimal pre-existing coronary collateral ﬂow
(41). In addition, as shown here with the direct
quantiﬁcation of myocardial water content, experi-
mental studies offer the possibility of histological
validation.
In this study, the ROIs for quantiﬁcation of T2
relaxation time were placed in the entire wall thick-
ness, then were carefully and individually adjusted
by hand to avoid the right and left ventricular
cavities. Therefore, ROIs might include different
myocardial states (i.e., hemorrhage, microvascular
obstruction). We took this approach to mimic the
histological water content evaluation, which was
performed in the entire wall thickness. Given the
parallel courses of T2 relaxation times and water
content, we believe that the possible inclusion of
different myocardial states had little effect on the
results, although it might have had some inﬂuence
on the differences in absolute T2 relaxation times
between our study and others that used a different
methodological approach to select ROIs.
CONCLUSIONS
Contrary to the accepted view, the present work
consistently shows that edematous reaction during
the ﬁrst week after ischemia/reperfusion is not stable,
but follows a bimodal pattern. The ﬁrst wave of
edema appears abruptly upon reperfusion and dissi-
pates at 24 h. Conversely, the second wave appears
progressively days after ischemia/reperfusion and is
maximal around day 7 after reperfusion.
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Pathophysiology Underlying the
Bimodal Edema Phenomenon After
Myocardial Ischemia/Reperfusion
Rodrigo Fernández-Jiménez, MD,*y Jaime García-Prieto, BSC,* Javier Sánchez-González, PHD,*z Jaume Agüero, MD,*
Gonzalo J. López-Martín, RT,* Carlos Galán-Arriola, DVM,* Antonio Molina-Iracheta, DVM,* Roisin Doohan, BSC,*
Valentin Fuster, MD, PHD,*x Borja Ibáñez, MD, PHD*y
ABSTRACT
BACKGROUND Post-ischemia/reperfusion (I/R) myocardial edema was recently shown to follow a consistent bimodal
pattern: an initial wave of edema appears on reperfusion and dissipates at 24 h, followed by a deferred wave that initiates
days after infarction, peaking at 1 week.
OBJECTIVES This study examined the pathophysiology underlying this post-I/R bimodal edematous reaction.
METHODS Forty instrumented pigs were assigned to different myocardial infarction protocols. Edematous
reaction was evaluated by water content quantiﬁcation, serial cardiac magnetic resonance T2-mapping, and
histology/immunohistochemistry. The association of reperfusion with the initial wave of edema was evaluated in
pigs undergoing 40-min/80-min I/R and compared with pigs undergoing 120-min ischemia with no reperfusion.
The role of tissue healing in the deferred wave of edema was evaluated by comparing pigs undergoing standard
40-min/7-day I/R with animals subjected to infarction without reperfusion (chronic 7-day coronary occlusion) or
receiving post-I/R high-dose steroid therapy.
RESULTS Characterization of post-I/R tissue changes revealed maximal interstitial edema early on reperfusion in
the ischemic myocardium, with maximal content of neutrophils, macrophages, and collagen at 24 h, day 4, and
day 7 post-I/R, respectively. Reperfused pigs had signiﬁcantly higher myocardial water content at 120 min and T2
relaxation times on 120 min cardiac magnetic resonance than nonreperfused animals. Permanent coronary occlusion or
high-dose steroid therapy signiﬁcantly reduced myocardial water content on day 7 post-infarction. The dynamics of T2
relaxation times during the ﬁrst post-infarction week were altered signiﬁcantly in nonreperfused pigs compared with pigs
undergoing regular I/R.
CONCLUSIONS The 2 waves of the post-I/R edematous reaction are related to different pathophysiological
phenomena. Although the ﬁrst wave is secondary to reperfusion, the second wave occurs mainly because of tissue
healing processes. (J Am Coll Cardiol 2015;66:816–28) © 2015 by the American College of Cardiology Foundation.
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P ost-myocardial infarction (MI) tissue charac-terization offers the possibility of predictinglong-term remodeling and evaluating the
impact of interventions aimed at preserving cardiac
function. Reperfusion, the basis of myocardial protec-
tion during infarction, alters post-MI tissue com-
position compared with the nonreperfused setting
(1,2). Nonetheless, most current knowledge of tissue
modiﬁcations in the post-infarcted myocardium is
based on observations in nonreperfused hearts. There
is therefore a need for comprehensive tissue character-
ization in the context of ischemia/reperfusion (I/R).
The post-I/R myocardium is characterized by an
intense edematous reaction conﬁned to the post-
ischemic region (3–7) assumed to appear early after
I/R and persist in stable form for at least 1 week (8,9).
It has been used both experimentally and clinically as
a marker of ischemic “memory.” Noninvasive evalu-
ation of this post-I/R edematous reaction has be-
come possible with the development of T2-weighted
and T2-mapping cardiac magnetic resonance (CMR)
sequences able to accurately detect increases in water
content (10–12). Innumerable clinical and experi-
mental reports have been based on the unimodal
hypothesis of a persistent edematous reaction during
the ﬁrst week after I/R. However, we recently showed
that the post I/R edematous reaction is not constant,
but rather follows a bimodal pattern, with an initial
wave of edema appearing abruptly on reperfusion
and dissipating at 24 h, followed by a deferred wave
of edema appearing several days after I/R, increasing
to a maximum on post-reperfusion day 7 (13). These
experimental observations challenge the accepted
view (14) and call for a mechanistic study to unravel
the pathophysiological mechanisms underlying this
newly recognized phenomenon.
In the present study, we used a large animal model
(pig) of MI to characterize the tissue changes taking
place in the post I/R myocardium by histological and
CMR methods. Under the hypothesis that the initial
wave of edema is a direct consequence of reperfusion
while the deferred wave is caused by healing pro-
cesses, we manipulated each wave independently
through the use of reperfused and nonreperfused
MI models, and exposure to high-dose steroid
therapy, interventions that are known to alter healing
processes.
METHODS
STUDY DESIGN, PROTOCOLS, AND IMAGING ANALYSIS.
The study population was 40 castrated male
Large-White pigs. The study (Figure 1) was
approved by the Institutional Animal Research
Committee and conducted in accordance with
recommendations of the Guide for the Care
and Use of Laboratory Animals. MI was
generated by 40-min angioplasty-balloon oc-
clusion of the mid-left anterior descending
(LAD) coronary artery followed by balloon
deﬂation and re-establishment of blood ﬂow (15). Short
follow-up (120min) nonreperfusedMIwas achieved by
maintaining balloon inﬂation until sacriﬁce and heart
excision. Long follow-up (7 days) nonreperfused MI
was achieved by implanting an intravascular CMR-
compatible coil in the mid-LAD to generate perma-
nent coronary occlusion. Full methods can be found in
the Online Appendix.
Myocardial water content was quantiﬁed in sam-
ples from the infarcted and remote myocardium of
all pigs by using the desiccating technique as the
reference standard: water content (%) ¼ [(wet
weight  dry weight)/wet weight] 100. Samples of
ischemic myocardium were analyzed by histology
and immunohistochemistry. Histological sections
were stained with hematoxylin and eosin and Mas-
son trichrome, and with antibodies against F4/80
(macrophages) and PM1 (neutrophils).
CMR examinations were performed immediately
before MI and at subsequent post-MI follow-up time
points until sacriﬁce. Examinations were conducted
with a Philips 3-Tesla Achieva Tx whole body scanner
(Philips Healthcare, Best, the Netherlands) equipped
with a 32-element phased-array cardiac coil. The im-
aging protocol included a standard segmented cine
steady-state free-precession sequence to provide
high-quality anatomic references, a T2-weighted tri-
ple short-tau inversion recovery sequence, and T2
turbo spin multiecho mapping. The imaging parame-
ters are detailed in the Online Appendix.
CMR images were analyzed using dedicated soft-
ware (MR Extended Work Space 2.6, Philips Health-
care) by 2 experienced observers blinded to group
allocation.
STATISTICAL ANALYSIS. Normal distribution of each
data subset was checked using graphical methods
and a Shapiro-Wilk test. For quantitative variables
showing a normal distribution, data are expressed as
mean  SD. For quantitative variables showing a non-
normal distribution, data are expressed as median
and interquartile range. A Kruskal-Wallis test was
conducted for comparison of hemorrhage, number
of inﬂammatory cells, and collagen content among
groups over the histopathological time course.
Given the hypothesis-driven nature of the study,
comparisons between groups of pigs sacriﬁced at
SEE PAGE 829
AB BR E V I A T I ON S
AND ACRONYM S
CMR = cardiac magnetic
resonance
I/R = ischemia/reperfusion
LAD = left anterior descending
MI = myocardial infarction
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post-infarction day 7 were planned in advance.
Quantitative variables showing a normal distribution
were therefore compared using a two-tailed Student
t test, whereas quantitative variables showing a
non-normal distribution were compared using a
Wilcoxon rank sum test. All statistical analyses were
performed with Stata 12.0 (StataCorp, College Station,
Texas).
RESULTS
DYNAMICS OF TISSUE CHANGES DURING THE FIRST
WEEK AFTER REPERFUSED MI. To characterize
changes associated with the 2 waves of edema, we
ﬁrst studied histological changes during the ﬁrst
week after standard I/R. Samples for this analysis
came from a group of animals whose bimodal CMR
and water content results were previously reported
(13). The time course of tissue changes in the post-I/R
myocardium is summarized in Table 1 and illustrated
in Figure 2A with representative staining images in
Figure 2B. The density of inﬁltrating neutrophils was
maximal at 24 h post-I/R and remained high at day 4
FIGURE 1 Study Design
120 min 24 hours Day 4 Day 7
120 min 24 hours Day 4 Day 7
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    Ischemia/
No Reperfusion
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CMR
BASELINE
CMR CMR CMR
CMR CMR CMR
CMR CMR CMR CMR
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n = 10
N = 40
n = 5 n = 5
n = 5 n = 5 n = 5
n = 5 n = 5
n = 15 n = 10
n = 10
n = 5
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(n =5)
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(n =5)
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(n =5)
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(n =5)
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(n =5)
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(n =5)
Group 7
(n =5)
Group 1
(n =5)
Histology
Histology
Histology Histology Histology
Histology
Histology Histology
IV steroids
40 min Ischemia/
      Reperfusion
The study population comprised 8 groups of pigs (n ¼ 5 per group). Groups 1 to 5 were used for the histopathological characterization of myocardial tissue changes
during the ﬁrst week post-ischemia/reperfusion. Groups 6 to 8 were used to decipher the mechanisms underlying the bimodal edematous reaction in the ﬁrst week after
ischemia/reperfusion. Cardiac magnetic resonance (CMR) scans were performed at all follow-up stages until sacriﬁce, so that animals sacriﬁced at day 7 underwent
baseline, 120 min, 24 h, day 4, and day 7 CMR. CMR data and myocardial water content from animals in groups 1 to 5 have been reported previously (13).
IV ¼ intravenous.
TABLE 1 Tissue Changes in the Ischemic Myocardium During Week 1 Post-I/R
R-120 Min R-24 H R-Day 4 R-Day 7 p Value
Hemorrhage, score 0–5 0 (0–1) 2 (2–3) 4 (3–5) 1 (0–2) 0.02
Neutrophils,* n/mm2 69.0  94.7 677.6  318.3 454.5  312.5 94.9  86.8 <0.01
Macrophages,* n/mm2 5.5  11.0 20.6  30.1 154.4  295.8 12.6  20.5 <0.01
Collagen,† % 0  0 0  0 4.5  1.1 13.3  3.2 <0.01
Values are median (interquartile range) or mean  SD. Interstitial hemorrhage is graded from 0 (absence)
to 5 (very severe). p value for among-group comparison. *In the lesion area. †In the granulation tissue area.
I ¼ ischemia; R ¼ reperfusion.
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before dropping signiﬁcantly by day 7 post-I/R.
The density of inﬁltrating macrophages also
increased signiﬁcantly from day 1 to a peak on day 4
before dropping signiﬁcantly at day 7. Interstitial
hemorrhage was apparent at 24 h, peaking on day 4
post-I/R. There was no evidence of increased collagen
deposition until day 4, with a further increase in
content observed at post-I/R day 7.
INITIAL WAVE OF EDEMA AND REPERFUSION. To
study the potential association between the initial
wave of edema and reperfusion, a new group of 5 pigs
(Group 7 in Figure 1) underwent ischemia (angio-
plasty-balloon mid-LAD coronary occlusion) and were
sacriﬁced after 120-min CMR without being
reperfused. When compared with animals undergoing
40-min coronary occlusion followed by 80-min
reperfusion (Group 2 in Figure 1), myocardial water
content in the ischemic region of the nonreperfused
pigs was signiﬁcantly lower than in reperfused ani-
mals sacriﬁced at the same time (80.8  0.4% vs.
84.5  0.5%; p < 0.0001) (Figure 3A).
CMR results agreed with histological water content
data: although baseline (pre-ischemia) T2 relaxation
times in nonreperfused and reperfused pigs were
similar (45.3  1.4 ms vs. 48.7  0.6 ms), the 120-min
CMR T2 relaxation times in the ischemic region of
nonreperfused pigs were signiﬁcantly lower than
those of reperfused pigs (57.0 3.0ms vs. 73.3 10.0ms;
FIGURE 2 Histopathological Changes in the Ischemic Myocardium During the First Week After Ischemia/Reperfusion
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Neutrophil and macrophage density in the lesion area and collagen content in the granulation tissue (A) and representative images of his-
tological changes in the ischemic myocardium (B) during the ﬁrst week post-ischemia/reperfusion. For each time point, images are shown of
staining with hematoxylin and eosin (H/E), anti-PM1, anti-F4/80, and Masson trichrome. Data are mean  SEM. PMN ¼ polymorphonuclear
leukocytes; R ¼ reperfusion.
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p < 0.01) (Figure 3B). In agreement with quantitative
T2 maps, qualitative T2-weighted signal intensity in
nonreperfused pigs was signiﬁcantly lower than that
in reperfused pigs, with the intensity at 120-min
CMR in the former similar to that observed pre-
ischemia (baseline) (Figure 3C). Histological analysis
revealed signiﬁcantly less interstitial edema in the
ischemic area of nonreperfused pig hearts
(Figure 3D).
DEFERRED WAVE OF EDEMA AND MI HEALING. To
study the potential association between the deferred
wave of edema and MI healing, we modiﬁed tissue
healing in the post-infarcted myocardium with 2 in-
dependent strategies: permanent coronary occlusion
and high-dose steroid therapy.
Five pigs were subjected to chronic occlusion
without reperfusion by delivery of a CMR-compatible
coil to the mid-LAD (Group 8 in Figure 1). All animals
underwent serial CMR examinations (baseline, 120
min, days 1, 4, and 7) and were sacriﬁced after day 7
CMR. Permanent occlusion of the coronary artery
signiﬁcantly attenuated the deferred wave of edema,
with myocardial water content in the ischemic region
at day 7 signiﬁcantly lower in the nonreperfused pigs
than in reperfused pigs—Group 5 (82.5  1.0% vs. 85.2
 0.9%; p < 0.01) (Figure 4A).
Permanent coronary occlusion altered the dynamics
of serial CMR T2 relaxation times (Figures 4B and 5).
In agreement with the outcome of acute occlusion
experiments, T2 relaxation times in the ischemic
region on 120-min CMR were signiﬁcantly lower in
nonreperfused pigs, whereas T2 relaxation times at
24-h CMR did not differ between nonreperfused
and reperfused pigs. Thereafter, T2 relaxation times
diverged; at day 4, a trend toward lower T2 relaxation
FIGURE 3 Effect of Preventing Reperfusion on the Initial Wave of Post-Myocardial Infarction Edema
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Mean differences in absolute water content at 120 min from ischemia onset between the ischemic and remote myocardial regions were 5.2% for
reperfused pigs and 1.5% for nonreperfused pigs (A); the latter showed an z70% lower relative increase in myocardial water content in
the ischemic area. The nonreperfused pigs also demonstrated signiﬁcantly lower 120-min cardiac magnetic resonance T2 relaxation times in the
ischemic region (B). Representative T2-weighted triple short-tau inversion recovery (STIR) and T2-mapping images (C) from representative pigs
subjected to ischemia with reperfusion (40-min ischemia plus 80-min reperfusion) and with no reperfusion (120-min ischemia). Data are mean
 SEM; all T2 maps were scaled between 30 and 120 ms. Representative images of ischemic myocardial tissue stained with hematoxylin
and eosin from 2 reperfused (D, top) and 2 nonreperfused (D, bottom) pigs sacriﬁced at 120 min after ischemia onset. Note the evident increase
in extracellular space, most probably caused by extracellular edema, in reperfused pigs compared with nonreperfused animals.
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times was detected in the ischemic myocardium of
chronically nonreperfused pigs. Consistent with the
water content analysis, at day 7 this difference was
statistically signiﬁcant (63.8 2.5ms in nonreperfused
pigs vs. 78.4  10.6 ms in reperfused pigs; p ¼ 0.02)
(Figures 4B and 5).
Histological analysis at day 7 post-infarction
revealed different healing patterns per reperfusion
status. Permanent occlusion resulted in lower col-
lagen density in the lesion area (4.7  2.4% vs. 10.8 
3.1%; p ¼ 0.01) (Figures 4C and 4D). The extent of
necrosis within the lesion area was signiﬁcantly
higher in the nonreperfused pigs (68.9  21.7% vs.
8.9  12.7%; p < 0.001) (Figure 6), and the proportion
of granulation tissue was correspondingly lower
(31.1  21.7% vs. 91.1  12.7%; p < 0.001) (Figure 6).
Five pigs underwent 40-min/7-day I/R and received
high intravenous doses of steroids, commencing
after the 120-min CMR (Group 6 in Figure 1). All
animals underwent serial CMR examinations (base-
line, 120 min, days 1, 4, and 7) and were sacriﬁced
after day 7 CMR. The pigs received 3 doses of
intravenous methylprednisolone (30 mg/kg/dose)
within the ﬁrst 24 h post-I/R, followed by 1 daily
dose of intravenous methylprednisolone (30 mg/kg)
on the following 3 days.
Administration of steroids signiﬁcantly altered the
deferred wave of edema, with myocardial water
FIGURE 4 Effect of Preventing Reperfusion on the Deferred Wave of Post–Myocardial Infarction Edema
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Mean differences in absolute myocardial water content on day 7 between the ischemic and remote regions were 5.1% in reperfused and 2.3% in
nonreperfused pigs (A); the latter showed an z55% lower relative increase in myocardial water content in the ischemic area. Absolute T2
relaxation times in the ischemic myocardium during the ﬁrst week after ischemia/reperfusion (I/R) in reperfused and nonreperfused pigs
show divergence over time (B). Data are mean  SEM. Representative Masson trichrome staining of ischemic myocardium sections taken from
reperfused (top) and nonreperfused (bottom) pigs at day 7 after ischemia onset (C). Collagen is stained light blue. Lack of reperfusion
produced a lower collagen density in the lesion area (D). The chart shows data from individual animals together with mean  SEM.
NoR ¼ no reperfusion.
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content signiﬁcantly lower in the ischemic region at
day 7 than in the untreated pigs in Group 5 (83.3 
0.8% vs. 85.2  0.4% for steroid-treated and
untreated pigs, respectively; p ¼ 0.01) (Figure 7A).
This effect was not accompanied by signiﬁcant dif-
ferences in T2 relaxation times on day 7 CMR (77.3 
13.0 ms steroid-treated vs. 78.4  10.6 ms untreated;
p > 0.10) or at any of the earlier time points evaluated
(Figures 7B and 8).
According to the histological analysis, high-dose
steroid therapy resulted in lower collagen density in
the lesion area (6.1  3.4% vs. 10.8  3.1%; p ¼ 0.05)
(Figures 7C and 7D). The proportions of necrosis and
granulation tissue within the lesion area were similar
in the 2 groups: 17.3  18.7% and 82.7  18.7%,
respectively, in steroid-treated pigs vs. 8.9  12.7%
and 91.1  12.7% in nontreated pigs (p > 0.10)
(Figure 6). Water content and hemorrhage scores in
the myocardium of pigs sacriﬁced on day 7 after
ischemia onset is summarized in Table 2.
DISCUSSION
Recent work has shown that the edematous reaction
in the reperfused post-infarcted myocardium is not
stable, but follows a bimodal pattern. An initial wave
of edema appears on reperfusion, abating almost
completely by 24 h, followed by a deferred wave that
initiates days after I/R and peaks around 1 week after
infarction (13). In the present study, we explored the
possible mechanisms underlying these 2 waves of
post-I/R edema through a comprehensive histopath-
ological analysis and state-of-the-art CMR serial
evaluations in the pig model. Our results show
that the 2 waves of post-I/R edema are produced
by different processes that can be independently
modulated (Central Illustration). The absence of re-
perfusion almost completely abolishes the initial
wave, indicating that it is a direct consequence of
the reperfusion process. The deferred wave is sub-
stantially altered by interventions that impair healing
in the post-infarcted myocardium (absence of reper-
fusion and high-dose steroid therapy), thus impli-
cating tissue healing processes in this second phase
of edema. Elucidation of the pathophysiology un-
derlying bimodal post-I/R edema has potential
translational implications in diagnosis, prognosis,
and therapy. Pharmacological or other interventions
targeting the pathways implicated in the initial or
deferred waves of post-I/R edema could contribute
to better cardiac recovery and remodeling, and thus
improve prognosis in patients experiencing an
acute MI. Additionally, this study provides a
comprehensive histological characterization of the
dynamic changes occurring in a large animal model
of reperfused MI.
Water is the major component of healthy cardiac
tissue. In steady-state conditions, myocardial water
content is stable and mostly intracellular, with only a
very small interstitial component in the extracellular
matrix. During MI, edema occurs initially as car-
diomyocyte swelling during the early stages of
FIGURE 5 Effect of Preventing Reperfusion on Myocardial T2 Relaxation Time
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Permanent coronary occlusion altered the dynamics of serial cardiac magnetic resonance T2 relaxation times in the ischemic region as it is shown by these
representative T2-mapping images from reperfused and nonreperfused pigs for all time points. All T2 maps were scaled between 30 and 120 ms.
Abbreviations as in Figures 2 and 4.
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ischemia (7). Myocardial edema is then exacerbated
signiﬁcantly on restoration of blood ﬂow to the
ischemic region. This reperfusion-associated increase
seems to be caused by increased cell swelling (5) and,
more importantly, by interstitial edema secondary to
reactive hyperemia and leakage from capillaries
damaged when hydrostatic pressure is restored on
reperfusion (3,6). For many years, this myocardial
edema was believed to remain stable for at least 1
week (8–10); this view led many experimental studies
and clinical trials to rely on the ability of CMR and
other imaging tools to retrospectively evaluate post-
MI edema (10–12). The concept of stable post-I/R
edema was recently challenged in an experimental
analysis by our group in a pig model of I/R, revealing
the bimodal pattern of the edematous response (13).
The present study conﬁrms our original description
of a bimodal response and provides insight into the
underlying pathophysiological mechanisms.
The association between the initial, hyperacute
edematous response and the reperfusion process has
been reported previously (2,16). In agreement with
those studies, here we show that the absence of
reperfusion almost completely abolishes the early
increase in water content and the CMR-measured
regional T2 relaxation times in the ischemic myocar-
dium. Indirect histological detection of interstitial
edema (increased extracellular volume) was consis-
tent with the water content and CMR data. Our study
demonstrates that the reperfusion-driven hyperacute
edematous reaction (4) is exhausted after 24 h;
moreover, these processes can be visualized and
FIGURE 6 Effect of Nonreperfusion and High-Dose Steroid Therapy on the Proportion of Necrosis/Granulation Tissue Within the
Healing Myocardium
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(A) Proportion of necrosis and granulation tissue within the lesion area of pigs sacriﬁced on day 7 after ischemia onset. (B) Histological sections
stained with hematoxylin and eosin show features of myocardial infarction repair in pigs sacriﬁced on day 7 after ischemia onset: full transverse
sections of infarcted myocardium (left; 1 magniﬁcation) and granulation tissue (upper subpanel) and necrotic tissue (lower subpanel)
(right; 40) from 1 representative pig per group.*Granulation tissue. ‡Necrotic tissue. Abbreviations as in Figure 4.
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quantiﬁed by state-of-the-art contemporaneous T2
CMR sequences, a ﬁnding of special translational
relevance. Although water content in the ischemic
myocardium decreases signiﬁcantly during the ﬁrst
24 h post-reperfusion, it does not return to normal
values, whereas T2 relaxation time does decrease to
values seen in the pre-ischemia baseline scan (13).
These data indicate that myocardial water content
may not be the only factor inﬂuencing post-infarction
T2 relaxation time. The fact that the interstitial
hemorrhage was more pronounced at 24 h than
early after reperfusion (Table 2) suggests a possible
contribution from the well-described paramagnetic
effect of hemoglobin denaturation products (17).
We hypothesized that the deferred wave of edema
might be related to early healing, a process coinciding
with the deferred edema wave. To test this hypothe-
sis, we used 2 independent strategies to manipulate
this biological phenomenon: high-dose steroid ther-
apy and absence of reperfusion. Steroids are well
known to interfere with collagen deposition in heal-
ing infarcts (18,19) and absence of reperfusion is
FIGURE 7 Effect of High-Dose Steroid Therapy on the Deferred Wave of Post–Myocardial Infarction Edema
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Mean differences in absolute water content between the ischemic and remote myocardial regions were 5.1% in reperfused nontreated pigs
and 2.8% in reperfused steroid-treated pigs (A); the latter showed an z45% lower relative increase in myocardial water content in the
ischemic area. Absolute T2 relaxation times in the ischemic myocardium during the ﬁrst week post-I/R were similar in nontreated and steroid-
treated pigs (B). Data are mean  SEM. Masson trichrome staining of ischemic myocardium sections taken from nontreated (top) and steroid-
treated (bottom) pigs on day 7 post-I/R (C). Steroid treatment showed a lower collagen density in the lesion area (D). The chart shows data
from individual animals together with mean  SEM. Abbreviations as in Figure 4.
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associated with signiﬁcant delay to healing (1,2,20),
in contrast with reperfusion, which accelerates this
process. Both interventions altered the deferred
wave of edema, as demonstrated by the signiﬁ-
cant reductions in water content in the ischemic
myocardium of steroid-treated and nonreperfused
animals compared with reperfused animals not
receiving steroids. CMR data in nonreperfused pigs
paralleled the water content measures, with T2
relaxation times at day 7 signiﬁcantly lower than in
reperfused pigs.
However, T2 relaxation times in steroid-treated
pigs did not differ from values in untreated pigs.
This apparent discrepancy might be explained by
the effect of steroid therapy on collagen content:
myocardial tissue from steroid-treated pigs showed
a signiﬁcant reduction in collagen content compared
with untreated pigs, in agreement with previous
reports (18). Collagen deposition correlates inversely
with CMR T2 relaxation times (21–23); this effect
may thus have compensated for the reduced water
content, resulting in no net alteration in CMR
T2 relaxation time in untreated pigs. The counter-
balancing effects of water and collagen content
highlight the likelihood that CMR T2 relaxa-
tion time is a composite measure of several phe-
nomena occurring in the post-I/R myocardium.
Collagen deposition was also reduced by per-
manent occlusion, where CMR T2 relaxation times
and water content were consistent with each other.
Notably, the infarct composition was different in
steroid-treated and nonreperfused hearts at day 7.
The proportions of necrosis and granulation
tissue within the myocardial lesion were similar
in steroid-treated and standard reperfused pigs,
whereas lesions in the nonreperfused pigs had
a much higher proportion of necrotic tissue, indi-
cating a delay to healing. Several factors might
contribute to the discrepancies in water content
and T2 relaxation time observed between non-
reperfused pigs and steroid-treated reperfused pigs:
distinct healing characteristics; different myocardial
perfusion status related to circulation-induced
increases in T2 relaxation time (24); and indirect
inﬂuences, such as inﬂammation (25,26) and angio-
genesis (27).
The results of the present study show that the
2 waves of post-I/R edema are caused by different
phenomena that can be independently modulated.
TABLE 2 Myocardial Water Content and Hemorrhage Score in Pigs*
40 Min/7 Days
I/R (Group 5)
40 Min/7 Days I/R þ
Steroid Therapy
(Group 6)
7-Day Coronary
Occlusion
(Group 8)
p
Value†
p
Value‡
Water content, ischemic, % 85.2  0.9 83.3  0.8 82.5  1.0 0.01 <0.01
Water content, remote, % 80.1  0.3 80.4  0.3 80.2  0.4 NS NS
Hemorrhage, score 0–5 1 (0–2) 0 (0–3) 1 (1–2) NS NS
Values are mean  SD or median (interquartile range). Interstitial hemorrhage is graded from 0 (absence)
to 5 (very severe). *Sacriﬁced on day 7 after ischemia onset. †Comparison between Group 5 (I/R with no
other intervention) and Group 6 (I/R plus steroid therapy). ‡Comparison between Group 5 (I/R with no
other intervention) and Group 8 (I/No R).
NS ¼ not signiﬁcant; other abbreviations as in Table 1.
FIGURE 8 Effect of High-Dose Steroid Therapy on Myocardial T2 Relaxation Time
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Treatment with high-dose steroid therapy did not alter the dynamics of serial cardiac magnetic resonance T2 relaxation times in the ischemic region as it is shown
by these representative T2-mapping images from reperfused nontreated and treated pigs for all time points. All T2 maps were scaled between 30 and 120 ms.
Abbreviations as in Figures 2 and 4.
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CENTRAL ILLUSTRATION Mechanisms Underlying the Bimodal Edema Phenomenon After
Myocardial Ischemia/Reperfusion
Fernández-Jiménez, R. et al. J Am Coll Cardiol. 2015; 66(7):816–28.
A
B
Two distinct waves of edema emerge within the ﬁrst week after ischemia/reperfusion (I/R) because of different pathophysiological processes.
The initial wave, appearing abruptly on reperfusion, is a direct consequence of the reperfusion process itself, whereas the deferred wave,
appearing progressively days after I/R, is mainly caused by tissue healing processes. (A) Reperfusion is associated with a very abrupt
edematous reaction that separates myocardial ﬁbers from each other, resolving by day 1. Post-infarction, an initial neutrophil inﬁltration
(peaking by day 1) is followed by macrophage inﬁltration (peaking by day 4). From day 4 on, necrotic cardiomyocytes are progressively
replaced by granulation tissue and collagen. (B) Myocardial water content was evaluated by histology. Boxes represent water content
measurements in pigs; blue ¼ regular I/R protocol; salmon ¼ permanent coronary occlusion (nonreperfused myocardial infarction; initial
edema wave abrogated, deferred wave signiﬁcantly attenuated); green ¼ I/R plus steroid therapy (deferred wave signiﬁcantly attenuated).
The lines show cardiac magnetic resonance T2 relaxation time course in the ischemic myocardium; blue ¼ ﬁrst week after infarction (2 peaks
closely track the water content changes); salmon ¼ nonreperfused myocardial infarction (both waves of cardiac magnetic resonance–evaluated
edema signiﬁcantly attenuated); and green ¼ I/R plus steroid therapy (continuous line after initiation of therapy). In this last case, T2
relaxation time does not track attenuation of the deferred wave as evaluated by the histological reference standard, highlighting the need for
caution in interpreting cardiac magnetic resonance analysis of the post-myocardial infarction heart. Double arrowed line ¼ discrepancy
between water content and T2 relaxation time at day 7 in steroid group. NoR ¼ no reperfusion.
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Although the initial wave is mainly caused by the
reperfusion itself, the deferred wave of edema is
mainly caused by healing processes. Additionally, the
present study shows that myocardial T2 relaxation
time seems to be affected by dynamic factors occur-
ring during the repair of the infarcted tissue, high-
lighting the need for caution in interpreting CMR
analysis of the post-MI heart.
STUDY LIMITATIONS. Extrapolation of the results of
this experimental study to the clinic should be done
cautiously. Nonetheless, the pig is one of the most
clinically translatable large animal models for the
study of I/R issues given its similar coronary artery
anatomy and distribution to humans and minimal
pre-existing coronary collateral ﬂow. The use of a
large animal model is of great translational value
(28), especially considering the difﬁculty of per-
forming such a comprehensive serial CMR study
(including 1 examination immediately on reperfu-
sion) and histological validation in patients. The time
course of tissue changes in the post-I/R myocardium
in pigs, albeit slightly shorter, is similar to that in
humans (21). Moreover, the process of infarct healing
is qualitatively similar in both species, in that infarct
healing involves a sequential inﬁltration of neutro-
phils and macrophages, removal of necrotic myo-
cytes, formation of granulation tissue, and collagen
deposition. The present study does not provide in-
formation on the localization of the elevated water
content within the myocardial tissue; indeed, there
are no reliable methods to distinguish between
intracellular and interstitial increases in myocardial
water content (25).
In this study, the regions of interest for T2
relaxation time quantiﬁcation included the entire
wall thickness and were individually adjusted by
hand to carefully avoid the right and left ventricular
cavities. Regions of interest might therefore include
different myocardial states (e.g., hemorrhage or
microvascular obstruction). We took this approach to
mimic the histological evaluation of water content,
which assesses the entire wall thickness. We believe
that the possible inclusion of different myocardial
states had little effect on the results relating to the
pathophysiology of bimodal edema given that this
biological process has also been measured by histo-
logical means in the present study. However, it
might have had some inﬂuence on the differences
in absolute T2 relaxation times between our study
and others taking a different approach to region of
interest selection.
CONCLUSIONS
The present study elucidates the pathophysiology
underlying the bimodal edematous reaction after I/R.
The initial wave of edema, appearing abruptly on
reperfusion and dissipating at 24 h, is directly sec-
ondary to the reperfusion process itself. The deferred
wave of edema, appearing progressively days after
I/R and peaking around day 7, is mainly caused by
tissue healing processes.
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Rationale: The impact of cardioprotective strategies and ischemia duration on postischemia/reperfusion (I/R) 
myocardial tissue composition (edema, myocardium at risk, infarct size, salvage, intramyocardial hemorrhage, 
and microvascular obstruction) is not well understood.
Objective: To study the effect of ischemia duration and protective interventions on the temporal dynamics of myocardial 
tissue composition in a translational animal model of I/R by the use of state-of-the-art imaging technology.
Methods and Results: Four 5-pig groups underwent different I/R protocols: 40-minute I/R (prolonged ischemia, 
controls), 20-minute I/R (short-duration ischemia), prolonged ischemia preceded by preconditioning, or prolonged 
ischemia followed by postconditioning. Serial cardiac magnetic resonance (CMR)-based tissue characterization 
was done in all pigs at baseline and at 120 minutes, day 1, day 4, and day 7 after I/R. Reference myocardium at risk 
was assessed by multidetector computed tomography during the index coronary occlusion. After the ﬁnal CMR, 
hearts were excised and processed for water content quantiﬁcation and histology. Five additional healthy pigs 
were euthanized after baseline CMR as reference. Edema formation followed a bimodal pattern in all 40-minute 
I/R pigs, regardless of cardioprotective strategy and the degree of intramyocardial hemorrhage or microvascular 
obstruction. The hyperacute edematous wave was ameliorated only in pigs showing cardioprotection (ie, those 
undergoing short-duration ischemia or preconditioning). In all groups, CMR-measured edema was barely 
detectable at 24 hours postreperfusion. The deferred healing-related edematous wave was blunted or absent in 
pigs undergoing preconditioning or short-duration ischemia, respectively. CMR-measured infarct size declined 
progressively after reperfusion in all groups. CMR-measured myocardial salvage, and the extent of intramyocardial 
hemorrhage and microvascular obstruction varied dramatically according to CMR timing, ischemia duration, 
and cardioprotective strategy.
Conclusions: Cardioprotective therapies, duration of index ischemia, and the interplay between these greatly 
inﬂuence temporal dynamics and extent of tissue composition changes after I/R. Consequently, imaging techniques 
and protocols for assessing edema, myocardium at risk, infarct size, salvage, intramyocardial hemorrhage, and 
microvascular obstruction should be standardized accordingly.  (Circ Res. 2017;121:439-450. DOI: 10.1161/
CIRCRESAHA.117.310901.)
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Ischemia/reperfusion (I/R) results in a dramatic change of myocar-dial tissue composition, mainly in the ﬁrst days after myocardial 
infarction (MI).1,2 Edema formation, inﬂammation, microvascular 
injury, and ultimately healing, among other phenomena, accom-
pany irreversible loss of cardiac myocytes after MI. Cardiac mag-
netic resonance (CMR) can noninvasively identify most of these 
phenomena; however, accounting for the temporal dynamics and 
factors affecting post-MI tissue composition might be crucial for a 
precise assessment of related imaging end points. To date, this has 
not been studied in a comprehensive manner.
Editorial, see p 326 
Meet the First Author, see p 312
For years, the intense edematous reaction appearing in the 
postischemic region early after MI was thought to persist in sta-
ble form for at least 1 week.3,4 On this basis, delineating the ex-
tent of post-MI edema by CMR rapidly became established as a 
measure of the original occluded coronary artery perfusion terri-
tory (myocardium at risk [MaR]).5,6 Thus, the amount of salvaged 
myocardium7—a theoretically better surrogate of the effect of 
cardioprotective therapies8—has been estimated from quantiﬁca-
tions of the extent of delayed gadolinium enhanced myocardium 
(infarct size [IS]) and the extent of myocardial edema (assumed 
to delineate the MaR) in the same imaging session. Consequently, 
multiple clinical and experimental studies have used CMR-
measured edema and IS as end points, within a single imaging 
session performed at a variety of post-MI time points.9 Recent 
evidence has challenged the view of a stable post-MI edema reac-
tion, demonstrating dynamic changes in edema in a pig model of 
MI.10,11 In this model, an initial hyperacute edema reaction on re-
perfusion resolves within 24 hours and is followed by a deferred 
healing-related edema wave occurring a few days after reperfu-
sion. Notably, intramyocardial hemorrhage (IMH) and microvas-
cular obstruction (MVO) can counteract the high-intensity edema 
signal on T2 sequences by reducing tissue T2 relaxation time. 
The impact of IMH and MVO on the bimodal edematous reac-
tion is, thus, a matter of intense debate.12–15 Moreover, the extent/
degree of edema might be lower in patients undergoing infarct-
limiting cardioprotective interventions.16,17 Another variable that 
might differently affect post-MI tissue composition is ischemia 
duration.18 However, CMR exams were performed at different 
time points in these studies, precluding a deﬁnitive interpretation.
In summary, temporal dynamics and extent of post-I/R 
key phenomena (edema, necrosis, MVO, and IMH) might be 
affected by duration of the index ischemic event, by the ap-
plication of cardioprotective interventions and the interplay 
between them, but to date, this has not been studied in a com-
prehensive manner. To elucidate these, we designed an experi-
mental study in which pigs underwent different myocardial I/R 
protocols. CMR was performed at baseline and at 120 minutes, 
24 hours, 4 days, and 7 days after I/R for the serial noninvasive 
assessment of myocardial edema, extent of IMH and MVO, 
IS, and myocardial salvage. Histology and quantiﬁcation of 
Nonstandard Abbreviations and Acronyms
CMR cardiac magnetic resonance
IMH intramyocardial hemorrhage
I/R ischemia/reperfusion
IR-TFE inversion recovery turbo ﬁeld echo
IS infarct size
LAD left anterior descending
LGE late gadolinium enhancement
LV left ventricle
LVEF left ventricular ejection fraction
MaR myocardium at risk
MDCT multidetector computed tomography
MI myocardial infarction
MVO microvascular obstruction
ROI region of interest
STIR short-tau triple inversion-recovery
T2W T2-weighted
Novelty and Signiﬁcance
What Is Known?
• Edema formation, inﬂammation, and microvascular injury contribute to 
irreversible loss of cardiac myocytes after myocardial I/R.
• The presence and extent of these processes and tissue healing are 
associated with outcome after MI.
• Evaluation of myocardial tissue composition changes by CMR imaging 
(ie, tissue characterization) serves as surrogate end points in experi-
mental and clinical studies and clinical trials.
What New Information Does This Article Contribute?
• By using serial CMR exams in a translational large animal model of I/R, 
this study shows that the temporal dynamics and extent of post-MI tis-
sue composition changes are greatly inﬂuenced by the application of 
cardioprotective interventions, the duration of the index ischemia, and 
the interplay between them.
• Rather than estimates of the ischemic area alone, the degree and spa-
tial extent of myocardial edema seems to be a surrogate marker of 
ischemic insult severity.
• These ﬁndings highlight the need for protocol standardization when 
using post-MI imaging techniques to measure relevant end points in 
experimental and clinical studies.
Post-MI tissue composition is highly dynamic and could be char-
acterized by CMR, which has been used to assess surrogate out-
comes and efﬁcacy end points in many experimental and clinical 
studies. However, there is paucity of studies tracking the tempo-
ral dynamics of these processes in a comprehensive manner. Our 
current work shows that the degree and extent of post-MI tissue 
composition changes (edema, necrosis, hemorrhage, and MVO) 
as assessed by CMR are greatly inﬂuenced by the time of image 
acquisition, duration of ischemia, cardioprotective strategies, and 
the interplay between them. Therefore, clinical and experimental 
imaging protocols for post-MI tissue characterization aiming at 
quantifying edema, myocardial area at risk, IS, myocardial sal-
vage, IMH, and MVO should take into consideration these dynam-
ics and be as standardized as possible.
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myocardial water content by reference standard were per-
formed at sacriﬁce immediately after the ﬁnal CMR scan.
Methods
Study Design and MI Procedure
The study population comprised 25 Large White male pigs weighing 
30 to 40 kg. The study was approved by the Institutional and Regional 
Animal Research Committees, and the study design is summarized 
in Online Figure I. Five pigs were euthanized with no intervention 
other than baseline CMR and served as reference healthy subjects. 
A group of 5 pigs underwent reperfused transmural acute MI by 
closed-chest I/R, consisting of 40-minute left anterior descending 
coronary artery occlusion followed by balloon deﬂation and rees-
tablishment of blood ﬂow,10 and were euthanized at 7 days after I/R 
serving as controls. Three additional groups of 5 animals each un-
derwent modiﬁed I/R protocols incorporating different protective 
strategies followed by sacriﬁce on day 7: preconditioning, 40-minute 
I/R preceded by three 5-minute cycles of balloon inﬂation/deﬂation 
in the left anterior descending; postconditioning, 40-minute I/R fol-
lowed by four 1-minute cycles of balloon inﬂation/deﬂation in the 
left anterior descending; and short-duration ischemia, 20-minute I/R.
Arterial enhanced multidetector computed tomography (MDCT) was 
performed during the index coronary occlusion, between minute 10 and 
minute 20 of ischemia, to delineate the reference MaR (MDCT-MaR, 
hypoperfused region during coronary occlusion).19 Comprehensive CMR 
exams were performed at baseline and at 120 minutes, 24 hours, day 4, 
and day 7 after I/R. Animals were immediately euthanized after the ﬁnal 
follow-up CMR scan, and myocardial tissue samples from ischemic ar-
eas were rapidly collected for histology and evaluation of water content.
Full methods are provided in the Online Data Supplement.
Arterial Enhanced MDCT Protocol and Analysis
Arterial phase MDCT studies were performed on a 64-slice com-
puted tomographic-scanner (Brilliance CT 64; Philips Healthcare, 
Cleveland, OH) after intravenous administration of iodinated con-
trast media.19 MDCT images were analyzed using dedicated soft-
ware (MR Extended Work Space 2.6; Philips Healthcare, Best, The 
Netherlands) by 2 observers blinded to group allocation. Short axes 
orientation were obtained from volumetric computed tomographic 
images by multiplanar reconstruction using equivalent anatomic co-
ordinates used for T2-weighted short-tau triple inversion-recovery 
(T2W-STIR) planning acquisition. MaR and remote areas were visu-
ally identiﬁed based on contrast enhancement differences, manually 
delineated, and expressed as a percentage of left ventricle (LV) area.
Detailed information about imaging MDCT protocol and analysis 
is shown in the Online Data Supplement.
CMR Protocol and Analysis
Baseline CMR scans were performed immediately before MI, and 
scans were subsequently repeated at all postinfarction follow-up times 
until sacriﬁce. CMR examinations were conducted with a Philips 
3-Tesla Achieva Tx whole body scanner (Philips Healthcare, Best, The 
Netherlands) equipped with a 32-element phased-array cardiac coil. The 
imaging protocol included a standard segmented cine steady-state free-
precession sequence to provide high quality anatomic references and as-
sessment of LV mass, wall thickness, and LV ejection fraction (LVEF); 
a T2W-STIR sequence to assess the extent of edema and IMH; a T2-
gradient-spin-echo mapping sequence to provide precise myocardial T2 
relaxation time properties;20 and a T1-weighted inversion recovery turbo 
ﬁeld echo sequence acquired 10 to 15 minutes after the administration 
of gadolinium contrast (late gadolinium enhancement [LGE]) to assess 
IS and MVO. To avoid any interference with T2 measures at immedi-
ate reperfusion, gadolinium contrast was not administered at baseline 
CMR scans. CMR images were analyzed using dedicated software 
(MR Extended Work Space 2.6; QMassMR 7.6; Medis, Leiden, The 
Netherlands) by 2 observers experienced in CMR analysis and blinded 
to group allocation. Detailed information about imaging protocol and pa-
rameters and CMR analysis can be found in the Online Data Supplement.
Myocardial Water Quantiﬁcation and Histological 
Analysis
Paired myocardial samples were collected within minutes of sacri-
ﬁce from the ischemic myocardium of all pigs. Myocardial water 
content was quantiﬁed by the desiccation technique and expressed 
as a percentage of wet weight.10,11 Histological sections of the at-risk 
myocardium were stained with hematoxylin and eosin, Masson tri-
chrome, and antineutrophil antibody.11 Full methods are presented in 
the Online Data Supplement.
Statistical Analysis
Normal distribution of each data subset was checked using graphi-
cal methods and a Shapiro–Wilk test. Leven test was performed to 
check homogeneity of variances. For quantitative variables, data are 
expressed as mean±SD. A 1-way ANOVA was conducted for among-
group comparison of myocardial water content and MDCT-MaR. To 
take account of repeated measures, generalized mixed models were 
applied for the study and comparison of the temporal evolution of 
T2, CMR-MaR, IS, IMH, MVO, and salvage myocardium within and 
between groups. Pairwise comparisons among groups and time points 
were performed and P value adjusted for multiple comparisons using 
the Hochberg method. Post hoc test of trends over time for imaging 
parameters by group was performed by using coefﬁcients of orthogo-
nal polynomials. A Kruskal–Wallis test was conducted to compare the 
number of inﬂammatory cells and collagen content among groups eu-
thanized at day 7. Associations between measured T2 relaxation time 
and IMH, MVO, IS, and LVEF were evaluated by Pearson correlation 
coefﬁcient. All statistical analyses were performed with Stata v12.0 
(StataCorp, College Station, TX). Graphs were generated with Stata 
12.0 or GraphPad-Prism v6.0 (GraphPad Software, Inc, La Jolla, CA).
Results
Impact of Cardioprotective Strategies and Ischemia 
Duration on T2 and Myocardial Water Content
T2 relaxation time determined at time points ≤7 days post-
reperfusion are summarized in Table 1. As already reported, 
after 40-minute I/R, T2 relaxation times were signiﬁcantly 
prolonged at reperfusion, almost completely normalized at 
Table 1. Time Proﬁle of Myocardial T2 Relaxation in the 
Ischemic Porcine Myocardium During the First Week After 
Different I/R Protocols and Cardioprotective Strategies
 
T2 Relaxation Time, ms
Baseline R-120 min R-24 h R-Day 4 R-Day 7
40-min 
I/R 
(controls)
46.5 (3.0) 74.8 (14.4) 46.7 (4.9) 66.4 (8.3) 78.9 (11.7)
40-min I/
R+PostC
43.1 (4.1) 73.4 (8.8) 46.1 (2.5) 72.5 (17.0) 76.7 (16.8)
PreC+40-
min I/R
43.1 (1.0) 62.5 (2.8)* 49.1 (1.2) 59.2 (10.8)* 57.6 (10.3)*
20-min 
I/R
46.6 (2.0) 58.3 (1.5)* 49.9 (1.9) 50.1 (3.1)* 48.7 (1.5)*
Values are mean (SD). No signiﬁcant differences were found between groups 
at baseline. A bimodal T2 time course was observed for all 40-min I/R pigs, with 
no signiﬁcant differences detected between 40-min I/R and 40-min I/R+PostC. 
In contrast, PreC blunted both T2 peaks, whereas after 20-min I/R, the ﬁrst peak 
was blunted and the second, absent. I/R indicates ischemia/reperfusion; PostC, 
postconditioning; and PreC, preconditioning.
*Statistically signiﬁcant differences (P<0.05) compared with the same 
time point in the 40-min I/R (control) group. P value is adjusted for multiple 
comparisons among groups for each time point.
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24 hours, then increasing again to reach a peak on day 7.10 
Preconditioning before 40-minute I/R resulted in a signiﬁ-
cantly shorter T2 relaxation time at reperfusion and an ear-
lier and shorter deferred peak, occurring on day 4 rather than 
day 7. Conversely, postconditioning had no effect on ede-
ma dynamics, with animals showing the standard bimodal 
pattern with an initial peak at reperfusion and a deferred T2 
prolongation peaking on day 7 (Figure 1A and 1B). Pigs sub-
jected to short-duration ischemia (20-minute I/R) showed a 
unimodal pattern of edema, with T2 prolongation at reperfu-
sion, albeit blunted compared with 40-minute I/R, and no 
deferred peak. True myocardial water content values in the 
Figure 1. Time proﬁle of T2 relaxation time and measurements of myocardial water content in the ischemic myocardium after 
different ischemia/reperfusion (I/R) protocols. A, Time profile of absolute T2 relaxation time (ms) in the ischemic myocardium of pigs 
undergoing different I/R protocols. Data are shown as mean±standard error of the mean. B, Representative serial cardiac magnetic 
resonance T2-mapping images from pigs that underwent 40-min I/R (control), 40-min I/R followed by postconditioning (PostC), 40-min I/R 
preceeded by preconditioning (PreC), or 20-min I/R; examinations were made at baseline, 120 min, 24 h, 4 d, and 7 d after reperfusion. 
All T2 maps were scaled between 30 and 120 ms. C, Measurements of myocardial water content (%) in healthy pigs and in the ischemic 
myocardium of pigs subjected to different I/R protocols and euthanized at day 7 after I/R. Myocardial water content (mean±SD, %) in 
the healthy pig myocardium was 79.4±0.6%. Myocardial water content (mean±SD, %) in the ischemic myocardium of pigs undergoing 
40-min I/R (controls), 40-min I/R+PostC, 40-min I/R preceded by PreC, and 20-min I/R (short-duration ischemia) at day 7 after I/R 
was 85.2±0.9%, 84.7±1.4%, 82.2±1.1%, and 79.8±0.2%, respectively. Between-group differences of water content in the ischemic 
myocardium remained statistically significant with the exception of 40-min I/R+PostC vs 40-min I/R and 20-min I/R vs healthy. Data 
represented are means±standard error of the mean.
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ischemic myocardium were comparable with those estimat-
ed from T2 relaxation times on day 7 CMR (Figure 1C).
Impact of Cardioprotective Strategies and Ischemia 
Duration on CMR-Measured MaR
Mean MaR measured by MDCT in the different groups was 
as follows (% of LV): 40-minute I/R (controls), 28.3±4.3%; 
preconditioning plus 40-minute I/R, 31.7±6.9%; 40-minute 
I/R plus postconditioning, 31.3±4.0%; and short-duration 
ischemia (20-minute I/R), 24.6±6.7% (statistically nonsigniﬁ-
cant differences as compared with controls). Measurements of 
MaR determined by T2W-CMR in these groups at different 
times after reperfusion are summarized in Table 2.
CMR-measured MaR and T2 relaxation time showed simi-
lar time course patterns. Pigs subjected to 40-minute I/R with or 
without postconditioning had signiﬁcant swelling of the former-
ly ischemic myocardium at reperfusion (Online Table I; Online 
Movies I through IV). Consequently, at early reperfusion, CMR-
measured MaR as delineated by T2W-STIR was signiﬁcantly 
higher than MaR measured by the reference standard MDCT in 
these pigs (Figure 2A and 2B). Conversely, preconditioned and 
20-minute I/R pigs developed edema at reperfusion but without 
myocardial swelling (Online Table I; Online Movies V through 
VIII), and, therefore, MaR measured by CMR was similar to 
the value recorded by MDCT at this time point in these groups. 
In all study groups, the initial edema wave dissipated by 24 
hours postreperfusion, and CMR measurements systematically 
underestimated MaR at this time point. On days 4 and 7 postre-
perfusion, CMR-measured MaR in control and postconditioned 
pigs was similar to MaR measured by MDCT. Conversely, in 
preconditioned pigs, CMR- and MDCT-measured MaR values 
were similar on day 4, but on day 7, CMR underestimated MaR 
because of partial resolution of the deferred edema wave, which 
appeared earlier, peaking on day 4. In pigs undergoing short-
duration ischemia (20-minute I/R), CMR underestimated MaR 
at all time points after the ﬁrst reperfusion scan because of the 
absence of the deferred edema wave.
Impact of Cardioprotective Strategies and Ischemia 
Duration on IS, Myocardial Salvage, IMH, and MVO
CMR measurements of IS and myocardial salvage after re-
perfusion are summarized in Table 2. IS was maximal at re-
perfusion and progressively shrank during the ﬁrst week after 
MI in all groups. Whereas postconditioning had no effect on 
IS, preconditioning signiﬁcantly reduced IS at all time points 
(Figure 3A and 3B). In pigs undergoing short-duration isch-
emia, IS was negligible at all time points. In parallel with the 
temporal variations in CMR-measured MaR, myocardial sal-
vage estimated by CMR dynamically changed over time and 
according to the I/R protocol applied (Table 2). The time pro-
ﬁle of myocardium salvage as assessed by reference MDCT-
measured MaR and CMR IS is presented in Online Table II.
CMR measurements of IMH and MVO after reperfu-
sion are summarized in Online Table III. IMH was apparent 
at 24 hours, peaking on day 4 post-I/R (Figure 2C), whereas 
MVO was apparent early after reperfusion, peaking on day 1 
post-I/R and progressively decreasing thereafter (Figure 3C). 
Presence and extent of IMH and MVO were unaffected by 
postconditioning, signiﬁcantly reduced by preconditioning, 
and negligible after short-duration ischemia.
Table 2. Time Proﬁle of MaR, IS and Myocardial Salvage as Assessed by CMR During the First 
Week After Reperfused Myocardial Infarction in Pigs Subjected to Different I/R Protocols and 
Cardioprotective Strategies
Group CMR Measure 
Follow-Up
R-120 min R-24 h R-Day 4 R-Day 7
40-min I/R (controls) MaR, % of LV 42.9 (5.7) 2.2 (1.7) 27.1 (3.4) 30.1 (2.3)
IS, % of LV 39.2 (3.8) 30.2 (3.1) 28.2 (4.6) 25.4 (4.0)
Myocardial salvage, % 8.3 (6.4) −1310 (996) −4.4 (14.2) 15.7 (13.3)
40-min I/R+PostC MaR, % of LV 48.8 (6.2)* 1.9 (2.0) 33.9 (4.9)* 32.5 (3.2)
IS, % of LV 46.2 (5.6)* 33.1 (3.4) 32.8 (4.5)* 30.4 (3.6)*
Myocardial salvage, % 5.2 (4.8) −1060 (513) 3.3 (3.9) 6.6 (3.0)
PreC+40-min I/R MaR, % of LV 29.1 (1.4)* 4.2 (1.4) 24.6 (7.5) 17.2 (5.7)*
IS, % of LV 21.0 (7.2)* 18.5 (10.2)* 7.5 (3.7)* 6.1 (4.7)*
Myocardial salvage, % 28.2 (22.6)* −389 (361)* 68.0 (13.6)* 64.0 (23.9)*
20-min I/R MaR, % of LV 27.7 (3.3)* 3.6 (1.1) 4.2 (2.2)* 2.2 (1.9)*
IS, % of LV 6.1 (4.5)* 3.0 (1.0)* 2.2 (0.8)* 1.5 (0.8)*
Myocardial salvage, % 78.8 (13.7)* 17.3 (18.7)* 25.2 (75.5) 3.4 (79.0)
Values are mean (SD). A bimodal trend over time after reperfusion was observed for CMR-MaR and CMR-salvage ([CMR 
MaR−CMR IS]/CMR MaR, %) in all groups of pigs with the exception of the 20-min I/R group in which a negative linear trend or no 
clear trend was shown for CMR-MaR and salvage, respectively. In contrast, a strong negative linear trend over time was shown 
for IS in all groups. P values for signiﬁcant trends were all <0.01. CMR indicates cardiac magnetic resonance; I/R, ischemia/
reperfusion; IS, infarct size; LV, left ventricle; MaR, myocardium at risk; PostC, postconditioning; PreC, preconditioning; and R, 
reperfusion.
*Statistically signiﬁcant differences (P<0.05) as compared with the same time point in the 40- min I/R (control) group. P value 
is adjusted for multiple comparisons among groups for each time point and imaging parameter.
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Impact of Cardioprotective Strategies and Ischemia 
Duration on Histological Features of MI
The histological analysis of pigs euthanized at day 7 postreper-
fusion are summarized in Online Table IV. Postconditioning 
had no discernable effect on lesion size, granulation tissue 
content, neutrophil inﬁltration, or collagen content (Figure 4). 
Preconditioning resulted in smaller lesion areas, a higher pro-
portion of granulation tissue, and lower neutrophil inﬁltration 
Figure 2. Time proﬁle of cardiac magnetic resonance (CMR)-myocardium at risk (MaR) and intramyocardial hemorrhage (IMH) 
after different ischemia/reperfusion (I/R) protocols. A, Time profile of CMR-MaR measured by T2-weighted short-tau triple inversion-
recovery (T2W-STIR) in pigs undergoing different I/R protocols. Arterial enhanced multidetector computed tomography (MDCT) was 
performed during coronary occlusion in all pigs as a reference measure of MaR. Data are shown as mean±standard error of the mean. 
B, Representative images from pigs that underwent 40-min I/R (control), 40-min I/R followed by postconditioning (PostC), 40-min I/R 
preceeded by preconditioning (PreC), or 20-min I/R; serial CMR T2W-STIR examinations were made at 120 min, 24 h, 4 d, and 7 d after 
reperfusion. Images are from the same pigs as those shown in the Figure. C, Temporal evolution of IMH in pigs subjected to different I/R 
protocols and followed ≤7 d after reperfusion. Data are means±standard error of the mean. LV indicates left ventricle.
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and collagen content. Pigs undergoing short-duration isch-
emia showed no signs of tissue lesion and a low degree of 
neutrophil inﬁltration.
Association Between T2 and IMH, MVO, IS, and 
LVEF
Overall, T2 relaxation time in the ischemic region at 120 min-
utes post-I/R correlated positively with the degree of IMH and 
MVO: the longer the T2 at early reperfusion, the larger the 
extent of IMH and MVO. Conversely, the deferred T2 peak 
(highest value between day 4 and day 7) correlated positively 
with IS and inversely with LVEF: the greater the deferred T2 
peak, the larger the infarct and the lower the LVEF on day 7 
(Figure 5).
Discussion
In this study, we have comprehensively characterized the im-
pact of cardioprotective strategies (preconditioning and post-
conditioning) and ischemia duration on the temporal evolution 
and extent of myocardial tissue composition changes (edema, 
necrosis, IMH, and MVO) by CMR. In all instances of necro-
sis (positive LGE at day 7), a bimodal edematous response is 
seen, regardless of the presence and degree of IMH or MVO; 
however, when necrosis is absent (in animals undergoing 
short-duration ischemia with no day-7 LGE), the edematous 
reaction is unimodal, with a blunted reperfusion-related edema 
wave and no healing-related deferred wave. Preconditioning, 
which signiﬁcantly reduces IS, modulates the intensity of both 
the initial and deferred edema waves. The deferred wave also 
peaks earlier in preconditioned than in nonpreconditioned in-
farctions. CMR-measured IS declined progressively after re-
perfusion in all groups, whereas the extent of IMH and MVO 
varied according to CMR timing and protocol applied. T2 re-
laxation time in the ischemic area early after reperfusion is 
correlated with the severity of IMH and MVO, whereas the 
deferred peak of T2 relaxation time is strongly associated with 
IS and LVEF.
Consequently, imaging protocols for post-MI tissue char-
acterization aiming at quantifying edema, MaR, IS, myocardi-
al salvage, IMH, and MVO should account for these dynamics 
and be as standardized as possible (Figure 6).
Modulation of the Post-I/R Edema by 
Cardioprotecitve Strategies and Ischemia Duration
The possibility of protecting the myocardium during an acute 
MI (cardioprotection) has interested the scientiﬁc commu-
nity for several decades.2,21 Many studies use IS normalized 
to MaR as an acute end point, on the assumption that post-
I/R edema is steady. However, recent studies suggest that the 
extent of edema might be inﬂuenced by cardioprotective con-
ditioning interventions.16,17 However, these previous clinical 
studies were not designed to address the effect of conditioning 
interventions on edema formation, and subjects underwent a 
single CMR examination that was not at the same time point 
for all individuals.16,17
Our results show that preconditioning (a potent cardio-
protective strategy) and short ischemia duration have a ma-
jor impact on the intensity and dynamics of post-MI edema 
(Figure 1). Preconditioning reduced the initial edema wave 
and also the deferred wave, which peaked early, on day 4, con-
trasting with the peak on day 7 in control animals. Shortening 
the duration of coronary occlusion to 20 minutes (20-minute 
I/R) also blunted initial edema wave, and in this case, the sec-
ond edema wave was absent. These CMR results are consis-
tent with histologically determined water content at day 7 after 
MI, which was reduced in pigs undergoing preconditioning 
and within the normal range in pigs undergoing short-duration 
ischemia (Figure 1C).
Figure 3. Time proﬁle of cardiac magnetic resonance (CMR)-
measured infarct size and microvascular obstruction (MVO) 
after different ischemia/reperfusion (I/R) protocols. A, Time 
profile of infarct size measured by T1-weighted inversion recovery 
turbo field echo (T1-IR-TFE) after administration of gadolinium 
to pigs undergoing different I/R protocols. Data are shown as 
mean±standard error of the mean. B, Representative images from 
pigs that underwent 40-min I/R (control), 40-min I/R followed by 
postconditioning (PostC), 40-min I/R preceded by preconditioning 
(PreC), or 20-min I/R; serial CMR T1-IR-TFE examinations were 
made at 120 min, 24 h, 4 d, and 7 d after reperfusion. Images are 
from same pigs as those shown in Figures 2 and 3. C, Temporal 
evolution of MVO in pigs subjected to different I/R protocols and 
followed ≤7 d after reperfusion. Data are means±standard error 
of the mean. Note that pigs subjected to 20-min I/R did not show 
MVO at any evaluated time point. LV indicates left ventricle.
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Impact of IMH and MVO on the Occurrence of the 
Bimodal Edematous Reaction
The extent of IMH and MVO varies as a function of time 
from the acute ischemic event.11,12 IMH is moreover closely 
associated with the development of MVO, conferring a worse 
prognosis when present.12 More importantly, in the present 
study, edema followed a bimodal T2 pattern in all pigs un-
dergoing 40-minute I/R (with or without preconditioning or 
postconditioning) regardless of the degree of IMH or MVO 
(Figure 1), which was almost absent in preconditioned pigs 
(Figures 2C and 3C). Notably, all pigs, including those un-
dergoing short-duration ischemia, showed a signiﬁcant drop 
in T2 from the hyperacute phase to 24 hours postreperfusion 
(Figure 1). These ﬁndings suggest that the main driver of the 
drop in T2 is rapid resorption of the initial reperfusion-related 
edema, regardless of the degree of IMH and MVO, and re-
inforce the reality of bimodal post-MI edema. Nevertheless, 
IMH exerts some inﬂuence on T2 relaxation time, as we pre-
viously conceded,10,11,14,20 and might explain the slightly less 
noticeable drop in T2 at 24 hours in pigs with almost no IMH 
or MVO (pigs given preconditioning or short-duration isch-
emia; Figure 1).
Impact of Cardioprotective Strategies and Ischemia 
Duration on CMR-Measured Myocardial Area at 
Risk and Salvage
Parametric T2 mapping improves the detection and quan-
tiﬁcation of myocardial edema;20 however, this methodol-
ogy is not universally available, contrasting with T2W-STIR, 
which is available from all major vendors. In this regard, 
CMR-measured MaR as delineated by the extent of edema 
on T2W-STIR imaging paralleled T2 relaxation time proﬁle. 
The present study shows that the edema-sensitive T2W-STIR 
CMR sequence overestimates MaR (as compared with the 
reference standard, MDCT in this study) at early time points 
(120 minutes) after reperfusion in pigs subjected to 40-minute 
I/R with no protective strategies or undergoing postcondition-
ing (which did not protect in this study). This overestimation 
is mainly driven by the massive swelling of the reperfused 
myocardium (Online Movies I through IV). By 24 hours, 
there is a systematic underestimation of MaR by CMR in all 
cases, mainly driven by the substantial resorption of edema 
and normalization of T2 relaxation time.10 This underestima-
tion resulted in biologically implausible negative myocardial 
salvage data at 24 hours in most pigs (Table 2). This ﬁnd-
ing reinforces the idea that MaR (and consequently salvaged 
myocardium) may not reliably be quantiﬁed by CMR around 
this time point. Conversely, on days 4 and 7, CMR-measured 
MaR was similar to MaR measured by MDCT (Figure 2A). 
However, the dynamics of postischemia edema are altered by 
cardioprotective strategies and ischemia duration, with further 
implications for CMR-measured MaR and salvage.
Thus, the smaller extent of edema at reperfusion in pigs 
that underwent preconditioning or short-duration ischemia 
(Figure 2) was associated with less prolonged T2 relaxation 
times (Figure 1) and lower degree of myocardial swelling. 
Interestingly, these 2 groups of cardioprotected animals had 
Figure 4. Impact of cardioprotection and ischemia duration on histological features of myocardial infarction. Representative 
histological images of porcine ischemic myocardium 7 d after 40-min ischemia/reperfusion (I/R; control), 40-min I/R followed by 
postconditioning (PostC), 40-min I/R preceded by preconditioning (PreC), and 20-min I/R. Images show staining with hematoxylin and 
eosin (H/E), antiPM1 antibody (PMN), and Masson trichrome. Stained sections were used to quantify lesion extent, proportion of necrosis 
and granulation tissue, neutrophil density, and percentage of collagen within granulation tissue. Note the scarce neutrophil infiltration in 
porcine myocardium subjected to PreC or 20-min I/R, accompanied by small patchy areas of granulation tissue (PreC) or its absence (20-
min I/R). Scale bars, 100μΜ.
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signiﬁcantly smaller infarcts on day 7 (Figure 3). The car-
dioprotection (reduced IS) afforded by preconditioning or 
short-duration ischemia was demonstrated by CMR (LGE; 
Figure 3) and histology (Figure 4). In pigs undergoing short-
duration ischemia, necrosis was barely detectable, and so was 
edema and CMR-measured MaR from day 1 on, supporting 
the notion that the deferred edema wave is related to post-
MI healing.11 This would imply that interventions that protect 
the myocardium could affect edema dynamics, therefore, hav-
ing an impact on CMR estimations of MaR and salvage, as 
suggested by indirect clinical evidence before.16,17 However, 
whether any intervention that reduces IS diminishes myocar-
dial edema remains to be demonstrated. A paradigmatic ex-
ample of such interplay may be seen in the group subjected to 
short duration of ischemia (Table 2). In this group, IS is small 
and stable on day 1 (3.0% of LV), day 4 (2.2% of LV), and day 
7 (1.5% of LV); however, a dramatic change is seen in CMR-
measured salvage index (17.3%, 25.2%, and 3.4% of MaR on 
days 1, 4, and 7, respectively). Of note, when using the MaR 
standard reference MDCT value to calculate salvage, salvage 
index remains stable (87.4%, 90.0%, and 94.4% of MaR on 
days 1, 4, and 7, respectively; Online Table II). The latter mea-
surements (based on MDCT-MaR) are consistent with the sig-
niﬁcant cardioprotective effect seen by early reperfusion (ie, 
short ischemia duration).
Decrease of CMR-Based IS During the First Week 
After MI
Previous studies show rapid resorption of LGE myocardium 
(a surrogate of IS) between ≈day 1 and day 7 after MI.4,22 
Consistent with these observations, our data show a progres-
sive decrease of CMR-based IS in all study groups (Figure 3). 
The massive swelling of the early postreperfused myocardium 
might explain the large IS detected in our study 120 minutes 
after reperfusion. Interestingly, animals that underwent pre-
conditioning showed LGE-positive myocardial regions early 
after reperfusion that became LGE negative by day 4 or day 7 
CMR (Figure 3). This phenomenon might indicate early and 
transient expansion of extracellular volume without irrevers-
ible myocardial injury.22 These data highlight the importance 
of performing CMR infarct imaging within a consistently de-
ﬁned and narrow time frame, preferably at the end of the ﬁrst 
week, when using IS as an end point in clinical trials during 
Figure 5. Association between T2, intramyocardial hemorrhage (IMH), microvascular obstruction (MVO), infarct size, and left 
ventricular ejection fraction (LVEF). Scatter plots showing positive association of T2 relaxation time in the ischemic myocardium 
during the hyperacute postreperfusion period (120 min) with (A) peak MVO (Pearson r=0.68) and (B) peak intramyocardial hemorrhage 
(Pearson r=0.75). C and D, The deferred T2 peak in the ischemic myocardium shows a strong positive association with day-7 infarct size 
(Pearson r=0.87) and a negative association with day-7 LVEF (Pearson r=−0.85). After adjustment for multiple testing, all P values for the 
correlations shown remained significant (P<0.05). Graphs include 4 groups of 5 pigs each undergoing 40-min ischemia/reperfusion (I/R; 
controls), 40-min I/R followed by postconditioning, 40-min I/R preceded by preconditioning, or 20-min I/R. LV indicates left ventricle.
125
448  Circulation Research  August 4, 2017
the acute post-MI period. Nevertheless, the fact that myocar-
dial edema and LGE follow a disparate dynamic pattern after 
ischemia/reperfusion highlights the complexity of measuring 
myocardial salvage in real practice.
T2 as a Maker of Post-I/R Myocardial Injury
The ability to predict the fate of the myocardium early af-
ter MI would be of great clinical value. Myocardial edema 
contributes to impaired post-MI microvascular perfusion by 
increasing extravascular compression and might contribute 
to altered coronary physiology indices.1,2 In this study, we 
show that T2 relaxation time in ischemic myocardium in the 
hyperacute CMR examination (after 2 hours of reperfusion) 
correlates with IMH and MVO—events that develop days 
after MI (Figure 5A and 5B). Conversely, the deferred T2 
peak correlated directly with IS and inversely with LVEF—
parameters associated with post-MI healing (Figure 5C and 
5D). Therefore, myocardial T2 relaxation time might be a 
quantitative surrogate of the ischemic insult or therapeutic ef-
fect, rather than a surrogate of MaR.
However, these ﬁndings might apply only to the reperfused 
MI because the bimodal edema response is less pronounced 
in nonreperfused MI.11 These ﬁndings warrant further ex-
perimental and clinical studies speciﬁcally addressing the 
prognostic signiﬁcance of T2 at different time points and the 
perfusion status of the myocardium.
Limitations
Caution is needed when extrapolating experimental results 
to the clinic. However, the pig is one of the most clinically 
translatable large animal models for the study of reperfused 
MI.23,24 The nature of our experimental study, that is, longitu-
dinal follow-up, precluded individual histological gold stan-
dard measurements of area at risk (ie, Evans Blue by coronary 
reocclusion), IS (ie, triphenyl tetrazolium chloride), or MVO 
(thioﬂavin-S) at each time point. In addition, the heart was har-
vested at sacriﬁce to perform reference standard myocardial 
water content measurements and histological quantiﬁcation of 
different tissue components, which otherwise might be altered 
by such procedures. It is fair to acknowledge that although 
previous studies have used histological standards to validate 
the use of CMR to measure IS and MVO22,25 and MDCT to 
measure MaR,19,26 there is probably no perfect noninvasive 
method for such purposes. In this regard, acutely detected 
LGE does not necessarily equate to irreversible injury and 
may contribute to severely distort estimates of salvaged myo-
cardium when comparing against a prereperfusion reference 
standard to assess MaR.22 Other reasons that might contribute 
to inaccurate estimations include damage extent beyond the 
boundaries of the actual MaR (deﬁned as the hypoperfused 
region during coronary occlusion);19 slightly shrinking of 
MaR in MDCT performed during coronary occlusion because 
of lack of perfusion in animal models with poor collateral 
circulation; and the presence of residual edema in salvaged 
Figure 6. Effect of timing of evaluation, ischemia duration, 
and protective interventions on cardiac magnetic resonance 
(CMR)-measured individual outcomes after myocardial 
infarction (MI). By using state-of-the-art CMR imaging, we 
have demonstrated that the temporal dynamics and extent of 
post-MI tissue composition changes are greatly influenced by 
the timing of imaging acquisition, application of cardioprotective 
interventions, and the duration of the index ischemia. These 
findings highlight the need for protocol standardization 
when using post-MI imaging techniques to measure edema, 
myocardial area at risk, infarct size (IS), myocardial salvage, 
intramyocardial hemorrhage (IMH), and microvascular 
obstruction (MVO) in experimental and clinical studies. 
According to the data presented, establishing the appropriate 
timing to measure IMH and MVO could occur somewhere 
around the first 24 to 48 h post-MI; whereas the optimal timing 
to measure edema, myocardium at risk (MaR), IS, and salvage 
could occur somewhere between day 4 and day 7 after MI. 
Nevertheless, caution should be exercised when addressing 
post-MI tissue characterization by any means given that several 
components and factors might additionally impact the dynamics 
and complex changes which undergo the heart after MI. y axis 
numbers and graphs represent real data relative to the highest 
point on the chart for the given imaging outcome (MaR, IS, MVO, 
and IMH). A value of 100 is the highest value for the (Continued )  
Figure 6 Continued. corresponding measure in controls (ie, pigs 
subjected to 40-min I/R) among all time points evaluated (120 
min, day 1, day 4, and day 7 after reperfusion). A value of 50 
means that the extent of the corresponding measure is half as 
the former highest value.
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myocardium which might contribute to overestimate of IS ear-
ly after reperfusion.22 Hybrid imaging techniques have been 
proposed to overcome some of these issues;27 however, further 
validation is needed.
Our study examined only anterior MI. The reasons for 
this choice include the avoidance of possible magnetic-ﬁeld 
nonhomogeneity related to the inferolateral wall6,28 and adher-
ence to recommendations for patient selection in clinical trials 
of cardioprotective interventions.21 The observed changes in 
tissue composition are likely to occur regardless of MI loca-
tion; however, caution should be exercised when extrapolating 
other results, especially those regarding the association of T2 
with ventricular outcome.
Our results do not necessarily invalidate the reported pro-
tective effects of the majority of preclinical postcondition-
ing studies published.29 However, our ﬁndings are in line with 
some recent experimental and clinical data.29,30 In this regard, 
ischemic postconditioning did not reduce the incidence of clini-
cal events in ST-segment–elevation MI (STEMI) patients in the 
DANAMI-3-iPOST trial (The Third Danish Study of Optimal 
Acute Treatment of Patients With ST Elevation Myocardial 
Infarction–Ischemic Postconditioning).31 Moreover, this inter-
vention did not reduce IS, myocardial salvage index, extent of 
MVO, or improve LVEF in the subset of patients who underwent 
CMR.31 Interspecies differences, small sample size, the lack of 
comorbidities and comedications in animal experiments, and the 
diversity of postconditioning protocols applied might explain the 
ambivalent preclinical and clinical data.29 Nevertheless, our goal 
was not to test the cardioprotective effect of postconditioning, 
but rather to use different protective strategies to characterize 
post-MI tissue over a range of injury severities. Indeed, the use 
of strategies that did not achieve cardioprotection reinforced our 
earlier results obtained by the standard I/R procedure.10,11
The regions of interest used to quantify T2 relaxation time 
in this study included the full wall thickness. The regions of 
interest might, therefore, include different myocardial states 
(such as hemorrhage or MVO). We took this approach to 
match our previous experimental work and because the differ-
entiation of such small areas might be challenging. This might 
have contributed to the differences in absolute T2 relaxation 
time between our study and others taking a different approach 
to region of interest selection.
Conclusions
In a translational large animal model of myocardial I/R and by 
using CMR, we have shown that the temporal dynamics and 
extent of post-MI tissue composition changes are greatly in-
ﬂuenced by application of cardioprotective interventions and 
the duration of the index ischemia. Post-MI LGE areas do not 
necessarily equate to necrotic myocardium because the extent 
of hyperenhanced ischemic tissue evolves rapidly during the 
ﬁrst week after reperfusion. The magnitude of IMH and MVO 
varies according to ischemia duration and cardioprotection. 
The greatest divergences are seen in the degree and spatial 
extent of myocardial edema during the ﬁrst week after MI, 
which seem to be a quantitative surrogate marker of ischemic 
damage or therapeutic effect.
These data highlight the need for protocol standardization 
when using post-MI imaging techniques to measure edema, 
MaR, IS, myocardial salvage, IMH, and MVO in experimental 
and clinical studies.
Acknowledgments
We thank Tamara Córdoba, Oscar Sanz, Eugenio Fernández, and other 
members of the Centro Nacional de Investigaciones Cardiovasculares 
Carlos III (CNIC) animal facility and farm for outstanding animal 
care and support and Roisin Doohan and Brenda Guijarro for assis-
tance with histological sample processing. Simon Bartlett (CNIC) 
provided English editing. Pictures from multidetector computed to-
mography and cardiac magnetic resonance equipment (Online Figure 
I; Figure 6) are reproduced with the permission of Philips Healthcare.
Sources of Funding
This study was supported by a competitive grant from the Carlos 
III Institute of Health-Fondo de Investigacion Sanitaria and the 
European Regional Development Fund (ERDF/FEDER; PI10/02268 
and PI13/01979), the Spanish Ministry of Economy, Industry, and 
Competitiveness (MEIC) and ERDF/FEDER (SAF2013-49663-EXP), 
and, in part, by the FP7-PEOPLE-2013-ITN Next generation training 
in cardiovascular research and innovation-Cardionext. R. Fernández-
Jiménez holds a FICNIC fellowship from the Fundació Jesús Serra, 
the Fundación Interhospitalaria de Investigación Cardiovascular, 
and the Centro Nacional de Investigaciones Cardiovasculares Carlos 
III (CNIC). J. Agüero is a FP7-PEOPLE-2013-ITN-Cardionext fel-
low. This research program is part of an institutional agreement be-
tween FIIIS-Fundación Jiménez Díaz and CNIC. This study forms 
part of a Master Research Agreement between the CNIC and Philips 
Healthcare. This study is part of a bilateral research program between 
Hospital de Salamanca Cardiology Department and the CNIC. The 
CNIC is supported by the MEIC and the Pro CNIC Foundation and is 
a Severo Ochoa Center of Excellence (MEIC award SEV-2015-0505).
Disclosures
J. Sánchez-González is a Philips Healthcare employee. The other au-
thors report no conﬂicts.
References
 1. Heusch G. The coronary circulation as a target of cardioprotection. Circ 
Res. 2016;118:1643–1658. doi: 10.1161/CIRCRESAHA.116.308640.
 2. Ibanez B, Heusch G, Ovize M, Van de Werf F. Evolving therapies for myo-
cardial ischemia/reperfusion injury. J Am Coll Cardiol. 2015;65:1454–
1471. doi: 10.1016/j.jacc.2015.02.032.
 3. Carlsson M, Ubachs JF, Hedstrom E, Heiberg E, Jovinge S, Arheden H. 
Myocardium at risk after acute infarction in humans on cardiac mag-
netic resonance: quantitative assessment during follow-up and validation 
with single-photon emission computed tomography. JACC Cardiovasc 
Imaging. 2009;2:569–576. doi: 10.1016/j.jcmg.2008.11.018.
 4. Dall’Armellina E, Karia N, Lindsay AC, Karamitsos TD, Ferreira V, Robson 
MD, Kellman P, Francis JM, Forfar C, Prendergast BD, Banning AP, Channon 
KM, Kharbanda RK, Neubauer S, Choudhury RP. Dynamic changes of ede-
ma and late gadolinium enhancement after acute myocardial infarction and 
their relationship to functional recovery and salvage index. Circ Cardiovasc 
Imaging. 2011;4:228–236. doi: 10.1161/CIRCIMAGING.111.963421.
 5. Aletras AH, Tilak GS, Natanzon A, Hsu LY, Gonzalez FM, Hoyt RF Jr, 
Arai AE. Retrospective determination of the area at risk for reperfused 
acute myocardial infarction with T2-weighted cardiac magnetic resonance 
imaging: histopathological and displacement encoding with stimulated 
echoes (DENSE) functional validations. Circulation. 2006;113:1865–
1870. doi: 10.1161/CIRCULATIONAHA.105.576025.
 6. Friedrich MG, Kim HW, Kim RJ. T2-weighted imaging to assess post-in-
farct myocardium at risk. JACC Cardiovasc Imaging. 2011;4:1014–1021. 
doi: 10.1016/j.jcmg.2011.07.005.
 7. Friedrich MG, Abdel-Aty H, Taylor A, Schulz-Menger J, Messroghli D, 
Dietz R. The salvaged area at risk in reperfused acute myocardial in-
farction as visualized by cardiovascular magnetic resonance. J Am Coll 
Cardiol. 2008;51:1581–1587. doi: 10.1016/j.jacc.2008.01.019.
 8. Engblom H, Heiberg E, Erlinge D, Jensen SE, Nordrehaug JE, Dubois-
Rande JL, Halvorsen S, Hoffmann P, Koul S, Carlsson M, Atar D, Arheden 
H. Sample size in clinical cardioprotection trials using myocardial salvage 
127
450  Circulation Research  August 4, 2017
index, infarct size, or biochemical markers as endpoint. J Am Heart Assoc. 
2016;5:e002708. doi: 10.1161/JAHA.115.002708.
 9. Kim HW, Van Assche L, Jennings RB, et al. Relationship of T2-weighted 
MRI myocardial hyperintensity and the ischemic area-at-risk. Circ Res. 
2015;117:254–265. doi: 10.1161/CIRCRESAHA.117.305771.
 10. Fernández-Jiménez R, Sánchez-González J, Agüero J, et al. Myocardial 
edema after ischemia/reperfusion is not stable and follows a bimodal pat-
tern: imaging and histological tissue characterization. J Am Coll Cardiol. 
2015;65:315–323. doi: 10.1016/j.jacc.2014.11.004.
 11. Fernández-Jiménez R, García-Prieto J, Sánchez-González J, Agüero J, 
López-Martín GJ, Galán-Arriola C, Molina-Iracheta A, Doohan R, Fuster 
V, Ibáñez B. Pathophysiology underlying the bimodal edema phenomenon 
after myocardial ischemia/reperfusion. J Am Coll Cardiol. 2015;66:816–
828. doi: 10.1016/j.jacc.2015.06.023.
 12. Carrick D, Haig C, Ahmed N, Rauhalammi S, Clerfond G, Carberry J, Mordi 
I, McEntegart M, Petrie MC, Eteiba H, Hood S, Watkins S, Lindsay MM, 
Mahrous A, Welsh P, Sattar N, Ford I, Oldroyd KG, Radjenovic A, Berry 
C. Temporal evolution of myocardial hemorrhage and edema in patients 
after acute ST-segment elevation myocardial infarction: pathophysiological 
insights and clinical implications. J Am Heart Assoc. 2016;5:e002834.
 13. Dharmakumar R. Building a uniﬁed mechanistic insight into the bimodal 
pattern of edema in reperfused acute myocardial infarctions: observations, 
interpretations, and outlook. J Am Coll Cardiol. 2015;66:829–831. doi: 
10.1016/j.jacc.2015.05.074.
 14. Fernández-Jiménez R, Fuster V, Ibanez B. Reply: “waves of edema” seem 
implausible. J Am Coll Cardiol. 2016;67:1869–1870. doi: 10.1016/j.
jacc.2016.01.052.
 15. Heusch P, Nensa F, Heusch G. Is MRI really the gold standard for the quan-
tiﬁcation of salvage from myocardial infarction? Circ Res. 2015;117:222–
224. doi: 10.1161/CIRCRESAHA.117.306929.
 16. Thuny F, Lairez O, Roubille F, et al. Post-conditioning reduces infarct size 
and edema in patients with ST-segment elevation myocardial infarction. J 
Am Coll Cardiol. 2012;59:2175–2181. doi: 10.1016/j.jacc.2012.03.026.
 17. White SK, Frohlich GM, Sado DM, Maestrini V, Fontana M, Treibel 
TA, Tehrani S, Flett AS, Meier P, Ariti C, Davies JR, Moon JC, Yellon 
DM, Hausenloy DJ. Remote ischemic conditioning reduces myocardial 
infarct size and edema in patients with ST-segment elevation myocardial 
infarction. JACC Cardiovasc Interv. 2015;8:178–188. doi: 10.1016/j.
jcin.2014.05.015.
 18. Ghugre NR, Pop M, Barry J, Connelly KA, Wright GA. Quantitative mag-
netic resonance imaging can distinguish remodeling mechanisms after 
acute myocardial infarction based on the severity of ischemic insult. Magn 
Reson Med. 2013;70:1095–105. doi: 10.1002/mrm.24531.
 19. Mewton N, Rapacchi S, Augeul L, Ferrera R, Loufouat J, Boussel L, 
Micolich A, Rioufol G, Revel D, Ovize M, Croisille P. Determination of 
the myocardial area at risk with pre- versus post-reperfusion imaging tech-
niques in the pig model. Basic Res Cardiol. 2011;106:1247–1257. doi: 
10.1007/s00395-011-0214-8.
 20. Fernandez-Jimenez R, Sanchez-Gonzalez J, Aguero J, Del Trigo M, 
Galan-Arriola C, Fuster V, Ibanez B. Fast T2 gradient-spin-echo (T2-
GraSE) mapping for myocardial edema quantiﬁcation: ﬁrst in vivo 
validation in a porcine model of ischemia/reperfusion. J Cardiovasc Magn 
Reson. 2015;17:92. doi: 10.1186/s12968-015-0199-9.
 21. Hausenloy DJ, Botker HE, Engstrom T, Erlinge D, Heusch G, Ibanez B, 
Kloner RA, Ovize M, Yellon DM, Garcia-Dorado D. Targeting reperfusion 
injury in patients with ST-segment elevation myocardial infarction: trials 
and tribulations. Eur Heart J. 2017;38:935–941. doi: 10.1093/eurheartj/
ehw145.
 22. Jablonowski R, Engblom H, Kanski M, Nordlund D, Koul S, van der Pals 
J, Englund E, Heiberg E, Erlinge D, Carlsson M, Arheden H. Contrast-
enhanced CMR overestimates early myocardial infarct size: mechanistic 
insights using ECV measurements on day 1 and day 7. JACC Cardiovasc 
Imaging. 2015;8:1379–1389. doi: 10.1016/j.jcmg.2015.08.015.
 23. Fernández-Jiménez R, Fernández-Friera L, Sánchez-González J, Ibáñez 
B. Animal models of tissue characterization of area at risk, edema and 
ﬁbrosis. Curr Cardiovasc Imaging Rep. 2014;7:1–10.
 24. Heusch G, Skyschally A, Schulz R. The in-situ pig heart with re-
gional ischemia/reperfusion - ready for translation. J Mol Cell Cardiol. 
2011;50:951–963. doi: 10.1016/j.yjmcc.2011.02.016.
 25. Wu KC. CMR of microvascular obstruction and hemorrhage in myo-
cardial infarction. J Cardiovasc Magn Reson. 2012;14:68. doi: 
10.1186/1532-429X-14-68.
 26. van der Pals J, Hammer-Hansen S, Nielles-Vallespin S, Kellman P, Taylor 
J, Kozlov S, Hsu LY, Chen MY, Arai AE. Temporal and spatial character-
istics of the area at risk investigated using computed tomography and T1-
weighted magnetic resonance imaging. Eur Heart J Cardiovasc Imaging. 
2015;16:1232–1240. doi: 10.1093/ehjci/jev072.
 27. Nensa F, Poeppel T, Tezgah E, Heusch P, Nassenstein K, Mahabadi AA, 
Forsting M, Bockisch A, Erbel R, Heusch G, Schlosser T. Integrated FDG 
PET/MR imaging for the assessment of myocardial salvage in reperfused 
acute myocardial infarction. Radiology. 2015;276:400–407. doi: 10.1148/
radiol.2015140564.
 28. Fernández-Friera L, García-Ruiz JM, García-Álvarez A, Fernández-
Jiménez R, Sánchez-González J, Rossello X, Gómez-Talavera S, López-
Martín GJ, Pizarro G, Fuster V, Ibáñez B. Accuracy of area at risk 
quantiﬁcation by cardiac magnetic resonance according to the myocardial 
infarction territory. Rev Esp Cardiol (Engl Ed). 2017;70:323–330. doi: 
10.1016/j.rec.2016.07.004.
 29. Heusch G, Rassaf T. Time to give up on cardioprotection? a critical ap-
praisal of clinical studies on ischemic pre-, post-, and remote conditioning. 
Circ Res. 2016;119:676–695. doi: 10.1161/CIRCRESAHA.116.308736.
 30. Bodi V, Ruiz-Nodar JM, Feliu E, et al. Effect of ischemic postconditioning 
on microvascular obstruction in reperfused myocardial infarction. Results 
of a randomized study in patients and of an experimental model in swine. 
Int J Cardiol. 2014;175:138–146. doi: 10.1016/j.ijcard.2014.05.003.
 31. Engstrøm T, Kelbæk H, Helqvist S, et al; Third Danish Study of Optimal 
Acute Treatment of Patients With ST Elevation Myocardial Infarction–
Ischemic Postconditioning (DANAMI-3–iPOST) Investigators. Effect of 
ischemic postconditioning during primary percutaneous coronary inter-
vention for patients with ST-segment elevation myocardial infarction: a 
randomized clinical trial. JAMA Cardiol. 2017;2:490–497. doi: 10.1001/
jamacardio.2017.0022.
128
????????????? ????????
?
????????? ???????
?
Study design  
???????????????????????????????????????? ?????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????? ??????????
???????????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????
??????????????????????????????? ?????????????????????????????????????????????????????????????????
???????????????????????????????????????????????? ?????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????? ??????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????
?
Myocardial infarction procedure  
???? ???????????????????????????????????????????????????????????????????????????????????????????
????????????? ??????????????????? ?????????????????????????????????????? ????????????????????????
?????????????????????????????????????????????????????????????????????????? ?????????????? ?????????
??????????????????????????? ???????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????? ??????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????????
????????????????????? ????????????????????????????? ?????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????? ??????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????
?
Conditioning strategies 
?????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????? ??????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????? ???????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????? ??????????????
??????????????? ????????????????????????????????????????????????????????????
?
Arterial enhanced MDCT protocol  
?????????????????? ???????????????????????????????????????????????????????????????????????
???????????????????????????????????????? ?????????????????????????????????????????????????????
?????????? ????????????????????????????????????????????????????????? ???????????????????????????
129
????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????????????
??????????????? ????????????????????????????????????????????????????????? ??????????????? ??????
?????????????????????????????? ?????????????????????????????????? ???????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????? ???????????????
???????????????????????????????????????????????????????????????????????????????????? ???????????
????????????????????????????????????????????????????????????????????????????????????????????????
?
Arterial enhanced MDCT analysis 
???????????????????????????????????????????????????????????????? ???????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????
??? ??????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????? ??????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????? ??????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????? ???????????????????????????????????????????? ????????????
?????????????????????????????????????????????????????????????????????????????????????????????????????
???? ????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????
?
CMR protocol 
??????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????? ??????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????? ?????????????????
????????????????????????????????????????????????????????????????? ???????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????? ???????
?????????????????????????? ??????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????? ??????
??????????????????????????????????????????????????????????? ?????????????????????????????????????????
?????????????????????????????????????????????????????????????? ?????????????????????????????
????????????????????????????????????? ????????????????????????? ?????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????
????????? ???????????????????????????????????????????? ??????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????? ??????????????????????????????????????????
????????????????????????? ?????????????????????? ?????????? ?????????????????????????????????????
???????????? ??????????????????????
????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????? ???
??????????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????
130
?
CMR analysis 
??????????????????????????????????????????????????????????????? ???????????????????????
?????????????????????????????????????????????? ????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????
?????????????????????????????????????????????????? ??????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????? ???????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????? ?????????????????????????????
??????????????? ?????????????????????????????????? ?????????????????????????????????????????????????
?????????????????????????????????????????????????? ????????????????????????????????????????????
?????????????????????????????????????????????????????????????? ??????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????????
???????????????? ???????????????????????????????????????????????? ??????????????????????????????
?????????????????????????????????????? ???????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????? ????????????????????????????????????????????????????????????????
???????????????????????????????????????
????????????????????????????????????????????????????? ????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????? ????????????????????????????????????????
???????????????????????????????????????????????????????????????????? ????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????? ????? ?????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????? ???????????????????????????
?????????????????????????????????????????????????????? ????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????
????? ???????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????????????
???????????? ??????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????
Quantification of myocardial water content  
???????????????????????????????????????????????? ???????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????
??????????
Histological and immunnohistochemical analysis 
????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????
??????? ????????????????
131
??????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????? ?????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????? ??????????????????????? ???????????????????
????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????
?????????? ?????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????
???????
?????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????? ?
132
????????????????????????????????????????
?
???????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????? ?????????????
????????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????? ????????????????????????????
????????????????????????????????????????????????????????????
?
?
?
? ?
133
????????????????????
?
??????????????????????????????????????????????????????? ???????????????????????????????????????????
????????????????????????? ???????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????
?
?????? ???? ??????? ? ??????????
? ? ????????? ????????? ?????????? ??????? ???????
??????????
??????????
??? ?????????? ??????????? ??????????? ??????????? ??????????? ???????????
???????????????? ???????????? ???????????? ???????????? ???????????? ????????????
???????????????? ?? ??????????? ??????????? ??????????? ???????????
???????? ??????? ?? ??????????? ??????????? ??????????? ???????????
????????????
??????
??? ?????????? ??????????? ???????????? ??????????? ??????????? ???????????
???????????????? ???????????? ???????????? ???????????? ???????????? ????????????
???????????????? ?? ??????????? ???????????? ??????????? ???????????
???????? ??????? ?? ??????????? ??????????? ??????????? ???????????
???????
??????????
??? ?????????? ??????????? ??????????? ??????????? ??????????? ???????????
???????????????? ???????????? ???????????? ???????????? ???????????? ????????????
???????????????? ?? ??????????? ??????????? ??????????? ???????????
???????? ??????? ?? ??????????? ??????????? ??????????? ???????????
??????????
??? ?????????? ???????????? ???????????? ???????????? ???????????? ????????????
???????????????? ???????????? ???????????? ???????????? ???????????? ????????????
???????????????? ?? ??????????? ??????????? ??????????? ????????????
???????? ??????? ?? ??????????? ??????????? ??????????? ???????????
?
??????????? ??????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????? ??????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????? ????????????
??????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????? ????????????????????????????????????????????
?????????????????????????? ????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????? ???????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????? ????????????????????????????????????????????????????????????????????? ????????
?????????????
????????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????? ???????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????
????????????? ??????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????
134
??????????????????????????????????????????????????????????????????? ??????????????????????
????????????????????????????????????????????????????????????????????????????????? ??????????
?????????????????????????????????????????????????????????????????????????????????????????
?
?
?
?
?
?
?
?
?
?
?
?
?
??????????? ???????????????????????????
???????????????????????????????????????????????? ?????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????? ??????????????? ????????????????????????? ???? ????
???????????????????????????????????????? ???????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????? ??????????????????????????????????? ????
?????????????????????????? ????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????? ?????????????????????????????????????????????????????????
???????????????????
????????????? ??????????????????? ???? ?????????????????????????????????????????????????
?????????????????????????????????????????????????????????????
?
?
?
?
?
?
? ?
?????? ??????????
? ????????? ?????????? ??????? ???????
????????????????????? ????????????? ???????????? ???????????? ???????????
?????????????????? ????????????? ???????????? ??????????? ???????????
????????????????? ????????????? ????????????? ????????????? ?????????????
?????????? ???????????? ??????????? ??????????? ????????????
135
???????????????????????????????????????????????????????????????? ?????????????????????????
???????????????????? ???????????????????????????????????????????????????????????????????????????
???????????
?
?????? ???? ??????? ??????????
? ? ????????? ?????????? ??????? ???????
??????????
??????????
????? ??????? ?????????? ?????????? ?????????? ??????????
????? ??????? ?????????? ?????????? ?????????? ??????????
????????????
??????
????? ??????? ?????????? ?????????? ?????????? ??????????
????? ??????? ?????????? ?????????? ?????????? ??????????
???????
??????????
????? ??????? ?????????? ??????????? ??????????? ??????????
????? ??????? ??????????? ??????????? ?????????? ??????????
?????????? ????? ??????? ?????????? ??????????? ??????????? ??????????????? ??????? ??? ??? ?? ??
?
??????????? ??????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????? ???
???????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????? ?????????????????????????????????????????????????????????
???????????????????
????????????? ??????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????? ???????????????????????????????????????????????????
? ?
136
??????????????????????????????????????????????????????? ????????????????????????????????????????????
???????
?
? ???????? ????????????????????
????????????
??????
???????
?????????? ??????????
???????? ? ?????????? ???????????? ???????????? ???????????? ???????????
??????????? ?? ?????????? ??????????? ??????????? ?????????? ??????????
????????????
????????? ? ?????????? ???????????? ???????????? ??????????? ???????????
?????????????
??????????? ?????????? ???????????? ???????????? ?????????? ???????????
?????????? ? ?????????? ??????????? ???????????? ???????????? ???????????
?
????????????????????????????????????????????????????????????????????????????????????? ?????????????????
??????????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????? ?????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????? ?????????????????????????????????
???????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????? ?????????
?????????????????????????????????????????????????????????????????????????????
?
? ?
137
????????????????????????
?
??? ?????????????????????????????????????????????????????????????????????????????????????
???????????????? ???????????????????????????????????????????????????????????????????????????????
????? ???????????? ?????????????????????????????????????????????? ??????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????J Am Coll Cardiol??????????????????
??? ?????????????????????????????????????????????????????????????????? ??????????????????????
??????????????? ??????????????????????????????????????? ?????????????????????????????????????????????
?????????????????????????????????????????? ??????Basic Res Cardiol????????????????????
??? ?????????????????????????????????????????????????????????????????????????????????????
????????????????? ??????????????????????????????????????????????????????????????????????????????
??????????????????????????????????? ????????????????????????????????J Am Coll Cardiol??
????????????????
??? ???????????????????????????????? ???????????????????????????? ??????????????????????????
??????????? ???????????????????????? ??????????? ???????????????????????? ????????????????
??? ???????????????????? ????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????? ??????????????????????????????
?????????????????????????????????????????????????????????????????????????Int J Cardiol??
?????????????????
??? ????????????????????????????????????????????????????????????? ??????????????????????????
???????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????? ??????????????????????????????J Cardiovasc Magn 
Reson??????????????
??? ?????????????????????? ??????????????????????????????????????????????????????????
??????????????Journal of animal science??????????????????
??? ?????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????? ?????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????Circulation????????????????????
??? ???????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????? ???????????????????????????????????
?????????????????????????????????Revista espanola de cardiologia???????????????????
??? ?????????????????????? ????????????????????????????????????????????????????????????????
???????????????????? ????????????????????????????????????????????????????????????????????????????
European heart journal cardiovascular Imaging??????????????????
???? ?????????????????????????????????????????? ??????????????????????????????????????????
???????????????? ???????????????????????????????????????????????? ???????????????????J Cardiovasc 
Magn Reson??????????????
???? ??????????????????????????????????????????????? ????????????? ??????????????????
??????????????????????????????? ???????? ?????????????????????????????? ??????????????
???????????????????? ??????????????????????????????????????????? ???????????????????????????????
?????? ??????????????????????????????????????????????????????????????????????????Eur Heart J??
?????????????????
???? ???????????????? ?????????????????????????????????????? ??????????????????????????? ??
?????????????????????????????????????????????????????? ????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????? ??????????????????????????????Int J 
Cardiol???????????????????
? ?
138
????????????????????????
?
??????????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????
?
????????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????
?
??????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????
?
???????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????
139
 Original research article #7. “Dynamic edematous response of the human heart to 
myocardial infarction: implications for assessing myocardial area at risk and 
salvage”.74 
 
 
Part of this work was presented by the doctoral student at the American Heart 
Association Scientific Sessions 2015, in Orlando (November 2015; Florida, USA).  
  
 
 
  
140
October 3, 2017 Circulation. 2017;136:1288–1300. DOI: 10.1161/CIRCULATIONAHA.116.0255821288
ORIGINAL RESEARCH ARTICLE
Editorial, see p 1301
BACKGROUND: Clinical protocols aimed to characterize the post–myocardial 
infarction (MI) heart by cardiac magnetic resonance (CMR) need to be 
standardized to take account of dynamic biological phenomena evolving early 
after the index ischemic event. Here, we evaluated the time course of edema 
reaction in patients with ST-segment–elevation MI by CMR and assessed its 
implications for myocardium-at-risk (MaR) quantiﬁcation both in patients and in a 
large-animal model.
METHODS: A total of 16 patients with anterior ST-segment–elevation MI 
successfully treated by primary angioplasty and 16 matched controls were 
prospectively recruited. In total, 94 clinical CMR examinations were performed: 
patients with ST-segment–elevation MI were serially scanned (within the ﬁrst 3 
hours after reperfusion and at 1, 4, 7, and 40 days), and controls were scanned 
only once. T2 relaxation time in the myocardium (T2 mapping) and the extent 
of edema on T2-weighted short-tau triple inversion-recovery (ie, CMR-MaR) 
were evaluated at all time points. In the experimental study, 20 pigs underwent 
40-minute ischemia/reperfusion followed by serial CMR examinations at 120
minutes and 1, 4, and 7 days after reperfusion. Reference MaR was assessed
by contrast-multidetector computed tomography during the index coronary
occlusion. Generalized linear mixed models were used to take account of repeated
measurements.
RESULTS: In humans, T2 relaxation time in the ischemic myocardium declines 
signiﬁcantly from early after reperfusion to 24 hours, and then increases up to 
day 4, reaching a plateau from which it decreases from day 7. Consequently, 
edema extent measured by T2-weighted short-tau triple inversion-recovery 
(CMR-MaR) varied with the timing of the CMR examination. These ﬁndings were 
conﬁrmed in the experimental model by showing that only CMR-MaR values 
for day 4 and day 7 postreperfusion, coinciding with the deferred edema wave, 
were similar to values measured by reference contrast-multidetector computed 
tomography.
CONCLUSIONS: Post-MI edema in patients follows a bimodal pattern that 
affects CMR estimates of MaR. Dynamic changes in post–ST-segment–elevation 
MI edema highlight the need for standardization of CMR timing to retrospectively 
delineate MaR and quantify myocardial salvage. According to the present clinical 
and experimental data, a time window between days 4 and 7 post-MI seems a 
good compromise solution for standardization. Further studies are needed to 
study the effect of other factors on these variables.
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Noninvasive tissue characterization by cardiac mag-netic resonance (CMR) after myocardial infarction (MI) offers the possibility to evaluate the impact
of interventions designed to preserve cardiac function 
and predict long-term remodeling.1 It has been postulat-
ed that an intense edematous reaction conﬁned to the 
postischemic region appears early after MI and persists in 
stable form for at least 1 week.2,3 On the basis of this as-
sumption, the use of edema-sensitive T2-CMR sequenc-
es to delineate the spatial extent of post-MI edema was 
rapidly incorporated as an index of the original occluded 
coronary artery perfusion territory (myocardium at risk, 
MaR).4,5 Quantiﬁcation of late gadolinium enhancement 
(LGE) and edema extent (assumed to delineate MaR) in 
the same imaging session has been extensively used to 
quantify the amount of salvaged myocardium, a theo-
retical surrogate of the effect of cardioprotective thera-
pies,6,7 thus reducing the required sample size in trials.8 
Consequently, CMR-based myocardial salvage has been 
and continues to be used as an end point in multiple 
clinical and experimental studies.9
On the basis of the assumed stable unimodal edem-
atous reaction during the ﬁrst week after MI, the timing 
of the end point imaging session in these studies varies 
considerably. However, recent work in the pig model 
showed that the post-MI edematous reaction is not sta-
ble, and instead follows a bimodal pattern.10 An initial 
reperfusion-related wave of edema appears abruptly on 
reperfusion and dissipates at 24 hours. This is followed 
by a healing-related deferred wave of edema appearing 
several days after MI, peaking around postreperfusion 
day 7.11 This coordinated bimodal edema pattern sug-
gests that CMR-quantiﬁed MaR may vary according to 
the day of imaging, but to date this has not been tested 
in a controlled manner. Some recent studies evaluated 
MaR extent in patients according to the timing of post-
MI imaging, but these were either retrospective analy-
ses12 or did not systematically scan patients at the same 
time points.13 Consequently, whether this phenomenon 
occurs in MI patients is unclear.
This study was designed to address these speciﬁc 2 
questions: (1) is post-MI edematous reaction bimodal in 
humans, and (2) does the bimodal edematous reaction 
affect the CMR-based quantiﬁcation of MaR and myocar-
dial salvage? We designed a longitudinal clinical study in 
which patients with ST-segment–elevation MI (STEMI) suc-
cessfully treated by primary angioplasty were prospective-
ly recruited and CMR performed within the ﬁrst 3 hours 
postreperfusion and at 24 hours, 4 days, 7 days, and 40 
days. The impact of the dynamic edematous response 
on post-MI CMR measures of MaR, infarct size (IS), and 
salvaged myocardium was evaluated in the pig model of 
reperfused MI by performing reference measures of MaR 
and a comprehensive serial CMR imaging study.
METHODS
Clinical Study
Design
Hemodynamically stable consecutive patients with a ﬁrst ante-
rior STEMI and undergoing primary percutaneous coronary 
intervention were prospectively recruited between February 
2015 and November 2015 ad hoc for this study. Patients eli-
gible for enrollment were aged ≥18 years, and showed symp-
toms consistent with STEMI for >90 minutes and ST-segment 
elevation ≥2 mm in ≥2 contiguous leads in V1 through V5, with 
an anticipated time from symptom onset to reperfusion of ≤8 
hours. Additional mandatory inclusion criteria were evidence 
of complete occlusion in the proximal or mid portion of the 
left anterior descending coronary artery (TIMI 0–1 initial ﬂow) 
and successful primary angioplasty evidenced by appropriate 
reestablishment of coronary ﬂow in the culprit artery (TIMI-3 
ﬂow after angioplasty). Exclusion criteria were Killip class III to 
IV, persistent systolic blood pressure <100 mm Hg, persistent 
heart rate <50 bpm or >110 bpm, presence of bifascicular 
or trifascicular block, evidence of second- or third-degree 
atrioventricular block, atrial ﬁbrillation, known history of pre-
vious MI, pregnancy, active breastfeeding, and the presence 
Clinical Perspective
What Is New?
• This work shows for the ﬁrst time that myocar-
dial edema in the week after ST-segment–eleva-
tion myocardial infarction in humans is a bimodal
phenomenon.
• An initial wave of edema appears abruptly at reper-
fusion, but it is signiﬁcantly attenuated by 24 hours.
• The initial wave of edema is followed by a second
(deferred) healing-related wave of edema several
days after reperfusion reaching a plateau ≈4 to 7
days after myocardial infarction.
• This bimodal edematous response has a major
impact on retrospective myocardial area at risk and
salvage quantiﬁcation by cardiac magnetic reso-
nance given that measures of edema are greatly
inﬂuenced by the timing of imaging.
What Are the Clinical Implications?
• Both cardiac magnetic resonance imaging techniques 
and timing of postinfarction imaging for assessing
myocardial area at risk and myocardial salvage should 
be standardized to take account of the pathophysiol-
ogy of the bimodal edematous phenomenon.
• The time frame between day 4 and 7 postinfarction
seems a good compromise solution according to
clinical and experimental data here presented.
• Our results have important implications for the
design and interpretation of clinical trials using
edema-sensitive cardiac magnetic resonance proto-
cols to quantify myocardium at risk and myocardial
salvage as an end point.
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of metallic objects or devices incompatible with MRI. Patients 
were managed according to current clinical guidelines.14,15
CMR examinations were performed within 3 hours of 
reperfusion (hyperacute reperfusion) and at 24 hours, 4 days, 
7 days, and 40 days after reperfusion (Figure 1A). Normal T2 
relaxation times (baseline) were obtained in 16 healthy age- 
and sex-matched volunteers. The study was approved by the 
hospital Ethics Committee, and all patients and volunteers 
gave written informed consent.
CMR Protocol
CMR examinations were conducted with a Philips 1.5-Tesla 
Achieva whole-body scanner (Philips Healthcare) equipped 
with a 16-element phased-array cardiac coil. At all time 
points, the imaging protocol included a standard segmented 
cine steady-state free-precession sequence to provide high-
quality anatomic references; a T2-weighted short-tau triple 
inversion-recovery (T2W-STIR) sequence to assess the extent 
of edema and intramyocardial hemorrhage (IMH); and a 
T2-gradient-spin-echo mapping sequence to provide precise 
myocardial T2 relaxation time properties.16 On day 7 and day 
40 CMR, LGE imaging was performed to assess infarct size 
and microvascular obstruction (MVO), using a T1-weighted 
inversion recovery turbo ﬁeld echo sequence acquired 10 to 
15 minutes after intravenous administration of 0.20 mmol 
gadobutrol contrast agent per kg body weight.
CMR Analysis
CMR images were analyzed using dedicated software 
(MR Extended Work Space 2.6, Philips Healthcare; and 
QMassMR 7.6, Medis) by 2 observers experienced in CMR 
analysis and blinded to time-point allocation and patient 
identiﬁcation. T2 maps were analyzed by placing the 
region of interest at the transmural ischemic, infarcted 
(with or without including areas suggestive of IMH), sal-
vage, and transmural remote areas in a midapical ventric-
ular short-axis slice corresponding to the same anatomic 
level in all acquisitions to track T2 relaxation time changes 
over time.16,17 The extent of edema, expressed as a percent-
age of left ventricular (LV) mass (CMR-MaR), was initially 
identiﬁed by using the full width at half-maximum with 
subsequent manual correction and visual border delinea-
tion after tracing the endocardial and epicardial contours 
of T2W-STIR short-axis images.18 Hypointense areas within 
the edematous zone, corresponding to IMH, were included 
within the edematous region.19,20 In addition, IMH area 
was calculated by manual delineation of the hypointense 
areas on T2W images19 and expressed as a percentage of 
LV mass.
IS, expressed as a percentage of LV mass, was deﬁned 
according to the extent of LGE after manually tracing the 
endocardial and epicardial contours on T1-weighted inver-
sion recovery turbo ﬁeld echo short-axis images. Abnormal 
areas were deﬁned using the full width at half-maximum, 
with manual correction if needed. Hypointense black areas 
within the necrotic zone, corresponding to MVO, were 
included within the necrotic area.19,20 In addition, the size 
of the MVO area was calculated by manual delineation of 
Figure 1. Study design. 
A, Clinical study design. Twenty-two consecutive anterior patients with STEMI fulﬁlling the inclusion criteria were assessed for 
eligibility: 3 patients refused to participate; 1 patient experienced anxiety and a claustrophobic reaction requiring premature 
termination of the ﬁrst CMR; 1 patient felt sick with vomiting before the ﬁrst CMR, which could not be performed; and 1 pa-
tient had a failed CMR study because of frequent episodes of premature ventricular contraction and nonsustained ventricular 
tachycardia during the scan. The clinical study population thus included 16 consecutive hemodynamically stable patients with 
anterior STEMI reperfused by primary percutaneous coronary intervention. CMR examinations including T2-weighted short-tau 
triple inversion-recovery and T2-gradient-spin-echo mapping sequences were per protocol scheduled at the following times 
after reperfusion: within the ﬁrst 3 hours and at 24 hours, 4 days, 7 days, and 40 days. To take account of baseline values, 
myocardial T2 relaxation time was measured in 16 healthy age- and sex-matched volunteers. B, Experimental study design. 
The study population comprised 20 pigs weighing 30 to 40 kg that underwent closed-chest 40 minutes reperfused acute an-
terior myocardial infarction. These pigs were euthanized at 120 minutes (n=5), 24 hours (n=5), 4 days (n=5), and 7 days (n=5) 
after myocardial infarction. Arterial enhanced multidetector computed tomography was performed during coronary occlusion 
in all pigs as a reference standard for measuring the myocardial area at risk. CMR scans, including T2-weighted short-tau triple 
inversion-recovery, T2 mapping, and late gadolinium enhancement imaging, were performed at every follow-up stage until 
euthanization. CMR indicates cardiac magnetic resonance; I/R, ischemia/reperfusion; MDCT, multidetector computed tomogra-
phy; PCI, percutaneous coronary intervention; and STEMI, ST-segment–elevation myocardial infarction.
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the hypointense areas on LGE images19 and expressed as a 
percentage of LV mass.
Detailed information about CMR imaging protocol and 
parameters, and imaging analysis is presented in the online-
only Data Supplement Methods.
Experimental Study
Design and MI Procedure
The study was approved by Institutional and Regional Animal 
Research Committees.
To study the impact of the dynamic edematous response 
on post-MI CMR time proﬁle measures of MaR, IS, and sal-
vaged myocardium, a group of 20 pigs underwent closed-
chest reperfused MI by the percutaneous catheter–based 
technique, with 40-minute angioplasty-balloon occlusion of 
the mid left anterior descending coronary artery, followed 
by balloon deﬂation and reestablishment of blood ﬂow10 
(Figure 1B). These pigs were euthanized at 120 minutes (n=5), 
24 hours (n=5), 4 days (n=5), or 7 days (n=5) after ischemia/
reperfusion (I/R). In all pigs, arterial enhanced multidetector 
computed tomography (MDCT) was performed during the 
index coronary occlusion, between minute 10 and minute 20 
of ischemia, to delineate the reference MaR (hypoperfused 
region during coronary occlusion).21 Comprehensive CMR 
scans were performed at every follow-up stage until euthani-
zation (ie, animals euthanized on day 7 underwent baseline, 
120 minutes, 24 hours, day4, and day7 CMR examinations).
Full methods can be found in the online-only Data 
Supplement Appendix.
Arterial Enhanced MDCT Protocol and Analysis
All MDCT studies were performed on a 64-slice CT scan-
ner (Brilliance CT 64, Philips Healthcare) after intravenous 
administration of 60 mL of 400 mgI/mL iomeprol (Iomeron 
400, Bracco Imaging).21 MDCT images were analyzed using 
dedicated software (MR Extended Work Space 2.6, Philips 
Healthcare). MaR and remote areas were visually identiﬁed 
based on contrast enhancement differences, manually delin-
eated, and expressed as a percentage of LV area.
CMR Protocol and Analysis
CMR examinations were conducted with a Philips 3-Tesla 
Achieva Tx whole body scanner (Philips Healthcare) equipped 
with a 32-element phased-array cardiac coil. The imaging 
protocol included an steady-state free-precession sequence 
to provide high-quality anatomic references, and assess-
ment of LV mass and wall thickness; a T2W-STIR sequence 
to assess the extent of edema and IMH; a T2-gradient-spin-
echo mapping sequence10,16; and a T1-weighted inversion 
recovery turbo ﬁeld echo sequence to assess IS and MVO. 
CMR images were similarly analyzed using dedicated soft-
ware (MR Extended Work Space 2.6, Philips Healthcare; and 
QMassMR 7.6, Medis) by 2 observers experienced in CMR 
analysis and blinded to group allocation.
Detailed information about MDCT and CMR imaging pro-
tocol and parameters, and imaging analysis, can be found in 
the online-only Data Supplement Methods.
Statistical Analysis
In the clinical study, the sample size calculation to 
detect a difference in T2 relaxation time in the ischemic 
myocardium between examination time points after STEMI 
was prespecified by using the user-written command nsize 
(Stata 12.0). A sample size of 16 patients was determined 
on the basis of our previous experimental results,10 a 95% 
confidence level, a statistical power of 80%, a conserva-
tive significant mean difference to detect of 15 ms in T2, 
a SD of 12, and multiple pairwise comparisons between 
time points.
Normal distribution of each data subset was checked 
by using graphical methods and a Shapiro-Wilk test. The 
Leven test was performed to check the homogeneity of 
variances. For quantitative variables, data are expressed as 
mean±SD. For categorical variables, data are expressed as 
frequencies and percentages. To take account of repeated 
measures, generalized linear mixed models were conducted 
to analyze the time course of T2 relaxation time, CMR-
MaR, IMH, MVO, IS, and salvaged myocardium. Models 
evaluating the time course of T2 or CMR-MaR were further 
adjusted by extent of hemorrhage, including the amount 
of IMH expressed as a percentage of the LV as a covariate, 
given that this parameter is known to affect T2. Given the 
hypothesis-driven nature of the study, comparisons among 
different time points were planned in advance. Nonetheless, 
P value was adjusted for multiple comparisons by using the 
Hochberg method.
All statistical analyses were performed with Stata v12.0 
(StataCorp).
RESULTS
Clinical Study
General Characteristics of the Population
Clinical characteristics of the study population are 
summarized in Table  1. Serial CMR was performed 
with informed consent in 16 consecutive patients 
with anterior STEMI fulﬁlling the inclusion criteria 
(mean age 58.8±14.5 years, 14 [87.5%] male) and 
successfully treated by primary percutaneous coro-
nary intervention. A total of 94 CMR examinations 
were performed: the 16 healthy volunteers were 
scanned once, and the 16 patients with STEMI were 
scanned at 2.2±0.5 hours, 24.8±1.8 hours, 3.8±0.4 
days, 6.8±0.6 days, and 41.7±4.3 days after reper-
fusion. In all patients, the ﬁrst CMR scan was per-
formed within the ﬁrst 3 hours (90–180 minutes) af-
ter primary percutaneous coronary intervention. The 
timing for the initial CMR scan (around the peak of 
reperfusion-related wave of edema) was identiﬁed 
before in a dedicated separate group of 5 pigs un-
dergoing serial CMR scans every 20 minutes during 
the 6 hours following reperfusion (see online-only 
Data Supplement Methods and Results, and online-
only Data Supplement Figures I and II). Evaluable T2-
mapping and T2W-STIR data were available in 100% 
of CMR scans performed. Information on vital status 
was available for all participants.
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Edema Time Course in Patients With 
STEMI 
T2 Relaxation Time
Mean myocardial T2 relaxation times in the 16 healthy 
volunteers (mean age 59.3±17.7 years, 12 [75%] male) 
were 53.1±4.1 ms and 51.1±4.5 ms for the midapical 
anteroseptal and posterolateral LV walls, respectively. 
In comparison with these values, hyperacute reper-
fusion in patients with STEMI (≤3 hours) was associ-
ated with signiﬁcantly longer T2 relaxation times in the 
ischemic area (Figure 2A and 2B). T2 relaxation time in 
patients with STEMI showed a systematic and signiﬁ-
cant decrease at 24 hours post-MI. This was followed 
by a rebound increase, with T2 relaxation times on day 
4 postreperfusion reaching values similar to those ob-
served during early reperfusion. Thereafter, T2 relax-
ation time progressively decreased, with values on day 
40 similar to those observed at 24 hours. Similar results 
were obtained after adjusting T2 for the amount of IMH 
(online-only Data Supplement Table I). During the ﬁrst 
week after MI, T2 relaxation time in the remote myo-
cardium showed a linear trend toward a progressive in-
crease, albeit slight. T2 relaxation times in the ischemic 
and remote myocardium at different postreperfusion 
time points are summarized in Table  2. T2 relaxation 
time was longer in the transmural ischemic myocardi-
um than in the remote myocardium at all time points 
evaluated. However, the differences observed at 24 
hours and 40 days, albeit statistically signiﬁcant, were 
of small magnitude and resulted in a wide overlapping 
of myocardial T2 values within ischemic and remote ar-
eas (Figure 2C). Individual trajectories for T2 relaxation 
time in the ischemic myocardium of STEMI patients are 
shown in online-only Data Supplement Figure III.
Extent of Edema (CMR-MaR)
The edematous area delineated by T2W-STIR sequences 
was similar in CMR scans performed at hyperacute re-
perfusion (≤3 hours) and on day 4 and day 7 (Figure 3). 
Conversely, the area of edema was signiﬁcantly smaller 
at 24 hours postreperfusion. On day 40 post-MI, the 
area of edema was comparable to that seen at 24 
hours. This time-course pattern for edema resembles 
that observed for T2 relaxation time, and similar results 
were obtained after adjusting the area of edema for 
the amount of IMH evaluated by T2W-STIR (online-only 
Data Supplement Table II). Edematous area at different 
postreperfusion time points is summarized in Table 2. 
Individual patient trajectories for area of edema mea-
surements are shown in online-only Data Supplement 
Figure IV.
Experimental Study
Dynamics of CMR-MaR After Reperfused MI in 
Comparison With the Reference Standard
CMR-measured MaR values at different times after re-
perfusion in pigs are summarized in Table 3 and online-
only Data Supplement Table III. Mean MaR as assessed 
by the MDCT reference method was 30.5±5.0% of the 
LV. Because of the initial swelling of the ischemic myo-
cardium (online-only Data Supplement Table IV), CMR-
measured MaR as delineated by T2W-STIR sequence
was signiﬁcantly higher than MaR measured by MDCT
at early reperfusion (Figure 4A and 4B). Coinciding with
the dissipation of the ﬁrst edema wave,10 MaR was
strikingly underestimated by CMR at 24 hours postre-
perfusion. Conversely, CMR-estimated MaR values for
day 4 and day 7 postreperfusion, coinciding with the
deferred edema wave,10 were similar to values mea-
sured by MDCT (ie, no overestimation or underestima-
tion). The dynamics of CMR-measured MaR resembled
the time course for myocardial T2 relaxation time and
water content in the ischemic area.10
Table 1. Baseline Patient Characteristics
Characteristic
All Patients 
(n=16)
Age, y 58.8±14.5
Male sex 14 (87.5)
Body mass index, kg/m2 27.1±2.9
Hypertension 9 (56.3)
Smoking 
  Current smoker 9 (56.3)
  Ex-smoker (0–10 y before) 4 (25.0)
Dyslipidemia 10 (62.5)
Diabetes mellitus 3 (18.8)
Ischemia duration, min* 185±115
Killip class at recruitment 
  I 11 (68.7)
  II 5 (31.3)
Infarct artery lesion location 
  Proximal left anterior descending coronary artery 16 (100.0)
  Mid left anterior descending coronary artery 0 (0.0)
Treatment at the time of primary percutaneous intervention 
  Heparin 16 (100.0)
  Oral antiplatelet
   Aspirin 14 (87.5)
   Clopidogrel 8 (50.0)
   Prasugrel 5 (31.3)
   Ticagrelor 4 (25.0)
  Thrombus aspiration 9 (56.3)
  Glycoprotein IIb/IIIa during primary percutaneous 
intervention
9 (56.3)
Data are presented as mean±SD or n (%). 
*Mean time from symptom onset to reperfusion.
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Dynamics of CMR-Measured IS, Myocardial 
Salvage, IMH, and MVO After Reperfused MI
CMR-measured IS and myocardial salvage in pigs are 
summarized in Table 3 and online-only Data Supplement 
Table III. A progressive reduction of IS was observed dur-
ing the ﬁrst week after I/R (Figure 4C and 4D). Matching 
the temporal variations in CMR-MaR, CMR-estimated 
myocardial salvage quantiﬁcation [(MaR-IS)/MaR, %] 
also changed dynamically during the ﬁrst week after I/R 
(online-only Data Supplement Figure V).
CMR-estimated IMH and MVO are summarized in 
online-only Data Supplement Table V. IMH was ap-
parent at 24 hours and peaked on day 4 post-I/R; in 
contrast, MVO was apparent at 120 minutes after re-
perfusion, peaking on day 1 post-I/R and progressively 
decreasing thereafter. The dynamics of CMR-estimated 
Figure 2. Temporal evolution of myocardial T2 relaxation time in patients with ST-segment–elevation myocardial 
infarction.  
A, Time course of absolute T2 relaxation time (ms) in the ischemic and remote myocardium in patients with ST-segment–
elevation myocardial infarction. Data are means and SD. For baseline values, myocardial T2 relaxation time was measured 
in 16 healthy age- and sex-matched volunteers. Dashed lines represent hypothetical mean trajectories for T2 from baseline 
to the hyperacute postreperfusion phase (≤3 hours). At all time points after reperfusion, T2 relaxation time in the ischemic 
myocardium of patients differed signiﬁcantly from baseline values in heathy volunteers. It is noteworthy that cardiac magnetic 
resonance T2 mapping revealed similar T2 values at ≤3 hours and on day 4 and day 7 postreperfusion; in contrast, T2 relax-
ation time was signiﬁcantly lower at 24 hours and on day 40 post-MI. B, Representative images from a patient with anterior 
ST-segment–elevation myocardial infarction who underwent serial cardiac magnetic resonance T2-mapping examinations at 
150 minutes, 26 hours, 4 days, 7 days, and 44 days after reperfusion. For baseline cardiac magnetic resonance T2 mapping, 
an image from a healthy volunteer is shown. All T2 maps were scaled between 30 and 120 ms. C, T2 values distribution in the 
ischemic and remote myocardium in patients with ST-segment–elevation myocardial infarction at different time points. Mean 
and SD from all individual regions of interest placed in these areas at all time points were analyzed. Blue and red colors repre-
sent distribution of T2 values in the remote and ischemic myocardium, respectively. Green color represents the overlapping of 
T2 values, ie, pixels from both areas having the same T2. The percentages shown in each panel represent the percent of the 
ischemic myocardium region of interest with T2 >2 SDs from the mean T2 in the remote myocardium (pink). Despite that the 
mean T2 relaxation time in ischemic myocardium at all time points was longer than mean T2 in the remote, overlapping was 
patent and widest at the 24-hour time point.
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IMH are consistent with histologically evaluated IMH in 
the same model previously reported.11
DISCUSSION
First Demonstration of the Postinfarction 
Bimodal Edema Reaction in the Human 
Heart
This is the ﬁrst comprehensive evaluation of patients 
with STEMI by serial CMR to include the hyperacute 
postreperfusion period (the ﬁrst 3 hours). CMR scans 
timing was designed as per the protocol of our previ-
ous experimental studies, in which we demonstrated 
the existence of bimodal post-MI edema in pigs.10,11
The main ﬁnding of the present clinical study is that, 
contrary to the accepted view, myocardial edema in the 
ischemic area after MI in humans is not stable, but rather 
follows a systematic bimodal pattern. An initial wave of 
edema appears abruptly very early after reperfusion, but 
it is signiﬁcantly attenuated by 24 hours. This is followed 
by a second (deferred) wave of edema several days after 
reperfusion reaching a plateau ≈4 to 7 days after MI.
The Initial Wave of Edema
To select the optimal timing for the ﬁrst CMR scan in STE-
MI patients, we ﬁrst analyzed the dynamics of the initial 
wave of edema in a series of 5 pigs; serial CMR scans were 
performed every 20 minutes until the reperfusion-related 
edema wave faded. It is interesting to note that this ini-
tial wave of edema peaked very early, being signiﬁcantly 
attenuated within a few hours after MI: at 180 minutes 
after reperfusion, the edema had declined by ≈50% from 
its maximum. In agreement with CMR data, quantiﬁca-
tion of myocardial water content and histological analy-
sis at 6 hours after MI revealed partial resolution of the 
massive interstitial edema seen earlier after reperfusion 
(see online-only Data Supplement Results).11 On the basis 
of these results in pigs, we decided to perform the ﬁrst 
CMR scan in patients within a narrow 3-hour time win-
dow after primary percutaneous coronary intervention to 
be able to detect the noon of the initial wave of edema.
Controversy on the Bimodal 
Postinfarction Edema Occurrence in 
Humans
The recent demonstration of bimodal edema in the 
postischemic myocardium in pigs10,11 has generated 
intense discussion in the cardiac imaging ﬁeld.6,22–28 
Whether this phenomenon occurs in humans has been 
explored in 2 recent studies. Carrick and colleagues13 
performed a longitudinal assessment of IMH and ede-
ma in 30 patients with STEMI, concluding that “myo-
cardial edema has a unimodal time course.” This popu-
lation was more heterogeneous than the population 
examined here: 20% had an open artery on angiogra-
phy (TIMI coronary ﬂow grade 2–3) and only 30% had 
an anterior MI, whereas all patients in our study had an 
anterior infarction with an occluded artery on angiog-
raphy. These factors might affect edema dynamics and 
visualization.11,18 In addition, patients in the Carrick et 
al study underwent 3 CMR examinations within the ﬁrst 
10 days after MI, at 8.6±3.1 hours, 2.9±1.5 days, and 
9.6±2.3 days.13 It is important to note that the ﬁrst of 
these examinations was performed between 4 and 12 
hours after reperfusion, which, according to the experi-
mental data we present here, is after the dissipation of 
the ﬁrst edema wave. Indeed, the T2 values in the in-
farcted zone reported for the ﬁrst CMR examination in 
Carrick et al are similar to those observed in the second 
scan in our clinical study, performed 24 hours after MI.
In the second report, Nordlund et al12 retrospectively 
analyzed pooled data from 3 studies assessing the MaR 
by qualitative CMR, concluding that no bimodal edema 
pattern was apparent. However, most patients in the 
evaluated studies underwent a single CMR scan at dis-
parate times to from each other, and there were no 
systematic serial examinations. It is important to note 
that no CMR scans were performed on day 0, and very 
few were performed on day 1 after MI. Moreover, no 
quantitative parametric T2 mapping was performed, 
despite this technique being demonstrated to improve 
detection and quantiﬁcation of myocardial edema.29 
Unlike these recent reports, our study was speciﬁcally 
designed to provide insight into the existence of bi-
modal edema in patients with MI by mimicking time 
points and CMR sequences performed in the previous 
experimental studies.10,11
Implications of the Bimodal Edema 
Phenomenon for Quantifying MaR and 
Salvage
On the basis of an assumed stable edematous reaction 
lasting for several days after MI and despite recent con-
troversy,30,31 T2-CMR sequences have been widely used 
to retrospectively quantify the MaR.6,29 In the present 
clinical study, we show that T2 relaxation time in the 
ischemic region changes systematically with the post-
MI timing of the examination. In parallel, we conﬁrmed 
signiﬁcant variation in the extent of the MaR as mea-
sured by T2W-STIR. Consistent with the drop in T2 re-
laxation time at 1 day post-MI, T2W-estimated MaR at 
this time point was signiﬁcantly lower than values ob-
tained before and subsequently.
We experimentally conﬁrmed clinical ﬁndings by ac-
complishing a comprehensive CMR serial imaging study 
in 20 pigs subjected to reperfused MI. Remarkably, we 
included prereperfusion MDCT imaging as a reference 
for the assessment of MaR,21 which otherwise we con-
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sidered unethical to perform in patients with STEMI. In 
the experimental study, our results show that, because 
of the bimodal pattern of post-I/R edema formation, 
the extent of MaR delineated by T2-CMR varies during 
the ﬁrst week after I/R. Speciﬁcally, the edema-sensitive 
T2W-STIR CMR sequence overestimates MaR in com-
parison with MDCT at early time points (120 minutes) 
after reperfusion, which is in agreement with previous 
reports.21 This overestimate is mainly driven by swelling 
of the reperfused myocardium. By 24 hours, the scenar-
io is completely altered, with a substantial resorption of 
edema and normalization of T2 relaxation time,10 re-
sulting in systematic underestimation of MaR by CMR. 
This underestimation resulted in biologically implausi-
ble negative myocardial salvage data at 24 hours. This 
ﬁnding reinforces the idea that MaR (and consequently 
salvaged myocardium) cannot reliably be quantiﬁed by 
CMR around this time point. Conversely, on days 4 and 
7, CMR-measured MaR was similar to MaR measured 
by MDCT.
More pronounced dynamic tissue changes were 
shown in the experimental model. This is a common 
phenomenon seen in the experimental setting in which 
many variables are controlled, as opposed to clinical 
studies. In addition, the more severe ischemic process 
in the porcine myocardium in the presence of poor 
collateral circulation, among other reasons, could in-
ﬂuence the magniﬁcation of this phenomenon. How-
ever, the parallel courses of T2 and CMR-MaR ﬂuctua-
tions observed in the clinical and experimental settings 
strengthen the message of the present study. Thus, our 
data suggest that between day 4 and day 7 would be a 
good compromise solution for the delineation of theo-
retical MaR.
Nevertheless, our results highlight the need for cau-
tion in interpreting CMR of the post-MI heart. In the 
clinical study, 3 of the 16 patients with STEMI showed 
more limited changes in T2 and extent of edema (see 
online-only Data Supplement Figures III and IV). Re-
markably, these 3 patients were older and showed sig-
niﬁcantly smaller infarcts and less extent of IMH and 
MVO, and greater myocardial salvage areas despite 
having longer intervals between symptom onset to re-
perfusion (data not shown). We speculate that there 
might be several factors affecting the dynamics of the 
bimodal edematous reaction such as the existence of 
preformed collateral circulation, episodes of spontane-
ous reperfusion/reocclusion during ischemia duration, 
or the presence of speciﬁc comorbidities. The impossi-
bility of controlling these aspects in the clinical scenario 
Table 2. CMR Data of Patients
Reperfusion Time
≤3 h 24 h 4 days 7 days 40 days
T2 transmural ischemic, ms 80.8 (10.9) 65.4 (5.5) 80.5 (11.3) 76.8 (12.1) 65.4 (7.2)
T2 transmural remote, ms 52.5 (6.7) 57.2 (6.2) 53.7 (6.2) 58.3 (5.9) 52.9 (8.3)
T2 infarct incl. hypointense 
core, ms
80.5 (16.4) 63.0 (9.0) 81.5 (15.3) 76.3 (16.6) 65.2 (8.4)
T2 infarct excl. hypointense 
core, ms
87.2 (15.1) 65.2 (8.8) 86.0 (16.6) 81.3 (16.9) 66.4 (7.0)
T2 salvaged, ms 70.2 (9.7) 64.4 (8.3) 78.5 (14.9) 68.9 (9.5) 62.3 (8.2)
Myocardial area at risk, % of 
left ventricle
39.9 (13.0) 21.8 (12.2) 42.8 (11.5) 42.9 (13.0) 20.1 (11.5)
Intramyocardial hemorrhage, % 
of left ventricle
0.6 (0.5) 1.1 (0.6) 1.7 (1.4) 1.7 (1.8) 0.7 (0.6)
Infarct size, % of left ventricle – – – 30.3 (14.6) 21.9 (11.9)
Microvascular obstruction, % of 
left ventricle
– – – 2.7 (2.4) 0.9 (0.8)
Data are presented as mean (SD). T2 maps were analyzed by placing regions of interests at the transmural ischemic, 
infarcted (with or without including areas suggestive of intramyocardial hemorrhage), salvage, and transmural remote 
areas in a midapical ventricular short-axis slice corresponding to the same anatomic level in all acquisitions to track 
T2 relaxation time changes over time. The different myocardial states were initially deﬁned by the localization relative 
to late gadolinium enhancement.17 One patient died between day 4 and day 7 cardiac magnetic resonance, and 1 
patient was unable to undergo late gadolinium enhancement imaging because of severe renal impairment; therefore, 
T2 information from the different myocardial states within the ischemic region was obtained from 14 of 16 patients. 
T2 relaxation time was longer in the transmural ischemic myocardium than in the remote myocardium at all time 
points evaluated (≤3 hour, day 1, day 4, day 7, and day 40 after reperfusion). At the 24-hour time point, T2 values were 
65.4±5.5 ms and 57.2±6.2 ms in the ischemic and remote myocardium, respectively (P<0.01). Similar results (even of 
greater magnitude) were shown when comparing T2 in the ischemic and remote myocardium at day 40 (65.4±7.2 ms 
versus 52.9±8.3 ms, P<0.01). However, T2 relaxation time in the ischemic myocardium showed signiﬁcant variations across 
time: T2 at 24 hours was statistically shorter than at ≤3 hours (65.4±5.5 ms versus 80.8±10.9 ms, P<0.01), than at day 4 
(65.4±5.5 ms versus 80.5±11.3 ms, P<0.01), and than at day 7 (65.4±5.5 ms versus 76.8±12.1 ms, P<0.01). In contrast, 
T2 in the ischemic myocardium at 24 hours did not differ from T2 at day 40 (65.4±5.5 ms versus 65.4±7.2 ms, P=0.99).
CMR indicates cardiac magnetic resonance.  
148
Fernández-Jiménez et al
October 3, 2017 Circulation. 2017;136:1288–1300. DOI: 10.1161/CIRCULATIONAHA.116.0255821296
and the limited sample size preclude any deﬁnitive con-
clusion in this regard, but further studies are warranted.
In comparison with T2W-STIR, parametric T2 map-
ping might improve the detection and quantiﬁcation of 
myocardial edema16; however, it is unlikely to alter the 
dynamic pattern of post-MI edema that is attributable 
to pathophysiological phenomena. The deferred edema 
wave is related to the post-MI healing process,11,32 and 
therefore interventions that protect the myocardium 
could affect the dynamics of edema, and thus bias MaR 
estimation. This idea is supported by recent suggestions 
that the extent of edema can be affected by the degree 
of damage9 or exposure to infarct-limiting interven-
tions.33–35 However, patients in these studies received 1 
CMR examination at a single time point, which was not 
the same for all. Therefore, a dedicated study would be 
needed to provide evidence to support this hypothesis.
IMH Is Not the Main Mechanism 
Underlying Bimodal Post-MI Edema
In the clinical study, IMH, assessed by T2W-CMR, 
peaked around day 4 after reperfusion. This ﬁnding is 
in agreement with the present experimental CMR data 
and histologically validated data from our previous pig 
study.11 Given that T2 can be affected by hemorrhage, 
some authors have argued that the bimodal post-MI 
T2-CMR pattern could be explained entirely by the de-
structive paramagnetic effects of deoxyhemoglobin, 
rather than by a real ﬂuctuation of tissue water con-
tent.13,36 However, if hemorrhage was the sole explana-
tion for the bimodal T2 pattern, it would be difﬁcult 
to understand why T2 (both in the pig model10 and in 
the present clinical study) and water content (in the pig 
model)10 increased to day 4, coinciding with the maxi-
mum extent of hemorrhage.11,23 In fact, in the clinical 
study, we observed no signiﬁcant inﬂuence of IMH on 
T2 relaxation time or area of edema delineation. The 
ﬁnding that infarcted (either with or without IMH areas) 
and salvaged myocardium displayed the same bimodal 
pattern strengthen our results. In line with our data, 
Carrick et al13 found small differences in T2 (<5 ms) be-
tween patients with and without hemorrhage, whereas 
Figure 3. Time proﬁle of edematous area in patients 
with ST-segment–elevation myocardial infarction.  
A, Time proﬁle of edematous area in patients with ST-seg-
ment–elevation myocardial infarction, evaluated by T2W-
STIR imaging. Data are means and SD. Cardiac magnetic 
resonance T2W-STIR scans at ≤3 hours and on day 4 and 
day 7 revealed a similar edematous area (% left ventricle); in 
contrast, the edematous area was signiﬁcantly smaller at 24 
hours and on day 40 post-MI. Note the parallel courses of 
T2 relaxation time ﬂuctuations and the extent of edema by 
cardiac magnetic resonance. B, Representative contiguous 
short-axis images from a patient with anterior ST-segment–
elevation myocardial infarction who underwent serial cardiac 
magnetic resonance T2W-STIR examinations at 150 minutes, 
26 hours, 4 days, 7 days, and 44 days after reperfusion. LV 
indicates left ventricle; and T2W-STIR, T2-weighted short-tau 
inversion recovery.
Table 3. Time Proﬁle of CMR-Assessed Myocardium at Risk, Infarct Size, and Myocardial Salvage During the 
First Week After Reperfused Myocardial Infarction in Pigs
CMR
Follow-Up
120 min After Reperfusion 
(n=20)
24 h After Reperfusion 
(n=15)
Day 4 After 
Reperfusion(n=10)
Day 7 After 
Reperfusion(n=5)
MaR, % of left ventricle 48.1 (6.0) 3.6 (2.8) 30.2 (6.2) 30.1 (2.3)
Infarct size, % of left ventricle 45.1 (5.3) 35.3 (5.2) 30.2 (4.3) 25.4 (4.0)
Myocardial salvage, % 4.7 (4.7) –1285 (858) –2.5 (20.3) 15.7 (13.3)
Data are presented as mean (SD). CMR data for each time point correspond to pooled data from all animals undergoing 40 minutes ischemia/reperfusion. 
n values decrease over time because 5 pigs were euthanized after each CMR examination for histological measurement of water content.10 The extent of 
myocardium at risk was assessed by MDCT reference during coronary occlusion in all animals (MDCT-MaR). MDCT-MaR as assessed during the index coronary 
occlusion was 30.5±5.0%, 29.6±4.7%, 29.1±3.9%, and 28.3±4.3% of left ventricle; for pigs followed up to 120 minutes (n=20), 24 hours (n=15), 4 days 
(n=10), and 7 days (n=5) after reperfusion. Myocardial salvage as assessed by MDCT/CMR [(MDCT MaR – CMR Infarct Size) / MDCT MaR, %] in each of these 
groups was –50.6±24.4% at 120 minutes, –20.4±16.9% at 24 hours, –4.8±17.1% at 4 days, and 9.1±19.9% at 7 days after reperfusion, respectively. Note 
that MDCT was performed in all pigs only once (during the index ischemic event). Online-only Data Supplement Table III shows all individual data from animals 
euthanized at each time point. 
CMR indicates cardiac magnetic resonance; MaR, myocardium at risk; and MDCT, multidetector computed tomography.
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Hammer-Hansen et al17 found that T2 relaxation time 
differed in the infarcted and salvaged myocardium, 
and both were signiﬁcantly longer than remote in the 
postreperfused dog heart. It is interesting to note that 
the later study followed animals at 4 and 48 hours after 
MI with results indicating a partial resolution of edema 
in the ﬁrst 48 hours after reperfusion.17,26 Nevertheless, 
hemorrhage might exert some inﬂuence on T2 relax-
ation time, as we previously conceded.10,11,16,23,24
Dynamics of Infarct Size Over the First 
Week After MI
Consistent with previous observations,3,37,38 our ex-
perimental data show a progressive decrease of 
CMR-based IS. The substantial swelling of the early 
postreperfused myocardium might explain the large IS 
detected in our experimental study 120 minutes af-
ter reperfusion. The early period after reperfusion is 
associated with signiﬁcant transient expansion of ex-
tracellular volume11,38; gadolinium gets trapped in this 
expanded extracellular volume, but when extracellu-
lar volume recedes, gadolinium no longer stays in this 
area. In this interpretation, acutely detected LGE does 
not necessarily equate to irreversible injury and may 
severely distort estimates of salvaged myocardium. 
These data highlight the importance of performing 
CMR infarct imaging within a consistently deﬁned and 
narrow time frame, preferably at the end of the ﬁrst 
week, when using IS as an end point in clinical trials 
during the acute post-MI period.
Chronotherapeutic Approaches
New treatments demonstrating signiﬁcant promise in 
preclinical experiments frequently produce no beneﬁts in 
clinical trials,1,39 and the present results hint that timing 
of intervention might be a key determinant of this mis-
match.40–43 We believe the discovery of the bimodal nature 
of post-MI edema will help in the design and new thera-
pies for reducing infarct size and post-MI LV dysfunction.
In summary, we present the ﬁrst demonstration that 
myocardial edema after MI is not stable in patients but 
instead follows a bimodal pattern, conﬁrming recent 
experimental ﬁndings in pigs. The identiﬁcation of such 
a pattern has important biological, diagnostic, prognos-
tic, and therapeutic implications, and opens a route to 
further exploration of factors inﬂuencing this phenom-
enon. Remarkably, this bimodal edematous response 
after MI has a major impact on CMR-MaR, and con-
sequently, myocardial salvage quantiﬁcation given that 
measures of edema are greatly inﬂuenced by the timing 
of post-MI imaging.
LIMITATIONS
Only patients with anterior STEMI were recruited to the 
clinical study. The reasons for this choice include the 
Figure 4. Temporal evolution of cardiac magnetic resonance-myocardium at risk and infarct size after reperfused 
myocardial infarction in the pig model.  
Time proﬁle of myocardium at risk evaluated by T2-weighted short-tau inversion recovery imaging (A) and infarct size evalu-
ated by T1-weighted inversion recovery turbo-ﬁeld echo in pigs subjected to 40 minutes inversion-recovery (C). Arterial 
enhanced multidetector computed tomography was performed during coronary occlusion in all pigs as a reference standard 
measure of myocardium at risk. Data are shown as mean±standard error of the mean. B and D, Representative images from a 
pig that underwent multidetector computed tomography during coronary occlusion followed by serial T2-weighted short-tau 
inversion recovery (B) and late gadolinium enhancement (D) examinations at 120 minutes, 24 hours, 4 days, and 7 days after 
reperfusion. LV indicates left ventricle; MaR, myocardium at risk; MDCT, multidetector computed tomography; T1-IR-TFE, T1-
weighted inversion recovery turbo-ﬁeld echo; and T2W-STIR, T2-weighted short-tau inversion recovery.
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avoidance of possible magnetic-ﬁeld nonhomogeneity 
related to the inferolateral wall.4,29 These eligibility crite-
ria closely resemble recommendations for patient selec-
tion in clinical trials of cardioprotective interventions.39,44 
The bimodal edema pattern may occur regardless of MI 
location; however, caution should be exercised when 
extrapolating results to other MI locations, especially re-
garding adequate visualization of the phenomenon by 
T2W-CMR in lateral MI where signal loss attributable to 
through-plane cardiac motion might occur.18 Given that 
patients were serially scanned, including 1 examination 
very early after reperfusion, we planned the shortest 
CMR protocol possible. For this reason we did not in-
clude T2* CMR as a diagnostic method for quantifying 
IMH in vivo.29 Instead, we assessed both edema and 
hemorrhage by T2W-STIR imaging, a sequence vali-
dated and used for these purposes by many authors.19
Extrapolation of the experimental results to the clin-
ic should be done with caution. Nonetheless, the pig 
is one of the most clinically translatable large-animal 
models for the study of reperfused MI.45 The similar 
edema and hemorrhage time courses in the pig and the 
patient cohort highlight the great translational value of 
the pig model, especially considering the difﬁculty of 
performing a comprehensive CMR study that includes 
serial examinations within the ﬁrst hours after reperfu-
sion and reference techniques for the assessment of the 
MaR. The fact that myocardial edema and LGE follow 
a disparate dynamic pattern after ischemia/reperfusion 
highlights the complexity of measuring myocardial sal-
vage in real practice. Thus, acutely detected LGE does 
not necessarily equate to irreversible injury and may 
contribute to severely distorted estimates of salvaged 
myocardium when comparing against a prereperfusion 
standard to assess MaR.38 Other reasons might contrib-
ute to inaccurate estimations. Among them, it has been 
previously demonstrated that damage after ischemia/
reperfusion may extend beyond the boundaries of the 
hypoperfused region during coronary occlusion21; that 
MaR might slightly shrink in MDCT performed during 
coronary occlusion because of a lack of perfusion in 
animal models with poor collateral circulation; and that 
residual edema in salvaged myocardium might contrib-
ute to the overestimation of infarct size early after re-
perfusion.38
Last, it is fair to acknowledge that although previ-
ous studies have validated the use of MDCT to measure 
MaR,21,46 there is probably no perfect method for such 
purpose, because there is no consensus on a standard-
ized method for the identiﬁcation of MaR on T2W-CMR 
imaging.47 Underestimation of the maximum intensity 
at time points exhibiting shorter myocardial T2, ie, 24 
hours and day 40, could potentially bias results in the 
case of the full width at half-maximum method. How-
ever, we believe the region of interest selection as ini-
tial thresholding for the full width at half-maximum 
method did not have a signiﬁcant impact on our results 
for several reasons. First, the blinded analysis included 
manual correction and visual border delineation after 
initial thresholding. Second, the hemorrhagic area was 
larger at day 4 and day 7 coinciding with the largest 
edematous area delineated. Third, the demonstration 
of a similar bimodal edema pattern by the use of a 
quantitative and more objective method, ie, T2 map-
ping, both in the human and pig myocardium strongly 
supports our ﬁndings here reported.
CONCLUSIONS
Contrary to the accepted view, the post-MI edematous 
reaction in patients is not stable, but follows a bimodal 
pattern. The initial edema wave appears early on re-
perfusion and dissipates by 24 hours. The deferred 
edema wave emerges thereafter and reaches a plateau 
lasting from approximately day 4 to day 7 postreperfu-
sion. Consequently, the MaR as measured by T2W-CMR 
changes dynamically according to timing of the CMR 
examination. Timing of CMR after MI for assessing MaR 
and salvaged myocardium needs to be standardized. 
According to the data presented, a time frame between 
day 4 and day 7 after reperfusion seems a good com-
promise solution although some other factors might af-
fect these variables.
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associated with SCD were detected by an ECG and
would have been missed by only a screening history
and physical examination.
This analysis exhibits the rather vague nature and
low yield of screening questionnaires. More than one-
third of athletes reported at least 1 positive cardiac
symptom or family history response. The American
Heart Association recently expanded their primary
recommendations for screening from a 12-point to a
14-point assessment (2). However, simply asking
more questions is unlikely to improve detection of
athletes at risk when the sensitivity and speciﬁcity of
the tool itself have considerable limitations.
SCD in NCAA athletes is more frequent than initial
estimates, with an overall incidence of 1:43,000, with
male basketball players having the highest risk of SCD
at 1:7,000 athletes per year (1). Strong consideration
must be given to implementing improved models of
prevention.
Accurate interpretation of an athlete’s ECG
requires proper training and experience. The false-
positive rate in this study was only 2.2%, and
approximately 1 in 4 athletes with abnormal ECG
ﬁndings were found to have a cardiac disorder asso-
ciated with SCD. Physician expertise, cardiology,
and institutional resources vary among NCAA in-
stitutions, which will affect both the capacity and
ability to implement ECG screening. Thus, the ﬁnd-
ings of this study may not be applicable to insti-
tutions with less experience. If an ECG is included in
the cardiovascular screening of athletes, it must be
interpreted with modern standards that distinguish
physiological cardiac remodeling from ﬁndings sug-
gestive of underlying cardiac pathology and be con-
ducted with adequate cardiology oversight and
resources to assist with the secondary investigation
of ECG abnormalities.
Screening history questionnaires have a high
response rate, and their value in the detection of
athletes at risk when used as the sole screening
tool is uncertain. ECG screening increases the
ability to identify athletes with disorders associated
with SCD and thus meet the primary objective of
pre-participation screening. An integrated cardio-
vascular screening that includes an ECG should be
considered best practice for the pre-participation
evaluation of college athletes.
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Myocardial Edema
Should Be Stratiﬁed
According to the State of
Cardiomyocytes Within
the Ischemic Region
We read the article by Fernández-Jiménez et al. (1)
published in the Journal with great interest. The in-
vestigators conclude that the evolution of myocardial
edema within a week after ischemia/reperfusion (I/R)
follows a bimodal pattern: T2 relaxation times and
water content reach the highest level at 2 h of reper-
fusion in the ischemia area, decrease to the lowest at
24 h, and rise to a peak again on day 7.
Myocardial edema, namely a bright signal intensity
zone on T2-weighted short tau inversion recovery
cardiac magnetic resonance, is referred to as an area
at risk that consists of irreversible and reversible
injured tissue. The cardiomyocytes located in the
irreversible region are necrotic and unsalvageable.
Irreversible region is surrounded by a reversible re-
gion encompassing cells that are integrated without
membrane disruption and can recover structure and
function after reperfusion. A severe degree of edema
will overwhelm the necrotic cells when reperfusion is
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performed for their defective sarcolemmal mem-
brane, which fails to control the volume of ﬂuids and
electrolytes (2). Combined with contrast delayed-
enhancement cardiac magnetic resonance to locate
and quantify infarct zone, it is feasible to identify the
salvageable myocardium as the area at risk minus
infarct size (3). As the state of cardiomyocytes is
different in salvageable and infarct regions, the
edema might follow disparate evolution patterns, so
it is of great necessity to stratify them to obtain
curves exhibiting speciﬁc regions.
As Fernández-Jiménez et al. (1) put it, “the ﬁrst
wave appears abruptly upon reperfusion and dissi-
pates at 24 h.” We quite agree with this phenomenon,
which is also observed in our research (4). We notice
that diastolic wall thickness signiﬁcantly increased
at early reperfusion, dropped sharply to nearly
normal at 24 h and remained constant until day 7 as is
shown in Figure 3 of Fernández-Jiménez et al. (1). It is
obvious that an abrupt elevation and absorption of
overloaded ﬂuids after ischemia/reperfusion forms
such a wave of diastolic wall thickness that is
consistent with the ﬁrst wave of T2 relaxation times.
However, we do not think it is appropriate to draw
the conclusion that the second wave is also developed
by edematous reaction.
Although edema might be generated by the
subsequent inﬂammatory response and myocardial
water content accumulates gradually, it is not the
predominant factor that elevates T2 relaxation times
of the ischemic tissue during the period from 24 h to
day 7. Foltz et al. (5) consider that T2 relaxation
ﬂuctuates with edema and hemoglobin oxidative
denaturation to methemoglobin in acute reperfused
hemorrhagic infarction, which is similar to the
bimodal pattern reported by Fernández-Jiménez et al.
(1). Compartmentalized deoxyhemoglobin and met-
hemoglobin are paramagnetic and would greatly
reduce T2 relaxation, whereas decompartmentalized
methemoglobin due to erythrocyte rupture is char-
acteristic of diamagnetism and would extend T2
relaxation time. Despite the different occlusion times
in these 2 articles (1,5), both of them occur with
intramyocardial hemorrhage, as is shown in Figure 3A
of Fernández-Jiménez et al. (1): hypointensity within
edematous tissue. In terms of amplitude of variation
in a different time, T2 relaxation time is more signif-
icant than water content in the myocardium.
Taking the edematous region as a whole without
differentiating the components within it, we ﬁnd that
T2 relaxation ﬂuctuations follow a bimodal pattern.
However, this curve does not exactly show evolution
of myocardial edema. To acquire more accurate
change curves reﬂecting the speciﬁc state of
cardiomyocytes, we should stratify the edema region
into salvageable and infarcted zones, or simply
edematous and hemorrhagic zones.
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REPLY: Myocardial Edema Should Be
Stratiﬁed According to the State of
Cardiomyocytes Within the Ischemic Region
We read with great interest the letter from Dr. Zhang
and colleagues commenting on our recently pub-
lished work (1). Noninvasive evaluation of myocardial
edema has become possible with the development of
T2-weighted and lately T2-mapping cardiac magnetic
resonance sequences able to detect changes in tissue
water content (2,3). Interestingly, although edema is
deﬁned as an abnormal water accumulation within a
tissue, it is well known that T2 relaxation properties
of myocardium are affected by other factors besides
water content such as hemorrhage or microvascular
obstruction, among others (4). Evaluation of tissue
water content by a reference standard is therefore
necessary for detecting, quantifying, and tracking the
Letters J A C C V O L . 6 5 , N O . 2 1 , 2 0 1 5
J U N E 2 , 2 0 1 5 : 2 3 5 2 – 6 1
2356
180
real post-myocardial infarction edema reaction. We
respectfully disagree with Dr. Zhang and colleagues
on their comment regarding the inappropriateness to
draw the conclusion from our work that the second
wave is also developed by edematous reaction.
Indeed, we demonstrated that T2 abnormalities and,
more importantly, increased water content in the
ischemic region, as measured by the gold standard
desiccation technique, were ultimately as high at day
7 as that documented at early reperfusion. Deﬁnitely,
the quantiﬁcation of the myocardial water content by
reference standards was crucial for demonstrating a
consistent appearance of 2 consecutive waves of real
edema during the ﬁrst week after ischemia/reperfu-
sion in our experimental study.
Dr. Zhang and colleagues point out that salvageable
and infarct regions might follow disparate edema evo-
lution patterns. From the cardiac magnetic resonance
point of view, we agree that placing a region of interest
in the full thickness of the left ventricular wall is trou-
blesome as it will contain different myocardial states.
However, the identiﬁcation of “clean” regions clearly
outside hemorrhage/microvascular obstruction areas
may be extremely difﬁcult and, more importantly, may
be subjected to a big source of bias. The quantiﬁcation
of water content by reference standard in such small
regions would be even more difﬁcult to perform as this
procedure needs to be done in a rapid and careful
manner, avoiding tissue manipulation as much as
possible. We tend to disagree with the idea that
edematous and infarcted zones are equivalent to
salvageable and hemorrhagic areas, respectively, as
suggested by Dr. Zhang and colleagues. In any case, we
believe that the possibility of including different
myocardial states had little effect on the results re-
ported in our work given that transmural extent of
infarction was >80% in all evaluated segments con-
taining the regions of interest, and the observed par-
allel course of T2 relaxation times and water content.
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Myocardial Salvage,
Area at Risk by T2w CMR
The Resolution of the Retrospective
Radio Wave Paradigm?
In 2006, in an editorial published in a fellow journal
by Pennell (1) T2-weighted (T2w) cardiac mag-
netic resonance (CMR) imaging was presented as
a promising method to retrospectively assess the
myocardial area at risk. The area at risk could
be reliably measured by contouring the myocardial
edema using T2w sequences. The combination with
late gadolinium-enhanced myocardial volume as-
sessed during the same examination allowed the ﬁnal
infarct size measurement, and from there the simple
and powerful concept of myocardial salvage was is-
sued (2). Since then, numerous trials assessing new
reperfusion strategies have used the salvage index as
a clinical endpoint (3).
With this in mind, we read with great interest in
the Journal, the paper by Fernández-Jiménez et al.
(4). These investigators, relying on very solid and
consistent work, unveil very new ﬁndings. They show
with striking results that myocardial edema after
ischemia reperfusion is highly variable and follows a
bimodal pattern. These ﬁndings are novel and chal-
lenge the accepted view on the development of
edema after an ischemic insult. In our opinion, these
ﬁndings also signiﬁcantly question the accepted view
of T2w CMR as a reliable tool to assess the area at risk,
and thus the myocardial salvage index, which we had
already challenged recently (5).
Although the investigators are very cautious about
this topic in their paper, we would value their opinion
on this debated issue of CMR retrospective accuracy
to assess the area at risk. Also, considering that these
investigators have used the myocardial salvage index
as an endpoint in a previous trial (3), we would
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real post-myocardial infarction edema reaction. We
respectfully disagree with Dr. Zhang and colleagues
on their comment regarding the inappropriateness to
draw the conclusion from our work that the second
wave is also developed by edematous reaction.
Indeed, we demonstrated that T2 abnormalities and,
more importantly, increased water content in the
ischemic region, as measured by the gold standard
desiccation technique, were ultimately as high at day
7 as that documented at early reperfusion. Deﬁnitely,
the quantiﬁcation of the myocardial water content by
reference standards was crucial for demonstrating a
consistent appearance of 2 consecutive waves of real
edema during the ﬁrst week after ischemia/reperfu-
sion in our experimental study.
Dr. Zhang and colleagues point out that salvageable
and infarct regions might follow disparate edema evo-
lution patterns. From the cardiac magnetic resonance
point of view, we agree that placing a region of interest
in the full thickness of the left ventricular wall is trou-
blesome as it will contain different myocardial states.
However, the identiﬁcation of “clean” regions clearly
outside hemorrhage/microvascular obstruction areas
may be extremely difﬁcult and, more importantly, may
be subjected to a big source of bias. The quantiﬁcation
of water content by reference standard in such small
regions would be even more difﬁcult to perform as this
procedure needs to be done in a rapid and careful
manner, avoiding tissue manipulation as much as
possible. We tend to disagree with the idea that
edematous and infarcted zones are equivalent to
salvageable and hemorrhagic areas, respectively, as
suggested by Dr. Zhang and colleagues. In any case, we
believe that the possibility of including different
myocardial states had little effect on the results re-
ported in our work given that transmural extent of
infarction was >80% in all evaluated segments con-
taining the regions of interest, and the observed par-
allel course of T2 relaxation times and water content.
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Myocardial Salvage,
Area at Risk by T2w CMR
The Resolution of the Retrospective
Radio Wave Paradigm?
In 2006, in an editorial published in a fellow journal
by Pennell (1) T2-weighted (T2w) cardiac mag-
netic resonance (CMR) imaging was presented as
a promising method to retrospectively assess the
myocardial area at risk. The area at risk could
be reliably measured by contouring the myocardial
edema using T2w sequences. The combination with
late gadolinium-enhanced myocardial volume as-
sessed during the same examination allowed the ﬁnal
infarct size measurement, and from there the simple
and powerful concept of myocardial salvage was is-
sued (2). Since then, numerous trials assessing new
reperfusion strategies have used the salvage index as
a clinical endpoint (3).
With this in mind, we read with great interest in
the Journal, the paper by Fernández-Jiménez et al.
(4). These investigators, relying on very solid and
consistent work, unveil very new ﬁndings. They show
with striking results that myocardial edema after
ischemia reperfusion is highly variable and follows a
bimodal pattern. These ﬁndings are novel and chal-
lenge the accepted view on the development of
edema after an ischemic insult. In our opinion, these
ﬁndings also signiﬁcantly question the accepted view
of T2w CMR as a reliable tool to assess the area at risk,
and thus the myocardial salvage index, which we had
already challenged recently (5).
Although the investigators are very cautious about
this topic in their paper, we would value their opinion
on this debated issue of CMR retrospective accuracy
to assess the area at risk. Also, considering that these
investigators have used the myocardial salvage index
as an endpoint in a previous trial (3), we would
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appreciate their opinion on the use of such an index
in the light shed by their paper.
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REPLY: Myocardial Salvage,
Area at Risk by T2w CMR
The Resolution of the Retrospective RadioWave Paradigm?
We appreciate the interest and comments from Dr.
Mewton and colleagues about our recently published
work (1). In the context of myocardial infarction (MI),
tissue edema appears initially in the form of car-
diomyocyte swelling during the early stages of
ischemia and is then signiﬁcantly exacerbated on
restoration of blood ﬂow to the ischemic region (2).
The relationship between MI and disturbed cardiac
magnetic resonance (CMR) T2 was initially reported 3
decades ago. However, the potential correlation be-
tween the extent of post-MI altered T2-weighted CMR
imaging and the actual area at risk (AAR) was not
proposed until 2006 (3). After this initial in vivo
report, the extent of post-MI T2 CMR alteration has
been exponentially used to quantify the extent of
AAR, assuming its accuracy in this regard. For many
years, the post-MI edematous reaction was assumed to
appear early after ischemia/reperfusion and to persist
in stable form for at least 1 week. Our recent report on
the post-ischemia/-reperfusion bimodal edema phe-
nomenon (1) disrupts this classical view and calls for
revisiting the assumptions described here.
Dr. Mewton and colleagues raise a highly relevant
issue: What are the implications of our ﬁndings for
the retrospective AAR (and myocardial salvage)
quantiﬁcation? Given that myocardial edema ﬂuctu-
ates during the ﬁrst week after MI, it seems intuitive
to argue that CMR-based AAR quantiﬁcation will vary
during the initial days after reperfusion, yet this is to
be formally proven. Our data suggest that the use
of CMR-based surrogate markers of infarct size
(i.e., normalized to AAR) in clinical trials evaluating
the effect of cardioprotective therapies, while inter-
esting to reduce sample size, is a risky business. This
call of warning is not new, and has been previously
proposed by other investigators (including Dr. Mew-
ton and colleagues), and our work supports this pre-
caution. Please note, given the controversy in the
ﬁeld, in our recently published METOCARD-CNIC
(Effect of Metoprolol in Cardioprotection During an
Acute Myocardial Infarction) trial, we intentionally
chose total infarct size as the primary endpoint,
having salvage index as a secondary analysis (4,5).
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Noninferiority of
6 Versus 12 Months of
Dual Antiplatelet Therapy
With great interest, I read the article by Colombo et al.
(1) that examined the noninferiority of 6 versus 12
months of dual antiplatelet therapy (DAPT) in
patients undergoing percutaneous coronary inter-
vention with second-generation drug-eluting stents.
The investigators described in the Results section
(p. 2091) that “There was at least 1 occurrence of the
primary composite endpoint by 12 months in 31 pa-
tients in the 6-month DAPT group (4.5%; 95% CI: 2.9
to 6.1) and 27 patients in the 12-month DAPT group
(3.7%; 95% CI: 2.3 to 5.1; p ¼ 0.469) (Table 5). There
was a 0.8% (95% CI: -2.4 to 1.7) difference in occur-
rence of the primary endpoint between the 6-month
and 12-month groups. The upper limit of the 95% CI
was lower than the pre-set margin of 2%, conﬁrming
the noninferiority hypothesis (p < 0.05).” However,
on the basis of the result (31 of 682 vs. 27 of 717) in
Table 5, the 95% conﬁdence interval (CI) for the dif-
ference between 2 sample proportions is -1.3% to
2.9% (90% CI: -1.0 to 2.5). Therefore, the upper limit
of the 95% CI appears more than the pre-set margin of
2%, rejecting the noninferiority hypothesis of 6
months versus 12 months of DAPT. It would be of
great help if the investigators could provide the
method they used to calculate 95% CI.
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SECURITY Did Not
Establish Noninferiority
In presenting the results of the SECURITY (Second-
Generation Drug-Eluting Stent Implantation Fol-
lowed by 6- Versus 12-Month Dual Antiplatelet
Therapy) trial, Colombo et al. (1) concluded that
“6 months of DAPT appeared noninferior to a
12-month regimen with respect to the primary com-
posite endpoint.” However, this conclusion, repeated
several times in the paper, is not supported by the
data.
The composite event was observed in 31 of 682
patients in the 6-month treatment arm, and in 27 of
717 patients in the 12-month arm. The risks were
correctly reported as 4.5% versus 3.7%, and the risk
difference as 0.8%. The 95% conﬁdence interval was
given as -2.4% to 1.7%, such that “the upper limit of
the 95% CI was lower than the pre-set margin of 2%,
conﬁrming the noninferiority hypothesis.” Unfortu-
nately, the conﬁdence bounds are incorrect. The
tell-tale sign of a problem is the asymmetry; the
conﬁdence interval should be approximately sym-
metric about the point estimate of 0.8%. Reanalysis
shows an asymptotic 95% conﬁdence interval of -1.3%
to 2.9%, which exceeds the noninferiority margin. If
an exact conﬁdence interval is preferred, which may
be a good idea given the low numbers of events, the
bounds are -1.7% to 3.9%. This means that the data
are compatible with an absolute excess risk of a
composite event of up to 2.9% (or 3.9%) in a patient
treated for 6 months, compared with a patient treated
for 12 months. Noninferiority up to an excess risk of
2% does not hold.
The problem remains if a 1-sided 95% conﬁdence
interval is obtained, as it should according to the
Methods section. A 1-sided upper limit on the risk
difference of 0.8% is 2.5% (asymptotic method) or
3.4% (exact method). In all instances, the upper limit
exceeds the noninferiority margin.
Another issue that argues against noninferiority is
the rather high proportion of patients (34%) in
the 6-month treatment group who continued their
medications beyond the scheduled stopping time.
Non-compliance with the assigned treatment dilutes
the contrast between the groups. This favors the null
hypothesis and causes a conservative bias in su-
periority trials: indeed, if a signiﬁcant difference is
observed between the treatment arms despite
noncompliance, the true difference must be even
greater. In contrast, in a noninferiority trial, the bias
caused by noncompliance runs against the tested
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morphological features of coronary plaque in culprit
lesions.
Various pathological types of vulnerable plaques
(e.g., plaque rupture, plaque erosion, and calciﬁed
nodules) can cause thrombosis with or without
luminal obstruction and could lead to acute coronary
syndromes, including myocardial infarction and
unstable angina (2). Plaque rupture is the most com-
mon cause of coronary thrombosis, accounting for
approximately 70% of fatal coronary thrombi (3).
Thin-capped ﬁbroatheroma is the characteristic
morphology of rupture-prone plaques, in which a thin
and inﬂamed ﬁbrous cap covers a large and soft lipid-
rich necrotic core, frequently with positive remodel-
ing mitigating luminal obstruction (mild stenosis by
angiography) (2). In intravascular ultrasound studies,
intravascular ultrasound–virtual histology–derived
thin-capped ﬁbroatheroma lesions are independently
associated with adverse cardiovascular events (4).
However, little is known about the natural history of
thin-capped ﬁbroatheroma and the detailed process
of vulnerable plaque rupture, because most published
studies have thus far been cross-sectional analyses,
and none have presented changes on serial intravas-
cular images.
What is the mechanism responsible for rupture of
vulnerable plaques? Although it is still uncertain that
coronary spasm could cause plaque rupture, Wang
et al. (5) provided evidence for the important role of
coronary spasm in triggering vulnerable plaque
rupture. Accordingly, we believe that by combining
the acetylcholine provocation test for the evaluation
of vasomotor abnormalities and intravascular imag-
ing for deﬁning plaque morphology, we can identify
patients at high risk for future adverse cardiovascular
events.
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“Waves of Edema”
Seem Implausible
Fernández-Jiménez et al. (1) described a bimodal time
course of myocardial edema in a pig model of
ST-segment elevation myocardial infarction. We
concur with their observations regarding a dynamic
pattern in infarct zone T2, but “waves of edema”
seem implausible.
We have studied myocardial hemorrhage in 245
patients with ST-segment elevation myocardial
infarction (NCT02072850). In a serial imaging sub-
study (n ¼ 30, 100% compliance), we observed a pro-
gressive increase in infarct zone T2 relaxation time in
patients without myocardial hemorrhage, whereas in
those with hemorrhage we observed a “bimodal”
pattern for T2 (milliseconds) but not for edema (area-
at-risk) (2). We conclude that the subacute reduction
in T2 can be explained by the destructive paramagnetic
effects of deoxyhemoglobin.
Myocardial hemorrhage is very common in reper-
fused pigs post–myocardial infarction (3). However,
Fernández-Jiménez et al. (1) concluded that other
myocardial states (i.e., myocardial hemorrhage) “had
little effect on the results,” despite ﬁnding that
infarct-zone hemorrhage increased progressively to
day 4 (p ¼ 0.02).
They describe tissue water content on the basis of
desiccation (1). This method provides no information
on water distribution, and baking will also desiccate
gelatinous blood clot.
Dark-blood T2 short-tau inversion recovery cardiac
magnetic resonance imaging has suboptimal accuracy
for imaging edema (4). Because the investigators’
model involved anterior ST-segment elevation
myocardial infarction (1), surface coil intensity issues
may have rendered the inferoposterior ventricular
wall dark and the anterior wall relatively bright.
Because of euthanasia, the initial population (n¼25)
was reduced successively by 25% to 75% (1), and
inevitably, results based on 5 animals are statistically
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fragile. Conclusions that are based on nonrandomized,
open-label drug assignment, partial blinding, and loss
to follow-up of the majority should be viewed
cautiously, especially when alternative explanations
may be valid (2,3).
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REPLY: “Waves of Edema” Seem Implausible
We read the comments of Dr. Berry and colleagues on
our recent study with great interest (1). On the basis
of an imaging substudy of 30 patients with myocar-
dial infarctions, they propose that the bimodal post-
infarction T2 cardiac magnetic resonance imaging
(CMR) pattern can be explained entirely by the effects
of myocardial hemorrhage rather than by the exis-
tence of 2 distinct waves of edema. Interestingly,
they state that patients with hemorrhages displayed
a “bimodal” pattern for T2 but not for edema, an
intriguing ﬁnding given that the identiﬁcation of
edema by CMR is based on T2.
We admire the important imaging work done by
Berry’s group. However, clinical studies by them-
selves are limited when it comes to mechanistic
interpretation; despite the obvious differences from
humans, pre-clinical animal models are the basis of
progress in the understanding of pathophysiological
mechanisms. It is also the case that desiccation
remains a reference technique for water content
quantiﬁcation, although it is true that it does not
differentiate between intra- and extracellular water
components, as we have acknowledged (1,2). Using
this technique, we were able to clearly demonstrate a
bimodal post-infarction edematous reaction (1,3), and
the dynamics of edema correlated with the observed
CMR changes. We agree with Berry et al. that quali-
tative T2 CMR sequences have suboptimal accuracy
for imaging edema, and for this reason, we included
in all cases 2 quantitative T2-mapping methods, in
addition to T2 short-tau inversion recovery (4). The
evidence from these independent approaches, con-
ducted in a human-like animal model, provide robust
evidence that myocardial ischemia and reperfusion is
followed by a genuinely bimodal edematous reaction.
We were challenged by the suggestion that “baking
will also desiccate gelatinous blood clot,” and we
have performed new experiments to address this.
Subjection of pig blood clots to the same desiccation
protocol resulted in a mean water content of about
75%. If Berry et al. were correct and the edema at
reperfusion (measured water content w84% to 85%)
were stable throughout reperfusion, hemorrhage
could account for the measured water content values
(w81% at 24 h) (1,3) only if it affects more than 40% of
the infarcted region. However, hemorrhage affected
“only” w10% of the injury area at 24 h (unpublished
data). In addition, if hemorrhage were the sole
explanation for the bimodal T2 pattern, it would be
difﬁcult to understand why T2 and water content
increased to day 4, coinciding with the peak of hem-
orrhage (1). These 2 lines of evidence (the extent of
hemorrhage in the model and the coincidence of
increased water content and T2 with peak hemor-
rhage) refute the interesting hypothesis proposed by
Berry and colleagues.
Complex biological events seldom have single
explanations, and we have consistently acknowl-
edged (1–4) that T2 can be affected by other factors,
including hemorrhage, in addition to myocardial
water content. It is plausible that the observed
bimodal post-infarction T2 pattern is due to at least 2
components: mainly the dynamic changes in
myocardial water content and a lesser contribution
from the classically described paramagnetic effect of
hemoglobin denaturation (1,3).
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To the Editor:
We read with interest the article by Vilahur and colleagues.1 The authors should be 
congratulated for using the human-like pig model of ischemia/reperfusion to provide 
evidence that ticagrelor may limit myocardial injury (necrosis and edema formation), 
as measured by cardiac magnetic resonance (CMR).
Given that CMR can accurately identify myocardial areas with high water con-
tent, it has been widely used in the past years to retrospectively delineate the 
myocardium at risk (MaR). It is interesting to note that it has been assumed that 
the postischemia/reperfusion edematous reaction is stable for several days after 
myocardial infarction. On this basis, experimental and clinical studies performed 
CMR examinations at a variable time after myocardial infarction. Our group recently 
demonstrated in a pig model of transmural myocardial infarction that myocardial 
edema after ischemia/reperfusion is not stable but rather follows a bimodal pat-
tern.2 In this model, an initial hyperacute edema reaction on reperfusion largely 
resolves within 24 hours, and is followed by a deferred healing-related edema wave 
occurring a few days after reperfusion.3 This coordinated bimodal edema pattern 
suggests that CMR-quantified MaR may vary according to the day of imaging and 
degree of injury (and subsequent healing), but to date this has not been tested in a 
controlled manner.
In the present article,1 intriguing data about histological (blue-dye injection) 
versus CMR (edema) measurements of the MaR are presented. Although the me-
dian of histological reference MaR was similar in all experimental groups (≈50% of 
the left ventricle), an important underestimation of MaR by T2-weighted short-tau 
inversion recovery CMR was reported at 24 hours in all study groups. Although 
individual comparison is not possible with the data presented, it is remarkable 
that even in placebo animals, a ≈25% underestimation of MaR by CMR was ob-
served (47.5% of left ventricle by histology versus 36.2% by 24-hour CMR). Thus, 
it seems plausible that the physiological resorption of the initial wave of edema 
contributed to these histology-CMR discrepancies. In fact, according to the data 
presented, salvage index quantification [1 – (infarct size/MaR), %] in placebo ani-
mals using dye histology or 24-hour CMR would be as disparate as 14% or 35%, 
respectively.
Consequently, although the infarct-limiting effect of ticagrelor in this article is ro-
bust, its effect on edema is less. The authors used T2-weighted short-tau inversion 
recovery CMR sequence, which suffers from technical limitations. Conversely, quan-
titative T2 mapping has been shown to strongly correlate with actual myocardial wa-
ter content measurements.4 It might be that the use of T2 mapping and, especially, 
a serial imaging protocol, including a hyperacute and later time points, would have 
helped in the interpretation of the mechanisms leading to injury sparing by ticagrelor.
Overall, we believe that the work by Vilahur et al adds incremental evidence of the 
risks of using nonstandardized CMR protocols and timings to measure MaR.
Letter by Fernandez-Jimenez et al Regarding 
Article, “Protective Effects of Ticagrelor on 
Myocardial Injury After Infarction”
© 2017 American Heart 
Association, Inc.
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4 DISCUSSION 
The results presented in this thesis work have been discussed in detail in the 
manuscripts published as a part of this dissertation. Nevertheless, a critical 
discussion of such results in the context of previous literature and evolving studies 
in the field can be found in this section. 
 
4.1 First demonstration of the post-infarction bimodal edema 
reaction 
Because edema has been perceived as both stable and persistent during at least 1 
week after myocardial I/R, numerous experimental and clinical studies have used 
T2W CMR imaging to retrospectively evaluate the edematous reaction associated 
with MI as a marker of “ischemic memory”. However, T2W imaging is subject to 
several technical limitations and does not offer quantitative T2 relaxation time tissue 
measurements that would allow for comparisons between different studies. Recently 
developed quantitative T2 mapping methods have been proposed to overcome at 
least some of the limitations for the detection and quantification of myocardial 
edema.53, 79 However, most of proposed T2 mapping sequences are time-
consuming, and are thus mostly used as a research tool. As a part of this thesis 
work, we initially performed an in vivo validation of a T2 GraSE mapping method 
that could be easily integrated in routine protocols, and used in our subsequent 
experimental and clinical work for a fast and accurate quantification and tracking of 
myocardial edema.69 
The results presented in this thesis work challenge the accepted view of the 
development of post-I/R myocardial edema. We first showed, through state-of-the-
art CMR analysis and histological validation in a pig model of I/R, that the edematous 
reaction during the first week after reperfusion is not stable, instead following a 
bimodal pattern.70 A first wave appears abruptly upon reperfusion and dissipates at 
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 24 hours. Conversely, a second wave of edema appears progressively days after 
I/R and increases to a maximum on postreperfusion day 7. To the best of our 
knowledge, this was the first study to comprehensively characterize the time course 
of myocardial edema during the first week after I/R, covering from very early to late 
reperfusion stages. In a previous study, Foltz et al. suggested a similar myocardial 
T2 relaxation time course in a pig model of I/R, with CMR scans at days 0, 2, and 7 
after reperfusion.80, 81 However, this study lacked histological validation of 
myocardial water content, and the observed T2 relaxation time fluctuations were 
interpreted as reflecting the oxidative denaturation of hemoglobin to methemoglobin 
rather than fluctuations in actual myocardial water content. The histological 
validation performed in the experiments presented in this dissertation demonstrates 
the consistent appearance of two consecutive waves of edema during the first week 
after I/R, a groundbreaking concept in the field. 
Remarkably, we were able to replicate these results in the clinical setting.74 Thus, 
we demonstrated for the first time that myocardial edema in the ischemic area after 
MI in humans is not stable, but rather follows a systematic bimodal pattern. In the 
same way as shown in the preclinical setting, an initial wave of edema appears 
abruptly very early after reperfusion but it is significantly attenuated by 24 hours. 
This is followed by a second (deferred) wave of edema several days after 
reperfusion reaching a plateau around days 4 to 7 after MI. CMR scans timing was 
designed as per the protocol of our previous experimental studies, in which we 
demonstrated the existence of bimodal post-MI edema in pigs,69, 70, 72, 73 including 
the hyperacute post-reperfusion period (the first 3 hours after primary PCI). 
Noteworthy, to select the optimal timing for the first CMR scan in ST-segment 
elevation MI patients, we first analyzed the dynamics of the initial wave of edema in 
a series of 5 pigs; serial CMR scans were performed every 20 minutes until the 
reperfusion-related edema wave faded.74 Interestingly, this initial wave of edema 
peaked very early, being significantly attenuated within a few hours after MI: at 180 
minutes after reperfusion the edema had declined by approximately 50% from its 
maximum. In agreement with CMR data, quantification of myocardial water content 
and histological analysis at 6 hours after MI revealed partial resolution of the 
massive interstitial edema seen earlier after reperfusion.72 On the basis of these 
results in pigs, we decided to perform the first CMR scan in patients within a narrow 
194
 3-hour time-window after primary PCI to be able to detect the noon of the initial wave 
of edema. 
 
4.2 Pathophysiology underlying the post-infarction edema 
reaction 
Under the hypothesis that the initial wave of edema is a direct consequence of 
reperfusion while the deferred wave is caused by healing processes, we then 
manipulated each wave independently through the use of reperfused and 
nonreperfused MI models, and exposure to high-dose steroid therapy, interventions 
that are known to alter healing processes.72 The absence of reperfusion almost 
completely abolishes the initial wave, indicating that it is a direct consequence of the 
reperfusion process. The deferred wave is substantially altered by interventions that 
impair healing in the post-infarcted myocardium (absence of reperfusion and high-
dose steroid therapy), thus implicating tissue healing processes in this second 
phase of edema. Moreover, these processes can be visualized and quantified by 
state-of-the-art contemporaneous T2 CMR sequences, a finding of special 
translational relevance. 
We later studied the impact of cardioprotective strategies (preconditioning and post-
conditioning) and ischemia duration on the temporal evolution and extent of 
myocardial edema and other tissue composition changes (necrosis, IMH and MVO) 
by CMR.73 Our results showed that preconditioning (a potent cardioprotective 
strategy) and short ischemia duration have a major impact on the intensity and 
dynamics of post-MI edema. Preconditioning reduced the initial edema wave and 
also the deferred wave, which peaked early, on day 4, contrasting with the peak on 
day 7 in control animals. Shortening the duration of coronary occlusion to 20 minutes 
(20min-I/R) also blunted initial edema wave, and in this case the second edema 
wave was absent. These CMR results are consistent with histologically determined 
water content at day 7 after MI, which was reduced in pigs undergoing 
preconditioning and within the normal range in pigs undergoing short-duration 
ischemia. The cardioprotection (reduced infarct size) afforded by preconditioning or 
short-duration ischemia was demonstrated by CMR and histology. In pigs 
undergoing short-duration ischemia necrosis was barely detectable, and so was 
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 edema from day 1 on, supporting the notion that the deferred edema wave is related 
to post-MI healing.  
We finally characterized the dynamic changes that take place in both the ischemic 
and remote myocardium during the first week after infarction in a clinically relevant 
animal model at the molecular level. This was undertaken by high-throughput 
multiplexed quantitative proteomics and histological analyses of pig myocardium at 
different times during the first week after I/R.71 In a first screening approach, we 
provided a detailed pattern of the time-course behavior of more than 5,000 proteins 
in both the ischemic and remote areas. This was followed by a further validation step 
in which we focused on most relevant protein changes. Our results reveal a highly 
coordinated, multimodal pattern of functional protein alterations in both myocardium 
regions in the early post-MI stages. Most notably, the remote myocardium 
undergoes transitory alterations in the contractile machinery that result in a stunned 
myocardium within the first 24 hours. 
Elucidation of the pathophysiology and molecular mechanisms underlying bimodal 
post-I/R edema has potential translational implications in diagnosis, prognosis, and 
therapy. Pharmacological or other interventions targeting the pathways implicated 
in the initial or deferred waves of post-I/R edema could contribute to better cardiac 
recovery and remodeling, and thus improve prognosis in patients experiencing an 
acute MI. 
 
4.3 Implications for quantifying myocardium at risk and salvage 
The disparate time points examined in different experimental and clinical studies are 
an important source of confusion in CMR evaluation of post-I/R edema. In parallel 
with T2 relaxation changes, we confirmed significant variation in the extent of the 
MaR as measured by T2W-STIR CMR both in the experimental and clinical 
setting.73, 74 Consistent with the drop in T2 relaxation time at 1 day post-MI, T2W-
estimated MaR at this time point was significantly lower than values obtained before 
and subsequently. Remarkably, we included pre-reperfusion contrast computed 
tomography imaging as a reference for the assessment of MaR in the preclinical 
work,82, 83 which otherwise we considered unethical to perform in acute MI patients. 
More pronounced dynamic tissue changes were shown in the experimental model. 
This is a common phenomenon seen in the preclinical setting in which many 
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 variables are controlled, as opposed to clinical studies. In addition, the more severe 
ischemic process in the porcine myocardium in the presence of poor collateral 
circulation, among other reasons, could influence the magnification of this 
phenomenon. However, the parallel courses of T2 and CMR-MaR fluctuations 
observed in the clinical and experimental settings strengthen the existence of a real 
bimodal edematous reaction after MI. 
Thus, our data suggest that between day 4 and day 7 would be a good compromise 
solution for the delineation of theoretical MaR. Nevertheless, our results highlight 
the need for caution in interpreting CMR of the post-MI heart. In the clinical study, 
several patients showed more limited changes in T2 and extent of edema. 
Remarkably, these patients were older and showed significantly smaller infarcts and 
less extent of IMH and MVO, and greater myocardial salvage areas despite having 
longer intervals between symptom onset to reperfusion. We speculate that there 
might be several factors affecting the dynamics of the bimodal edematous reaction 
such as the existence of preformed collateral circulation, episodes of spontaneous 
reperfusion/re-occlusion during ischemia duration, or the presence of specific 
comorbidities. The impossibility of controlling these aspects in the clinical scenario, 
and the limited sample size preclude any definitive conclusion in this regard, but 
warrants further clinical studies. 
As compared to T2W-STIR, parametric T2-mapping might improve the detection 
and quantification of myocardial edema; however, it is unlikely to alter the dynamic 
pattern of post-MI edema that is due to pathophysiological phenomena. The 
deferred edema wave is related to the post-MI healing process, and therefore 
interventions that protect the myocardium could affect the dynamics of edema, and 
thus bias MaR estimation. This idea was supported by recent suggestions that the 
extent of edema can be affected by the degree of damage28 or exposure to infarct-
limiting interventions.54-56 However, patients in these studies received one CMR 
examination at a single time point, which was not the same for all. Therefore a 
dedicated study was needed to provide evidence to support this hypothesis, which 
was tested in a subsequent set of experiments. 
By performing ad hoc experiments, we demonstrated that the dynamics of post-
ischemia edema are altered by cardioprotective strategies and ischemia duration, 
with further implications for CMR measured MaR and salvage.73 Thus, the smaller 
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 extent of edema at reperfusion in pigs that underwent preconditioning or short-
duration ischemia was associated with less prolonged T2 relaxation time and lower 
degree of myocardial swelling. Interestingly, these 2 groups of cardioprotected 
animals had significantly smaller infarcts on day 7. This would imply that 
interventions that protect the myocardium could affect edema dynamics, therefore 
having an impact on CMR estimations of MaR and salvage, as suggested by indirect 
preclinical84, 85 and clinical54-56 data before. However, whether any intervention that 
reduces infarct size diminishes myocardial edema remains to be demonstrated. 
 
4.4 Evolving controversy 
The recent demonstration of a bimodal edema in the post-ischemic myocardium in 
pigs70, 72 and humans74 has generated intense discussion in the cardiac imaging 
field.14, 18, 75-78, 86-93 Given that T2 can be affected by hemorrhage, some authors 
have argued that the bimodal post-MI T2 pattern could be explained entirely by the 
destructive paramagnetic effects of deoxyhemoglobin, rather than by a real 
fluctuation of tissue water content.89, 94 However, if hemorrhage was the sole 
explanation for the bimodal T2 pattern, it would be difficult to understand why T2 
(both in the pig model70 and in the clinical study74) and water content (in the pig 
model) increased to day 4, coinciding with the maximum extent of hemorrhage.72, 73 
In fact, in the clinical study we observed no significant influence of IMH on T2 
relaxation time or area of edema delineation. The finding that infarcted (either with 
or without IMH areas) and salvaged myocardium displayed the same bimodal 
pattern strengthen our results. In line with our data, Carrick, et al., found small 
differences in T2 (< 5 ms) between patients with and without hemorrhage;94 while 
Hammer-Hansen, et al., found that T2 relaxation time differed in the infarcted and 
salvaged myocardium, and both were significantly longer than remote in the post-
reperfused dog heart.95 Interestingly, the later study followed animals at 4 and 48 
hours after MI with results indicating a partial resolution of edema in the first 48 
hours after reperfusion.88, 95 Nevertheless, hemorrhage might exert some influence 
on T2 relaxation time, as we previously conceded.69, 70, 72, 77 
Whether this phenomenon occurs in humans has been explored in 3 recent studies. 
Carrick and colleagues performed a longitudinal assessment of IMH and edema in 
30 ST-segment elevation MI patients, concluding that “myocardial edema has a 
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 unimodal time course”.94 This population was more heterogeneous than the 
population examined in our work: 20% had an open artery on angiography (TIMI 
coronary flow grade 2-3) and only 30% had an anterior MI, whereas all patients in 
our study had an anterior infarction with an occluded artery on angiography. These 
factors might affect edema dynamics and visualization.38, 72 In addition, patients in 
the Carrick, et al., study underwent 3 CMR exams within the first 10 days after MI, 
at 8.6±3.1 hours, 2.9±1.5 days, and 9.6±2.3 days.94 Importantly, the first of these 
examinations was performed between 4 and 12 hours after reperfusion, which 
according to the experimental data we present here is during the dissipation of the 
first wave of edema. In fact, the T2 relaxation times in the infarcted zone reported 
for the first CMR examination in the work by Carrick, et al., are similar to those 
observed in the second scan in our clinical study, performed 24 hours after MI.  
In a second report, Nordlund, et al., retrospectively analyzed pooled data from 3 
studies assessing the MaR by qualitative CMR, concluding that no bimodal edema 
pattern was apparent.96 However, most patients in the evaluated studies underwent 
a single CMR scan at disparate times to from each other, and there were no 
systematic serial examinations. Importantly, no CMR scans were performed on day 
0, and very few were performed on day 1 after MI. Moreover, no quantitative 
parametric T2-mapping was performed, despite this technique being demonstrated 
to improve detection and quantification of myocardial edema.  
Finally, Stiermaier and colleagues retrospectively compared MaR, infarct size and 
salvage according to the time between infarction and CMR imaging in a large 
multicenter ST-segment elevation MI cohort.97 Their results did not provide sound 
evidence for a dynamic edematous reaction. Otherwise, they observed a slight rise 
and fall of MaR that was congruent with the amount of infarct size over the course 
of the first week after MI which is likely to be explained by the non-longitudinal 
retrospective nature of their data. Even more importantly, few CMR scans were 
performed within first 24 hours after reperfusion, and no CMR exams covered the 
first 12 hours after reperfusion when the first peak of edema was observed in our 
studies. Unlike these recent reports, our clinical study was specifically designed to 
provide insight into the existence of bimodal edema in MI patients by mimicking time-
points and CMR sequences performed in the previous experimental studies.70, 72, 73 
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 4.5 Limitations 
Extrapolation of the experimental results to the clinic should be done with caution. 
Nonetheless, the pig is one of the most clinically translatable large animal models 
for the study of reperfused MI as discussed before. The similar edema and 
hemorrhage time courses in the pig and the patient cohort74 highlight the great 
translational value of the pig model, especially considering the difficulty of 
performing a comprehensive CMR study that includes serial examinations within the 
first hours after reperfusion and reference methods for assessing the actual MaR. 
Nevertheless, the fact that myocardial edema and positive gadolinium enhanced 
areas follow a disparate dynamic pattern after I/R highlights the complexity of 
measuring myocardial salvage in real practice. 
The nature of the experimental study, that is, longitudinal follow-up, precluded 
individual histological reference standard measurements of area at risk (i.e., Evans 
Blue by coronary re-occlusion), infarct size (i.e., triphenyl tetrazolium chloride), or 
MVO (thioflavin-S) at each time point. In addition, the heart was harvested at 
sacrifice to perform reference standard myocardial water content measurements 
and histological quantification of different tissue components, which otherwise might 
be altered by such procedures. It is fair to acknowledge that although previous 
studies have used histological standards to validate the use of CMR to measure 
infarct size and MVO,98-100 and multi-detector computed tomography to measure 
MaR,82, 83 there is probably no perfect noninvasive method for such purposes. 
Similarly to the experimental study, only anterior ST-segment elevation MI patients 
were recruited to the clinical study. The reasons for this choice include the 
avoidance of possible magnetic-field non-homogeneity related to the inferolateral 
wall.44 These eligibility criteria closely resemble recommendations for patient 
selection in clinical trials of cardioprotective interventions.35, 36 The bimodal edema 
pattern may occur regardless of MI location; however, caution should be exercised 
when extrapolating results to other MI locations, especially regarding adequate 
visualization of the phenomenon by T2W CMR in lateral MI where signal loss due 
to through-plane cardiac motion might occur.38 Given that patients were serially 
scanned, including one examination very early after reperfusion, we planned the 
shortest CMR protocol possible. For this reason we did not include T2* CMR as a 
diagnostic method for quantifying IMH in vivo.44 Instead, we assessed both edema 
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 and hemorrhage by T2W-STIR imaging, a sequence validated and used for these 
purposes by many authors.32 
There is no consensus on a standardized method for the identification of MaR on 
T2W CMR imaging.101 Underestimation of the maximum intensity at time points 
exhibiting shorter myocardial T2, i.e. 24 hour and day 40, could potentially bias 
results in the case of the full-width at half-maximum method. However, we believe 
the region of interest (ROI) selection as initial threshold for the full-width at half-
maximum method did not have a significant impact in our results for several reasons. 
First, the blinded analysis included manual correction and visual border delineation 
after initial thresholding. Second, the hemorrhagic area was larger at day 4 and day 
7 coinciding with the largest edematous area delineated. Third, the demonstration 
of a similar bimodal edema pattern by the use of a quantitative and more objective 
method, i.e. T2-mapping, both in the human and pig myocardium strongly supports 
our findings. 
In the experimental studies, the ROI for quantification of T2 relaxation time were 
placed in the entire wall thickness, then were carefully and individually adjusted by 
hand to avoid the right and left ventricular cavities. Therefore, ROI might include 
different myocardial states (i.e., IMH and/or MVO). We took this approach to mimic 
the histological water content evaluation, which was performed in the entire wall 
thickness, and because the differentiation of such small areas might be challenging. 
This might have contributed to the differences in absolute T2 relaxation time 
between our study and others taking a different approach to ROI selection.91, 95 In 
contrast, in the clinical study T2 maps were analyzed by placing different ROI at the 
transmural ischemic, infarcted (with or without including areas suggestive of IMH), 
salvage, and transmural remote areas in order to stratify myocardial edema 
according to the state of cardiomyocytes within the ischemic region. The different 
myocardial states were initially defined by the localization relative to late gadolinium 
enhanced defined infarction, as previously described by others.95 
Finally, it is fair to acknowledge that the limited sample of MI patients included in our 
clinical study and the fact that this is a first time ever-described phenomenon both 
in the preclinical and clinical setting warrants further confirmation in other 
experimental settings and larger clinical cohorts, ideally performed by external 
independent groups.
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5 CONCLUSIONS 
 
1. Post-myocardial infarction tissue composition is highly dynamic and can be 
characterized by cardiac magnetic resonance, which has been used to 
assess surrogate outcomes and efficacy endpoints in many experimental and 
clinical studies.  
 
2. Accounting for the temporal dynamics, pathophysiology and factors affecting 
post-myocardial infarction tissue composition might be crucial for a precise 
assessment of related imaging endpoints. However, to date this has not been 
studied in a comprehensive manner. 
 
3. Given its shorter acquisition time, high accuracy in quantifying T2 relaxation 
time and good correlation with actual myocardial water content, and no 
requirement for specific software for data acquisition or post-processing, fast 
T2 gradient-spin-echo mapping of the heart is an attractive alternative to 
current cardiac magnetic resonance methods for T2 and edema 
quantification. 
 
4. Contrary to the accepted view, it is shown for the first time that myocardial 
edema in the week after ischemia/reperfusion is a bimodal phenomenon. 
 
5. The initial wave of edema, appearing abruptly on reperfusion and dissipating 
at 24 hours, is directly secondary to the reperfusion process itself. The 
deferred wave of edema, appearing progressively days after 
ischemia/reperfusion and reaching a plateau between days 4 to 7, is mainly 
caused by tissue healing processes. 
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 6. The temporal dynamics and extent of post-myocardial infarction tissue 
composition changes seem to be greatly influenced by the timing of imaging, 
the application of cardioprotective interventions, the duration of the index 
ischemia, and the interplay between them. 
 
7. Consequently, the bimodal edematous response after myocardial infarction 
has a major impact on the retrospective delineation of myocardial area at risk 
and salvage quantification by cardiac magnetic resonance. 
 
8. These findings highlight the need for protocol standardization when using 
post-infarction imaging methods to measure relevant efficacy and prognostic 
endpoints in experimental and clinical studies. 
 
9. The timeframe between day 4 and 7 post-infarction seems a good 
compromise solution according to the translational data here presented. 
However, further studies and expert consensus are needed to stablish more 
precise recommendations. 
 
 
CONCLUSIONES 
 
1. La evolución de la composición del tejido miocárdico post-infarto es un 
proceso muy dinámico que se puede caracterizar mediante resonancia 
magnética cardíaca. Ello se ha utilizado para evaluar parámetros de eficacia 
terapéutica y pronósticos en multitud de estudios experimentales y clínicos. 
 
2. El conocimiento de la evolución temporal, fisiopatología y factores que 
influyen en la composición del tejido miocárdico post-infarto es clave para 
una evaluación precisa de dichos parámetros de eficacia y pronósticos. Sin 
embargo, esto no se ha estudiado previamente de una forma detallada. 
 
3. La secuencia de mapeo cardíaco T2 basada en el método spin eco de 
gradiente es una buena alternativa a las secuencias actuales de resonancia 
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 magnética cardíaca para la determinación del tiempo de relajación T2 y la 
cuantificación del edema miocárdico, dado que ofrecen una alta precisión en 
la cuantificación del tiempo de T2 y buena correlación con la cantidad de 
agua presente en el tejido al mismo tiempo que un menor tiempo de 
adquisición, y la ausencia de requerimientos técnicos específicos para la 
adquisición y post-procesado de las imágenes. 
 
4. Contrariamente a la visión establecida, se demuestra por primera vez que el 
edema miocárdico en la semana posterior al proceso de 
isquemia/reperfusión es un fenómeno bimodal. 
 
5. La onda de edema inicial, que aparece abruptamente tras la reperfusión y 
que se disipa alrededor de las 24 horas, está directamente relacionada con 
el propio proceso de reperfusión. La onda de edema posterior, que aparece 
progresivamente días después del proceso de isquemia/reperfusión y 
alcanza una meseta entre el día 4 al 7, está originada fundamentalmente por 
los procesos de cicatrización del tejido. 
 
6. La evolución temporal y la magnitud de los cambios en la composición tisular 
del miocardio post-infarto están muy influenciados por el momento temporal 
en que se evalúa al individuo, la duración de la isquemia, la utilización de 
estrategias cardioprotectoras, y la interacción entre estos factores.  
 
7. Como consecuencia, la evaluación retrospectiva del miocardio en riesgo y la 
cuantificación del área salvada mediante resonancia magnética cardíaca 
están muy afectadas por la respuesta edematosa bimodal post-infarto. 
 
8. Estos hallazgos ponen de relieve la necesidad de estandarizar los protocolos 
de imagen cardíaca cuyo objeto sea evaluar parámetros de eficacia 
terapéutica y pronósticos en estudios experimentales y clínicos. 
 
9. En base a los resultados translacionales que aquí se presentan, el período 
de tiempo comprendido entre el día 4 y el 7 después del infarto pudiera ser 
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 un buen momento para este fin. Sin embargo, se necesitan estudios 
adicionales y un consenso de expertos para establecer recomendaciones 
más precisas. 
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